{ "version": "2.2", "instance": { "nvs-20260630.htm nvs-20260630-99_2.htm": { "nsprefix": "nvs", "nsuri": "http://novartis.com/20260630", "dts": { "inline": { "local": [ "nvs-20260630-99_2.htm", "nvs-20260630.htm" ] }, "schema": { "local": [ "nvs-20260630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd", "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions-ea/rol_ifrs_ea-dim_2025-03-27.xsd", "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions/rol_full_ifrs-dim_2025-03-27.xsd", "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd", "https://xbrl.sec.gov/country/2025/country-2025.xsd", "https://xbrl.sec.gov/currency/2025/currency-2025.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd", "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd", "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" ] }, "calculationLink": { "local": [ "nvs-20260630_cal.xml" ] }, "definitionLink": { "local": [ "nvs-20260630_def.xml" ], "remote": [ "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions-ea/dim_ifrs_ea_2025-03-27_role-995000.xml", "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions/dim_full_ifrs_2025-03-27_role-995000.xml" ] }, "labelLink": { "local": [ "nvs-20260630_lab.xml" ] }, "presentationLink": { "local": [ "nvs-20260630_pre.xml" ] } }, "keyStandard": 165, "keyCustom": 85, "axisStandard": 14, "axisCustom": 8, "memberStandard": 22, "memberCustom": 87, "hidden": { "total": 6, "http://xbrl.sec.gov/dei/2025": 6 }, "contextCount": 710, "entityCount": 1, "segmentCount": 109, "elementCount": 1002, "unitCount": 5, "baseTaxonomies": { "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full": 1108, "http://xbrl.sec.gov/dei/2025": 8 }, "report": { "R1": { "role": "http://novartis.com/20260630/role/DocumentAndEntityInformation", "longName": "0001000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630.htm", "first": true, "unique": true } }, "R2": { "role": "http://novartis.com/20260630/role/StatementOfIncome", "longName": "1001000 - Statement - Consolidated income statements", "shortName": "Consolidated income statements", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "ifrs-full:RevenueFromSaleOfGoods", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true }, "uniqueAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "ifrs-full:CostOfSales", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "unique": true } }, "R3": { "role": "http://novartis.com/20260630/role/StatementOfComprehensiveIncome", "longName": "1002000 - Statement - Consolidated statements of comprehensive income", "shortName": "Consolidated statements of comprehensive income", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "ifrs-full:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true }, "uniqueAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "ifrs-full:OtherComprehensiveIncomeNetOfTaxCashFlowHedges", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "unique": true } }, "R4": { "role": "http://novartis.com/20260630/role/BalanceSheet", "longName": "1003000 - Statement - Consolidated balance sheets", "shortName": "Consolidated balance sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "Q_I-YTD-CurrentYear", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_I-YTD-CurrentYear", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R5": { "role": "http://novartis.com/20260630/role/StatementOfChangesInEquity", "longName": "1004000 - Statement - Consolidated statements of changes in equity", "shortName": "Consolidated statements of changes in equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "Q_I-CurrentYear-2", "name": "ifrs-full:Equity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear-1_ifrsfull-2025ComponentsOfEquityAxis_ifrsfull-2025NoncontrollingInterestsMember", "name": "ifrs-full:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "unique": true } }, "R6": { "role": "http://novartis.com/20260630/role/StatementsOfCashFlow", "longName": "1005000 - Statement - Consolidated cash flow statements", "shortName": "Consolidated cash flow statements", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "ifrs-full:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true }, "uniqueAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "ifrs-full:DividendsReceivedClassifiedAsOperatingActivities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "unique": true } }, "R7": { "role": "http://novartis.com/20260630/role/DisclosureBasisOfPreparationQ", "longName": "2010100 - Disclosure - Basis of preparation", "shortName": "Basis of preparation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R8": { "role": "http://novartis.com/20260630/role/DisclosureSelectedCriticalAccountingPoliciesQ", "longName": "2010200 - Disclosure - Selected critical accounting policies", "shortName": "Selected critical accounting policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R9": { "role": "http://novartis.com/20260630/role/DisclosureSignificantTransactionsQ", "longName": "2010300 - Disclosure - Significant transactions", "shortName": "Significant transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "nvs:DisclosureOfSignificantTransactionsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "nvs:DisclosureOfSignificantTransactionsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R10": { "role": "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersQ", "longName": "2010400 - Disclosure - Summary of equity attributable to Novartis AG shareholders", "shortName": "Summary of equity attributable to Novartis AG shareholders", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "nvs:DisclosureOfEquityTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "nvs:DisclosureOfEquityTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R11": { "role": "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsQ", "longName": "2010500 - Disclosure - Financial instruments", "shortName": "Financial instruments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R12": { "role": "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsQ", "longName": "2010600 - Disclosure - Details to the consolidated statements of cash flows", "shortName": "Details to the consolidated statements of cash flows", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R13": { "role": "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateQ", "longName": "2010700 - Disclosure - Legal proceedings update", "shortName": "Legal proceedings update", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "nvs:LegalProceedingsUpdateTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "nvs:LegalProceedingsUpdateTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R14": { "role": "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresQ", "longName": "2010800 - Disclosure - Operating segment", "shortName": "Operating segment", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R15": { "role": "http://novartis.com/20260630/role/DisclosureRevenuesAndGeographicInformationQ", "longName": "2010900 - Disclosure - Revenues and geographic information", "shortName": "Revenues and geographic information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:DisclosureOfRevenueExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:DisclosureOfRevenueExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R16": { "role": "http://novartis.com/20260630/role/OtherInterimDisclosuresQ", "longName": "2011000 - Disclosure - Other interim disclosures", "shortName": "Other interim disclosures", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "nvs:OtherInterimDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "nvs:OtherInterimDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R17": { "role": "http://novartis.com/20260630/role/DisclosureSubsequentEventsQ", "longName": "2011100 - Disclosure - Subsequent events", "shortName": "Subsequent events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R18": { "role": "http://novartis.com/20260630/role/DisclosureSelectedCriticalAccountingPoliciesPoliciesQ", "longName": "2020200 - Disclosure - Disclosure - Accounting policies (Policies)", "shortName": "Disclosure - Accounting policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "18", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R19": { "role": "http://novartis.com/20260630/role/DisclosureSignificantTransactionsTablesQ", "longName": "2030300 - Disclosure - Significant acquisition of businesses (Tables)", "shortName": "Significant acquisition of businesses (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "19", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "nvs:FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "nvs:FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R20": { "role": "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersTablesQ", "longName": "2030400 - Disclosure - Summary of equity attributable to Novartis AG shareholders (Tables)", "shortName": "Summary of equity attributable to Novartis AG shareholders (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "20", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "nvs:SummaryOfTreasurySharesMovementsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "nvs:DisclosureOfEquityTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "nvs:SummaryOfTreasurySharesMovementsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "nvs:DisclosureOfEquityTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R21": { "role": "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsTablesQ", "longName": "2030500 - Disclosure - Financial instruments (Tables)", "shortName": "Financial instruments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R22": { "role": "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsTablesQ", "longName": "2030600 - Disclosure - Details to the consolidated statements of cash flows (Tables)", "shortName": "Details to the consolidated statements of cash flows (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "nvs:AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "nvs:AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R23": { "role": "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresTablesQ", "longName": "2030900 - Disclosure - Revenues and geographic information (Tables)", "shortName": "Revenues and geographic information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "nvs:DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "ifrs-full:DisclosureOfRevenueExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "nvs:DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "ifrs-full:DisclosureOfRevenueExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R24": { "role": "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresTablesQ", "longName": "2031000 - Disclosure - Other interim disclosures (Tables)", "shortName": "Other interim disclosures (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "nvs:OtherInterimDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "nvs:OtherInterimDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R25": { "role": "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ", "longName": "2040300 - Disclosure - Significant acquisition of businesses (Details)", "shortName": "Significant acquisition of businesses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "Q_I-YTD-CurrentYear", "name": "ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-8", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true }, "uniqueAnchor": { "contextRef": "Q_D-February-27-2026_dei-2025LegalEntityAxis_nvs-2026Q2AvidityBiosciencesIncMember", "name": "ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-9", "ancestors": [ "div", "div", "nvs:DisclosureOfSignificantTransactionsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "unique": true } }, "R26": { "role": "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q", "longName": "2040301 - Disclosure - Significant acquisition of businesses (Details 2)", "shortName": "Significant acquisition of businesses (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "Q_I-YTD-CurrentYear", "name": "nvs:AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-8", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_I-YTD-CurrentYear", "name": "nvs:AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-8", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R27": { "role": "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "longName": "2040302 - Disclosure - Significant acquisition of businesses (Details 3)", "shortName": "Significant acquisition of businesses (Details 3)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "Q_I-YTD-CurrentYear", "name": "nvs:AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-8", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:IdentifiableNetAssetsAcquiredThroughAcquisitionsApplyingTheOptionalConcentrationTestTableTextBlock", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_I-YTD-CurrentYear", "name": "nvs:AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-8", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:IdentifiableNetAssetsAcquiredThroughAcquisitionsApplyingTheOptionalConcentrationTestTableTextBlock", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R28": { "role": "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q", "longName": "2040303 - Disclosure - Significant acquisition of businesses (Details 4)", "shortName": "Significant acquisition of businesses (Details 4)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "Q_I-CurrentYear-1", "name": "nvs:CashAndCashEquivalentsRecognisedAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-8", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:IdentifiableNetAssetsAcquiredThroughAcquisitionsApplyingTheOptionalConcentrationTestTableTextBlock", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true }, "uniqueAnchor": { "contextRef": "Q_I-May-27-2025_dei-2025LegalEntityAxis_nvs-2026Q2RegulusTherapeuticsInc.Member", "name": "nvs:CashOfferPerOutstandingShareForAcquisitionsApplyingTheOptionalConcentrationTest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "1", "ancestors": [ "div", "div", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "unique": true } }, "R29": { "role": "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ", "longName": "2040400 - Disclosure - Summary of equity attributable to Novartis AG shareholders (Details)", "shortName": "Summary of equity attributable to Novartis AG shareholders (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "Q_I-CurrentQuarter-1", "name": "ifrs-full:Equity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "nvs:NetDividendPaid", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-8", "ancestors": [ "div", "div", "div", "div", "nvs:DisclosureOfEquityTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "unique": true } }, "R30": { "role": "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetails1Q", "longName": "2040401 - Disclosure - Summary of equity attributable to Novartis AG shareholders (Details 2)", "shortName": "Summary of equity attributable to Novartis AG shareholders (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "Q_D-ShareTransaction-July-2025", "name": "nvs:MaximalAmountOfShareBuybackProgramm", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-8", "ancestors": [ "div", "div", "div", "div", "nvs:DisclosureOfEquityTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-ShareTransaction-July-2025", "name": "nvs:MaximalAmountOfShareBuybackProgramm", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-8", "ancestors": [ "div", "div", "div", "div", "nvs:DisclosureOfEquityTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R31": { "role": "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ", "longName": "2040500 - Disclosure - Financial instruments (Details)", "shortName": "Financial instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "Q_I-YTD-CurrentYear_ifrsfull-2025ClassesOfAssetsAxis_nvs-2026Q2AvailableforsaleFinancialInvestmentsMember_nvs-2026Q2GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2026Q2CashAndCashEquivalents1Member", "name": "ifrs-full:FinancialAssetsAtFairValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "div", "div", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_I-YTD-CurrentYear_ifrsfull-2025ClassesOfAssetsAxis_nvs-2026Q2AvailableforsaleFinancialInvestmentsMember_nvs-2026Q2GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2026Q2CashAndCashEquivalents1Member", "name": "ifrs-full:FinancialAssetsAtFairValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "div", "div", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R32": { "role": "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q", "longName": "2040501 - Disclosure - Financial instruments (Details 2)", "shortName": "Financial instruments (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "Q_I-YTD-CurrentYear_ifrsfull-2025MeasurementAxis_ifrsfull-2025RecurringFairValueMeasurementMember_nvs-2026Q2GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2026Q2CurrentFinancialLiabilitiesAtFairValueMember", "name": "ifrs-full:FinancialLiabilitiesAtFairValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "div", "div", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_I-YTD-CurrentYear_ifrsfull-2025MeasurementAxis_ifrsfull-2025RecurringFairValueMeasurementMember_nvs-2026Q2GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2026Q2CurrentFinancialLiabilitiesAtFairValueMember", "name": "ifrs-full:FinancialLiabilitiesAtFairValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "div", "div", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R33": { "role": "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q", "longName": "2040502 - Disclosure - Financial instruments (Details 3)", "shortName": "Financial instruments (Details 3)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:TransfersOutOfLevel3OfFairValueHierarchyAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "div", "ifrs-full:DescriptionOfReasonsForTransfersOutOfLevel3OfFairValueHierarchyAssets", "div", "div", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "ifrs-full:TransfersOutOfLevel3OfFairValueHierarchyAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "div", "ifrs-full:DescriptionOfReasonsForTransfersOutOfLevel3OfFairValueHierarchyAssets", "div", "div", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R34": { "role": "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ", "longName": "2040600 - Disclosure - Details to the consolidated statements of cash flows (Details)", "shortName": "Details to the consolidated statements of cash flows (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "nvs:AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock", "div", "div", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "nvs:AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock", "div", "div", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R35": { "role": "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails1Q", "longName": "2040601 - Disclosure - Details to the consolidated statements of cash flows (Details 2)", "shortName": "Details to the consolidated statements of cash flows (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "ifrs-full:AdjustmentsForDecreaseIncreaseInInventories", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:CashFlowsFromChangesInWorkingCapitalAndOtherOperatingItemsIncludedInOperatingCashFlowFromContinuingOperationsTableTextBlock", "div", "div", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "ifrs-full:AdjustmentsForDecreaseIncreaseInInventories", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:CashFlowsFromChangesInWorkingCapitalAndOtherOperatingItemsIncludedInOperatingCashFlowFromContinuingOperationsTableTextBlock", "div", "div", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R36": { "role": "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q", "longName": "2040602 - Disclosure - Details to the consolidated statements of cash flows (Details 3)", "shortName": "Details to the consolidated statements of cash flows (Details 3)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "nvs:CashFlowFromNetIdentifiableAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:CashFlowsArisingFromAcquisitionsAndDivestmentsOfBusinessesTableTextBlock", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "nvs:CashFlowFromNetIdentifiableAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:CashFlowsArisingFromAcquisitionsAndDivestmentsOfBusinessesTableTextBlock", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R37": { "role": "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails3Q", "longName": "2040603 - Disclosure - Details to the consolidated statements of cash flows (Details 4)", "shortName": "Details to the consolidated statements of cash flows (Details 4)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "nvs:AcquisitionsApplyingTheOptionalConcentrationTest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true }, "uniqueAnchor": null }, "R38": { "role": "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q", "longName": "2040700 - Disclosure - Legal proceedings update (Details)", "shortName": "Legal proceedings update (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "Q_I-YE2021_ifrsfull-2025GeographicalAreasAxis_country-2025GR_ifrsfull-2025SignificantInvestmentsInAssociatesAxis_nvs-2026Q2NovartisHellasS.A.C.I.MetamorphosisAthensMember", "name": "nvs:EstimatedFinancialEffectOfContingentLiabilitiesDamagesClaimed", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "div", "nvs:LegalProceedingsUpdateTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_I-YE2021_ifrsfull-2025GeographicalAreasAxis_country-2025GR_ifrsfull-2025SignificantInvestmentsInAssociatesAxis_nvs-2026Q2NovartisHellasS.A.C.I.MetamorphosisAthensMember", "name": "nvs:EstimatedFinancialEffectOfContingentLiabilitiesDamagesClaimed", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "div", "div", "nvs:LegalProceedingsUpdateTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R39": { "role": "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ", "longName": "2040900 - Disclosure - Revenues and geographic information (Details)", "shortName": "Revenues and geographic information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "ifrs-full:RevenueFromSaleOfGoods", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true }, "uniqueAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "nvs:RevenueFromSaleOfGoodsAsPercentOfTotalNetSales", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock", "div", "div", "ifrs-full:DisclosureOfRevenueExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "unique": true } }, "R40": { "role": "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "longName": "2040901 - Disclosure - Revenues and geographic information (Details 2)", "shortName": "Revenues and geographic information (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "ifrs-full:RevenueFromSaleOfGoods", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true }, "uniqueAnchor": { "contextRef": "Q_D-QoQ-CurrentYear_ifrsfull-2025ProductsAndServicesAxis_nvs-2026Q2VanrafiaMember_nvs-2026Q2CoreTherapeuticAreaAndEstablishedBrandsAxis_nvs-2026Q2CardiovascularRenalAndMetabolicMember", "name": "ifrs-full:RevenueFromSaleOfGoods", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:DisclosureOfOperatingSegmentsNetSalesTableTextBlock", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "unique": true } }, "R41": { "role": "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q", "longName": "2040902 - Disclosure - Revenues and geographic information - Top 20 (Details 3)", "shortName": "Revenues and geographic information - Top 20 (Details 3)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "ifrs-full:RevenueFromSaleOfGoods", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true }, "uniqueAnchor": { "contextRef": "Q_D-QoQ-CurrentYear_nvs-2026Q2ProductPortfolioAxis_nvs-2026Q2RestOfPortfolioMember", "name": "ifrs-full:RevenueFromSaleOfGoods", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "unique": true } }, "R42": { "role": "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails4Q", "longName": "2040903 - Disclosure - Revenues and geographic information (Details 4)", "shortName": "Revenues and geographic information (Details 4)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "nvs:ProfitSharingIncome", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "nvs:ProfitSharingIncome", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R43": { "role": "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ", "longName": "2041000 - Disclosure - Other interim disclosures (Details)", "shortName": "Other interim disclosures (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "Q_D-QoQ-CurrentYear-1_ifrsfull-2025CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2025AccumulatedDepreciationAmortisationAndImpairmentMember", "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory", "div", "div", "nvs:OtherInterimDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-QoQ-CurrentYear-1_ifrsfull-2025CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2025AccumulatedDepreciationAmortisationAndImpairmentMember", "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "div", "ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory", "div", "div", "nvs:OtherInterimDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R44": { "role": "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails1Q", "longName": "2041001 - Disclosure - Other interim disclosures (Details 2)", "shortName": "Other interim disclosures (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:DisclosureOfAdditionsExcludingTheImpactOfBusinessAcquisitionsTableTextBlock", "div", "div", "nvs:OtherInterimDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-QoQ-CurrentYear", "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:DisclosureOfAdditionsExcludingTheImpactOfBusinessAcquisitionsTableTextBlock", "div", "div", "nvs:OtherInterimDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R45": { "role": "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails2Q", "longName": "2041002 - Disclosure - Other interim disclosures (Details 3)", "shortName": "Other interim disclosures (Details 3)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "Q_I-YTD-CurrentYear_dei-2025LegalEntityAxis_nvs-2026Q2AvidityBiosciencesIncMember_ifrsfull-2025TypesOfInterestRatesAxis_ifrsfull-2025FloatingInterestRateMember_nvs-2026Q2OtherBorrowingsAxis_nvs-2026Q2BridgeLoan1Member", "name": "ifrs-full:OtherBorrowings", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-7", "ancestors": [ "div", "div", "div", "div", "nvs:OtherInterimDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_I-YTD-CurrentYear_dei-2025LegalEntityAxis_nvs-2026Q2AvidityBiosciencesIncMember_ifrsfull-2025TypesOfInterestRatesAxis_ifrsfull-2025FloatingInterestRateMember_nvs-2026Q2OtherBorrowingsAxis_nvs-2026Q2BridgeLoan1Member", "name": "ifrs-full:OtherBorrowings", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-7", "ancestors": [ "div", "div", "div", "div", "nvs:OtherInterimDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R46": { "role": "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q", "longName": "2041003 - Disclosure - Other interim disclosures (Details 4)", "shortName": "Other interim disclosures (Details 4)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "nvs:BondsIssuedInThePeriod", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:DisclosureOfDetailedInformationAboutBorrowingsTableTextBlock", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-YTD-CurrentYear", "name": "nvs:BondsIssuedInThePeriod", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:DisclosureOfDetailedInformationAboutBorrowingsTableTextBlock", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R47": { "role": "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails4Q", "longName": "2041004 - Disclosure - Other interim disclosures (Details 5)", "shortName": "Other interim disclosures (Details 5)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "Q_I-YTD-CurrentYear", "name": "ifrs-full:ContractualCommitmentsForAcquisitionOfIntangibleAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:DisclosureOfLeasingCommitmentsTableTextBlock", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_I-YTD-CurrentYear", "name": "ifrs-full:ContractualCommitmentsForAcquisitionOfIntangibleAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "div", "td", "tr", "table", "div", "div", "nvs:DisclosureOfLeasingCommitmentsTableTextBlock", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } }, "R48": { "role": "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails5Q", "longName": "2041005 - Disclosure - Other interim disclosures (Details 6)", "shortName": "Other interim disclosures (Details 6)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "Q_D-July-5-2026_dei-2025LegalEntityAxis_nvs-2026Q2MyricxBioMember", "name": "nvs:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPaymentForAcquisitionsApplyingTheOptionalConcentrationTest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-8", "ancestors": [ "div", "div", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Q_D-July-5-2026_dei-2025LegalEntityAxis_nvs-2026Q2MyricxBioMember", "name": "nvs:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPaymentForAcquisitionsApplyingTheOptionalConcentrationTest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-8", "ancestors": [ "div", "div", "div", "div", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "nvs-20260630-99_2.htm", "first": true, "unique": true } } }, "tag": { "nvs_A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "0.25% CHF 500 million bond 2015/2025 of Novartis AG Basel Switzerland, issued at 100.64% [member]" } } }, "auth_ref": [] }, "nvs_A1.600CHF650MillionBond2027OfNovartisAGBaselSwitzerlandIssuedAt100.138Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "A1.600CHF650MillionBond2027OfNovartisAGBaselSwitzerlandIssuedAt100.138Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "1.600% CHF 650 million bond 2027 of Novartis AG Basel Switzerland, issued at 100.138% [member]" } } }, "auth_ref": [] }, "nvs_A1.650CHF435MillionBond2031OfNovartisAGBaselSwitzerlandIssuedAt100.148Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "A1.650CHF435MillionBond2031OfNovartisAGBaselSwitzerlandIssuedAt100.148Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "1.650% CHF 435 million bond 2031 of Novartis AG Basel Switzerland, issued at 100.148% [member]" } } }, "auth_ref": [] }, "nvs_A1.750CHF645MillionBond2034OfNovartisAGBaselSwitzerlandIssuedAt100.229Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "A1.750CHF645MillionBond2034OfNovartisAGBaselSwitzerlandIssuedAt100.229Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "1.750% CHF 645 million bond 2034 of Novartis AG Basel Switzerland, issued at 100.229% [member]" } } }, "auth_ref": [] }, "nvs_A1.750USD1000Million20202025NovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.852Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "A1.750USD1000Million20202025NovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.852Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "1.750% USD 1 000 million 2020/2025 Novartis Capital Corporation, New York, United States, issued at 99.852% [member]" } } }, "auth_ref": [] }, "nvs_A1.850CHF190MillionBond2049OfNovartisAGBaselSwitzerlandIssuedAt100.149Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "A1.850CHF190MillionBond2049OfNovartisAGBaselSwitzerlandIssuedAt100.149Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "1.850% CHF 190 million bond 2049 of Novartis AG Basel Switzerland, issued at 100.149% [member]" } } }, "auth_ref": [] }, "nvs_A1.850CHF280MillionBond2040OfNovartisAGBaselSwitzerlandIssuedAt100.268Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "A1.850CHF280MillionBond2040OfNovartisAGBaselSwitzerlandIssuedAt100.268Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "1.850% CHF 280 million bond 2040 of Novartis AG Basel Switzerland, issued at 100.268% [member]" } } }, "auth_ref": [] }, "nvs_A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "3.0% USD 1 750 million bond 2015/2025 of Novartis Capital Corporation, New York United States, issued at 99.010% [member]" } } }, "auth_ref": [] }, "nvs_A3.100EUR600Million20262032OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.525Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "A3.100EUR600Million20262032OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.525Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "3.100% EUR 600 million 2026/2032 of Novartis Finance S.A., Luxembourg, Luxembourg issued at 99.525% [member]" } } }, "auth_ref": [] }, "nvs_A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "3.4% USD 2 150 million bond 2014/2025 of Novartis Capital Corporation, New York United States, issued at 99.287% [member]" } } }, "auth_ref": [] }, "nvs_A3.500EUR600Million20262035OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.757Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "A3.500EUR600Million20262035OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.757Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "3.500% EUR 600 million 2026/2035 of Novartis Finance S.A., Luxembourg, Luxembourg issued at 99.757% [member]" } } }, "auth_ref": [] }, "nvs_A4.000EUR500Million20262041OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.833Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "A4.000EUR500Million20262041OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.833Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "4.000% EUR 500 million 2026/2041 of Novartis Finance S.A., Luxembourg, Luxembourg issued at 99.833% [member]" } } }, "auth_ref": [] }, "nvs_A4.100USD1250Million20262029NovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.883Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "A4.100USD1250Million20262029NovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.883Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "4.100% USD 1 250 million 2026/2029 Novartis Capital Corporation, New York, United States, issued at 99.883% [member]" } } }, "auth_ref": [] }, "nvs_A4.400USD1750Million20262031NovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.960Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "A4.400USD1750Million20262031NovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.960Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "4.400% USD 1 750 million 2026/2031 Novartis Capital Corporation, New York, United States, issued at 99.960% [member]" } } }, "auth_ref": [] }, "nvs_A4.600USD2000Million20262033NovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.574Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "A4.600USD2000Million20262033NovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.574Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "4.600% USD 2 000 million 2026/2033 Novartis Capital Corporation, New York, United States, issued at 99.574% [member]" } } }, "auth_ref": [] }, "nvs_A4.900USD2250Million20262036NovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.719Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "A4.900USD2250Million20262036NovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.719Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "4.900% USD 2 250 million 2026/2036 Novartis Capital Corporation, New York, United States, issued at 99.719% [member]" } } }, "auth_ref": [] }, "nvs_A5.600USD1000Million20262046NovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.536Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "A5.600USD1000Million20262046NovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.536Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "5.600% USD 1 000 million 2026/2046 Novartis Capital Corporation, New York, United States, issued at 99.536% [member]" } } }, "auth_ref": [] }, "nvs_A5.700USD2250Million20262056NovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.120Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "A5.700USD2250Million20262056NovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.120Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "5.700% USD 2 250 million 2026/2056 Novartis Capital Corporation, New York, United States, issued at 99.120% [member]" } } }, "auth_ref": [] }, "nvs_AccrualForTaxesDifferentThanIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "AccrualForTaxesDifferentThanIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails": { "parentTag": "ifrs-full_OtherCurrentNonfinancialLiabilities", "weight": 1.0, "order": 1.0 } }, "lang": { "en-us": { "role": { "label": "Accrual for taxes other than income taxes, current", "terseLabel": "Accrual for taxes other than income taxes" } } }, "auth_ref": [] }, "ifrs-full_AccrualsClassifiedAsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AccrualsClassifiedAsCurrent", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails": { "parentTag": "ifrs-full_OtherCurrentNonfinancialLiabilities", "weight": 1.0, "order": 3.0 } }, "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses", "label": "Accruals classified as current" } }, "en": { "role": { "documentation": "The amount of accruals classified as current. [Refer: Accruals]" } } }, "auth_ref": [ "r414" ] }, "nvs_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AccruedInterestOnDebtSecuritiesAndTimeDepositsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Accrued interest on debt securities and time deposits [member]" } } }, "auth_ref": [] }, "nvs_AccruedRoyaltiesPayableClassifiedAsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "AccruedRoyaltiesPayableClassifiedAsCurrent", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails": { "parentTag": "ifrs-full_OtherCurrentNonfinancialLiabilities", "weight": 1.0, "order": 4.0 } }, "lang": { "en-us": { "role": { "label": "Accrued royalties payable classified as current", "terseLabel": "Accruals for royalties" } } }, "auth_ref": [] }, "ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AccumulatedDepreciationAmortisationAndImpairmentMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Accumulated depreciation, amortisation and impairment [member]", "terseLabel": "Accumulated depreciation, amortisation and impairment" } } }, "auth_ref": [ "r5", "r13", "r50", "r60", "r63", "r215", "r237", "r245", "r248" ] }, "nvs_AcquiredCash": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "AcquiredCash", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Acquired cash" } } }, "auth_ref": [] }, "nvs_AcquiredCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "AcquiredCashAndCashEquivalents", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Acquired cash and cash equivalents", "negatedTerseLabel": "Acquired cash and cash equivalents" } } }, "auth_ref": [] }, "nvs_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Acquired research and development intangible assets recognised as of acquisition date", "terseLabel": "In-procees research and development" } } }, "auth_ref": [] }, "nvs_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDateMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDateMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Acquired research and development intangible assets recognised as of acquisition date [member]", "terseLabel": "Acquired research and development intangible assets recognised as of acquisition date" } } }, "auth_ref": [] }, "nvs_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Acquired research and development intangible assets recognised as of acquisition date through acquisitions applying the optional concentration test", "terseLabel": "In-process research and development assets recognised as of acquisition date through acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "nvs_AcquiredResearchAndDevelopmentMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AcquiredResearchAndDevelopmentMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Acquired research and development [member]", "terseLabel": "Acquired research and development" } } }, "auth_ref": [] }, "nvs_AcquisitionCommitmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "AcquisitionCommitmentsAbstract", "lang": { "en-us": { "role": { "label": "Acquisition commitments [abstract]" } } }, "auth_ref": [] }, "nvs_AcquisitionCommitmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "AcquisitionCommitmentsLineItems", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails5Q" ], "lang": { "en-us": { "role": { "label": "Acquisition commitments [line items]" } } }, "auth_ref": [] }, "nvs_AcquisitionCommitmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "AcquisitionCommitmentsTable", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails5Q" ], "lang": { "en-us": { "role": { "label": "Acquisition commitments [table]" } } }, "auth_ref": [] }, "nvs_AcquisitionFairValuePotentiallyRefundableContingentConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "AcquisitionFairValuePotentiallyRefundableContingentConsideration", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Fair value of potentially refundable contingent consideration" } } }, "auth_ref": [] }, "nvs_AcquisitionOfAssetsIntangibleAssetsOtherThanGoodwillByAssumingDirectlyRelatedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "AcquisitionOfAssetsIntangibleAssetsOtherThanGoodwillByAssumingDirectlyRelatedLiabilities", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Acquisition of assets (other than through business combinations) by assuming directly related liabilities" } } }, "auth_ref": [] }, "nvs_AcquisitionOfAssetsRightOfUseAssetsThroughLeasing": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "AcquisitionOfAssetsRightOfUseAssetsThroughLeasing", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Acquisition of assets (right of use assets) through leasing" } } }, "auth_ref": [] }, "ifrs-full_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Acquisition-date fair value of equity interest in acquiree held by acquirer immediately before acquisition date", "negatedTerseLabel": "Fair value of previously held equity interests", "terseLabel": "Fair value of previously held equity interests" } }, "en": { "role": { "documentation": "The acquisition-date fair value of equity interest in the acquiree held by the acquirer immediately before the acquisition date in a business combination achieved in stages. [Refer: Total for all business combinations [member]]" } } }, "auth_ref": [ "r148" ] }, "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Consideration transferred, acquisition-date fair value", "negatedTerseLabel": "Total purchase consideration for business combinations", "verboseLabel": "Net assets recognized as a result of acquistions of businesses" } }, "en": { "role": { "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Total for all business combinations [member]]" } } }, "auth_ref": [ "r143", "r253" ] }, "nvs_AcquisitionsAndDivestmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "AcquisitionsAndDivestmentsAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q", "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Acquisitions and divestments [axis]" } } }, "auth_ref": [] }, "nvs_AcquisitionsAndDivestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AcquisitionsAndDivestmentsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q", "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Acquisitions and divestments [member]" } } }, "auth_ref": [] }, "nvs_AcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "AcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": -1.0, "order": 3.6 } }, "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails3Q", "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Acquisitions applying the optional concentration test", "negatedTerseLabel": "Acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "nvs_AcquisitionsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AcquisitionsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q", "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Acquisitions [member]", "terseLabel": "Acquisitions" } } }, "auth_ref": [] }, "nvs_AcquisitionsThroughFinanceLeaseContractsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "AcquisitionsThroughFinanceLeaseContractsPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Acquisitions through finance lease contracts property plant and equipment" } } }, "auth_ref": [] }, "nvs_AdakveoMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AdakveoMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Adakveo [member]" } } }, "auth_ref": [] }, "nvs_AdditionalAmountOfSettlementInPrinciple": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "AdditionalAmountOfSettlementInPrinciple", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Additional amount of settlement in principle" } } }, "auth_ref": [] }, "nvs_AdditionalBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "AdditionalBorrowings", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Additional borrowings" } } }, "auth_ref": [] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails1Q" ], "lang": { "en-us": { "role": { "label": "Additions other than through business combinations, intangible assets other than goodwill", "terseLabel": "Additions", "verboseLabel": "Additions to intangible assets and goodwill" } }, "en": { "role": { "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r51", "r238" ] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails1Q" ], "lang": { "en-us": { "role": { "label": "Additions other than through business combinations, property, plant and equipment", "terseLabel": "Additions", "verboseLabel": "Additions to property, plant and equipment" } }, "en": { "role": { "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]" } } }, "auth_ref": [ "r6", "r216" ] }, "ifrs-full_AdditionsToRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdditionsToRightofuseAssets", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails1Q" ], "lang": { "en-us": { "role": { "label": "Additions to right-of-use assets" } }, "en": { "role": { "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]" } } }, "auth_ref": [ "r131", "r189" ] }, "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AddressTypeDomain", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Address Type [Domain]", "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "ifrs-full_AdjustedWeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustedWeightedAverageShares", "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Adjusted weighted average number of ordinary shares outstanding", "terseLabel": "Weighted average number of shares in diluted earnings per share" } }, "en": { "role": { "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r37" ] }, "nvs_AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Adjustment for change in provisions and other non-current liabilities", "terseLabel": "Change in provisions and other non-current liabilities" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInInventories", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Adjustments for decrease (increase) in inventories", "terseLabel": "(Increase)/decrease in inventories" } } }, "auth_ref": [ "r399" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInOtherAssets", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails1Q" ], "lang": { "en-us": { "role": { "terseLabel": "Change in other current and non-current assets", "label": "Adjustments for decrease (increase) in other assets" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]" } } }, "auth_ref": [ "r401" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Adjustments for decrease (increase) in trade accounts receivable", "terseLabel": "Increase/(decrease) in trade receivables" } } }, "auth_ref": [ "r399" ] }, "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss" } } }, "auth_ref": [ "r401" ] }, "ifrs-full_AdjustmentsForFinanceIncomeCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForFinanceIncomeCost", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Adjustments for finance income (cost)", "terseLabel": "Net financial expense", "negatedTerseLabel": "Net financial expense" } } }, "auth_ref": [ "r401" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails1Q" ], "lang": { "en-us": { "role": { "terseLabel": "Change in provisions and other current liabilities", "label": "Adjustments for increase (decrease) in other current liabilities" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in other current liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other current liabilities; Profit (loss)]" } } }, "auth_ref": [ "r401" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Adjustments for decrease (increase) in trade accounts payable", "terseLabel": "(Decrease)/increase in trade payables" } } }, "auth_ref": [ "r399" ] }, "ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Adjustments for losses (gains) on disposal of non-current assets", "terseLabel": "(Gains)/losses on disposal on property, plant and equipment; intangible assets; and other adjustments on financial assets; and other non-current assets, net" } } }, "auth_ref": [ "r396" ] }, "nvs_AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://novartis.com/20260630", "localname": "AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsTablesQ" ], "lang": { "en-us": { "role": { "label": "Adjustments for non-cash items from continuing operations [table text block]", "terseLabel": "Adjustments for non-cash items from continuing operations" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForReconcileProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForReconcileProfitLoss", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlowCalc2": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ", "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Reversal of non-cash items and other adjustments", "totalLabel": "Total reversal of non-cash items", "label": "Adjustments to reconcile profit (loss)", "verboseLabel": "Total" } } }, "auth_ref": [ "r66" ] }, "ifrs-full_AdjustmentsForSharebasedPayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AdjustmentsForSharebasedPayments", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Adjustment for share based payments", "terseLabel": "Equity-settled compensation plans" } } }, "auth_ref": [ "r400" ] }, "nvs_AdmuneTheraputicsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AdmuneTheraputicsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Admune Theraputics [member]", "terseLabel": "Admune Theraputics" } } }, "auth_ref": [] }, "nvs_AdvancedAcceleratorApplicationsAAAMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AdvancedAcceleratorApplicationsAAAMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Advanced Accelerator Applications (AAA) [member]", "terseLabel": "Advanced Accelerator Applications (AAA)" } } }, "auth_ref": [] }, "nvs_AfinitorVotubiaMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AfinitorVotubiaMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Afinitor/Votubia [member]" } } }, "auth_ref": [] }, "ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AggregateContinuingAndDiscontinuedOperationsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails1Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ", "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Aggregate continuing and discontinued operations [member]" } }, "en": { "role": { "documentation": "This member stands for the aggregate of continuing and discontinued operations. [Refer: Discontinued operations [member]; Continuing operations, unless line item indicates otherwise [member]]" } } }, "auth_ref": [ "r159" ] }, "nvs_AimovigMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AimovigMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "Aimovig [member]" } } }, "auth_ref": [] }, "nvs_AlconBrandNameMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AlconBrandNameMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Alcon brand name [member]", "verboseLabel": "Alcon brand name" } } }, "auth_ref": [] }, "nvs_AlconMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AlconMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q", "http://novartis.com/20260630/role/DisclosureOperatingSegmentsQ", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Alcon [member]", "terseLabel": "Alcon" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentFlag", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "nvs_AmericanDepositarySharesEachRepresenting1ShareMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AmericanDepositarySharesEachRepresenting1ShareMember", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "American Depositary Shares each representing 1 share [member]", "terseLabel": "American Depositary Shares each representing 1 share" } } }, "auth_ref": [] }, "nvs_AmiodaroneMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AmiodaroneMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Amiodarone [member]" } } }, "auth_ref": [] }, "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AmortisationIntangibleAssetsOtherThanGoodwill", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Amortisation, intangible assets other than goodwill", "terseLabel": "Amortization charge", "negatedTerseLabel": "Intangible assets amortization charge" } } }, "auth_ref": [ "r53", "r240" ] }, "nvs_AmountOfResolvedAction": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "AmountOfResolvedAction", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Amount of resolved action" } } }, "auth_ref": [] }, "nvs_AmountOfSettlementInPrinciple": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "AmountOfSettlementInPrinciple", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Amount of settlement in principle" } } }, "auth_ref": [] }, "nvs_AmountOfShareBuybackProgrammRelatedToIrrevocableNondiscretionaryArangement": { "xbrltype": "sharesItemType", "nsuri": "http://novartis.com/20260630", "localname": "AmountOfShareBuybackProgrammRelatedToIrrevocableNondiscretionaryArangement", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetails1Q" ], "lang": { "en-us": { "role": { "label": "Amount of share buyback programm related to irrevocable, non-discretionary arangement" } } }, "auth_ref": [] }, "nvs_AmountRecordedInEquityRelatedToHyperinflation": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "AmountRecordedInEquityRelatedToHyperinflation", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetails1Q" ], "lang": { "en-us": { "role": { "label": "Amount recorded in equity related to hyperinflation" } } }, "auth_ref": [] }, "ifrs-full_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedAbstract", "lang": { "en-us": { "role": { "label": "Amounts recognised as of acquisition date for each major class of assets acquired and liabilities assumed [abstract]" } } }, "auth_ref": [] }, "nvs_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Amounts recognised as of acquisition date for each major class of assets acquired and liabilities assumed [line items]" } } }, "auth_ref": [] }, "nvs_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedTable": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedTable", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Amounts recognised as of acquisition date for each major class of assets acquired and liabilities assumed [table]" } } }, "auth_ref": [] }, "nvs_AnthosTherapeuticsInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AnthosTherapeuticsInc.Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Anthos Therapeutics Inc. [member]", "terseLabel": "Anthos Therapeutics Inc." } } }, "auth_ref": [] }, "ifrs-full_ApplicableTaxRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ApplicableTaxRate", "calculation": { "http://novartis.com/20260630/role/DisclosureTaxesDetails3": { "parentTag": "ifrs-full_AverageEffectiveTaxRate", "weight": 1.0, "order": 1.0 } }, "lang": { "en-us": { "role": { "terseLabel": "Applicable tax rate from discontinued operations", "label": "Applicable tax rate" } }, "en": { "role": { "documentation": "The applicable income tax rate." } } }, "auth_ref": [ "r3", "r213" ] }, "nvs_AsiaAfricaAustralasiaMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AsiaAfricaAustralasiaMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Asia/Africa/Australasia [member]" } } }, "auth_ref": [] }, "nvs_AspenGlobalIncorporatedMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AspenGlobalIncorporatedMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Aspen Global Incorporated [member]", "terseLabel": "Aspen Global Incorporated" } } }, "auth_ref": [] }, "ifrs-full_Assets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Assets", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Assets", "totalLabel": "Total assets" } }, "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r118", "r119", "r121", "r173", "r176", "r267", "r268", "r304" ] }, "ifrs-full_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AssetsAbstract", "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Assets [abstract]" } } }, "auth_ref": [] }, "ifrs-full_AssetsAndLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AssetsAndLiabilitiesAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Assets and liabilities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r17", "r209", "r223", "r274", "r290" ] }, "ifrs-full_AssetsAndLiabilitiesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AssetsAndLiabilitiesDomain", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Assets and liabilities [domain]" } }, "en": { "role": { "documentation": "This member stands for assets and liabilities. It also represents the standard value for the 'Assets and liabilities' axis if no other member is used. [Refer: Assets; Liabilities]" } } }, "auth_ref": [ "r17", "r209", "r223", "r274", "r290" ] }, "ifrs-full_AssetsOtherThanCashOrCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AssetsOtherThanCashOrCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Assets other than cash or cash equivalents in subsidiary or businesses acquired or disposed", "terseLabel": "Non-current assets divested" } }, "en": { "role": { "documentation": "The amount of assets, other than cash or cash equivalents, in subsidiaries or other businesses over which control is obtained or lost. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r76" ] }, "nvs_AssociatedCompaniesAtFairValueThroughProfitAndLossMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AssociatedCompaniesAtFairValueThroughProfitAndLossMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Associated companies at fair value through profit and loss [member]" } } }, "auth_ref": [] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditorFirmId", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r383", "r384", "r385" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditorLocation", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r383", "r384", "r385" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditorName", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r383", "r384", "r385" ] }, "nvs_AvailableforsaleFinancialInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AvailableforsaleFinancialInvestmentsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Available-for-sale financial investments [member]" } } }, "auth_ref": [] }, "nvs_AveXisIncMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AveXisIncMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "AveXis, Inc. [member]", "terseLabel": "AveXis, Inc." } } }, "auth_ref": [] }, "ifrs-full_AverageEffectiveTaxRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "AverageEffectiveTaxRate", "calculation": { "http://novartis.com/20260630/role/DisclosureTaxesDetails3": { "parentTag": null, "weight": null, "order": null, "root": true } }, "lang": { "en-us": { "role": { "totalLabel": "Effective tax rate from continuing operations", "label": "Average effective tax rate" } }, "en": { "role": { "documentation": "The tax expense (income) divided by the accounting profit. [Refer: Accounting profit]" } } }, "auth_ref": [ "r3", "r213" ] }, "nvs_AvidityBiosciencesIncMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "AvidityBiosciencesIncMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Avidity Biosciences, Inc. [member]", "terseLabel": "Avidity Biosciences, Inc." } } }, "auth_ref": [] }, "nvs_BalanceSheetItemAxis": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "BalanceSheetItemAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Balance sheet item [axis]" } } }, "auth_ref": [] }, "nvs_BalanceSheetItemMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "BalanceSheetItemMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Balance sheet item [member]" } } }, "auth_ref": [] }, "ifrs-full_BasicEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BasicEarningsLossPerShare", "calculation": { "http://novartis.com/20260630/role/DisclosureEarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Basic earnings (loss) per share", "totalLabel": "Total basic earnings per share", "terseLabel": "Basic earnings per share" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } } }, "auth_ref": [ "r34", "r35" ] }, "ifrs-full_BasicEarningsLossPerShareFromContinuingOperations": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BasicEarningsLossPerShareFromContinuingOperations", "calculation": { "http://novartis.com/20260630/role/DisclosureEarningsPerShareDetails": { "parentTag": "ifrs-full_BasicEarningsLossPerShare", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Basic earnings (loss) per share from continuing operations", "terseLabel": "Basic earnings per share, Continuing operations", "verboseLabel": "Continuing operations" } }, "en": { "role": { "documentation": "Basic earnings (loss) per share from continuing operations. [Refer: Basic earnings (loss) per share; Continuing operations, unless line item indicates otherwise [member]]" } } }, "auth_ref": [ "r34", "r35" ] }, "ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BasicEarningsLossPerShareFromDiscontinuedOperations", "calculation": { "http://novartis.com/20260630/role/DisclosureEarningsPerShareDetails": { "parentTag": "ifrs-full_BasicEarningsLossPerShare", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Basic earnings (loss) per share from discontinued operations", "terseLabel": "Basic earnings per share, Discontinued operations", "verboseLabel": "Discontinued operations" } }, "en": { "role": { "documentation": "Basic earnings (loss) per share from discontinued operations. [Refer: Basic earnings (loss) per share; Discontinued operations [member]]" } } }, "auth_ref": [ "r35", "r36" ] }, "ifrs-full_BasicEarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BasicEarningsPerShareAbstract", "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Basic earnings per share [abstract]" } } }, "auth_ref": [] }, "nvs_BasisOfPreparationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "BasisOfPreparationAbstract", "lang": { "en-us": { "role": { "label": "Basis of preparation [abstract]" } } }, "auth_ref": [] }, "nvs_BeovuMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "BeovuMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "Beovu [member]" } } }, "auth_ref": [] }, "ifrs-full_BondsIssued": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BondsIssued", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureNonCurrentFinancialDebtDetails": { "parentTag": "ifrs-full_Borrowings", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails2Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "terseLabel": "Straight bonds", "label": "Bonds issued" } }, "en": { "role": { "documentation": "The amount of bonds issued by the entity." } } }, "auth_ref": [ "r410" ] }, "nvs_BondsIssuedInThePeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "BondsIssuedInThePeriod", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Bonds issued in the period" } } }, "auth_ref": [] }, "ifrs-full_BorrowingCostsCapitalised": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BorrowingCostsCapitalised", "calculation": { "http://novartis.com/20260630/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails": { "parentTag": "ifrs-full_InterestExpense", "weight": 1.0, "order": 4.0 } }, "lang": { "en-us": { "role": { "label": "Borrowing costs capitalised", "terseLabel": "Capitalized borrowing costs" } }, "en": { "role": { "documentation": "The amount of interest and other costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset." } } }, "auth_ref": [ "r18", "r224" ] }, "ifrs-full_Borrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Borrowings", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureNonCurrentFinancialDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "terseLabel": "Total including current portion of non-current financial debt", "label": "Borrowings", "verboseLabel": "The amount of outstanding funds that the entity is obligated to repay", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of outstanding funds that the entity is obligated to repay." } } }, "auth_ref": [ "r412" ] }, "ifrs-full_BorrowingsAdjustmentToInterestRateBasis": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BorrowingsAdjustmentToInterestRateBasis", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Borrowings, adjustment to interest rate basis" } }, "en": { "role": { "documentation": "The adjustment to the basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r407" ] }, "ifrs-full_BorrowingsByNameAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BorrowingsByNameAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Borrowings by name [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r407" ] }, "ifrs-full_BorrowingsByNameDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BorrowingsByNameDomain", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Borrowings by name [domain]" } }, "en": { "role": { "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]" } } }, "auth_ref": [ "r407" ] }, "nvs_BorrowingsCreditFacilityCommitted": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "BorrowingsCreditFacilityCommitted", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Borrowings credit facility committed" } } }, "auth_ref": [] }, "nvs_BorrowingsEURMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "BorrowingsEURMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Borrowings, EUR [member]" } } }, "auth_ref": [] }, "ifrs-full_BorrowingsInterestRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BorrowingsInterestRate", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Borrowings, interest rate", "terseLabel": "Interest rate on borrowings for new additions", "verboseLabel": "Borrowings, coupon" } }, "en": { "role": { "documentation": "The interest rate on borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r407" ] }, "ifrs-full_BorrowingsInterestRateBasis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BorrowingsInterestRateBasis", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails2Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Borrowings, interest rate basis" } }, "en": { "role": { "documentation": "The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r407" ] }, "nvs_BorrowingsInterestRateStepUp": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "BorrowingsInterestRateStepUp", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Borrowings interest rate step up", "terseLabel": "dup_1_Straight bonds" } } }, "auth_ref": [] }, "nvs_BorrowingsIssuanceDate": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "BorrowingsIssuanceDate", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Borrowings, issuance date", "terseLabel": "Borrowings, issuance year" } } }, "auth_ref": [] }, "nvs_BorrowingsLender": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "BorrowingsLender", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Borrowings, lender", "terseLabel": "Borrowings, issuer" } } }, "auth_ref": [] }, "ifrs-full_BorrowingsMaturity": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BorrowingsMaturity", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Borrowings, maturity", "terseLabel": "Borrowings, maturity year" } }, "en": { "role": { "documentation": "The maturity of borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r407" ] }, "ifrs-full_BorrowingsOriginalCurrency": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BorrowingsOriginalCurrency", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Borrowings, original currency" } }, "en": { "role": { "documentation": "The currency in which the borrowings are denominated. [Refer: Borrowings]" } } }, "auth_ref": [ "r407" ] }, "nvs_BorrowingsPremiumDiscount": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "BorrowingsPremiumDiscount", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Borrowings, premium discount", "terseLabel": "Borrowings, issue price" } } }, "auth_ref": [] }, "nvs_BorrowingsUSDMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "BorrowingsUSDMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Borrowings, USD [member]" } } }, "auth_ref": [] }, "nvs_BrandsAxis": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "BrandsAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Brands [axis]" } } }, "auth_ref": [] }, "nvs_BrandsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "BrandsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Brands [member]" } } }, "auth_ref": [] }, "nvs_BridgeLoan1Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "BridgeLoan1Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Bridge loan [member]" } } }, "auth_ref": [] }, "nvs_BusinessCombinationStepAcquisitionEquityInterestInAcquireeHoldingPercentage": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeHoldingPercentage", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage", "terseLabel": "Divested interest in associate" } } }, "auth_ref": [] }, "ifrs-full_BusinessCombinationsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BusinessCombinationsAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Business combinations [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r151", "r257" ] }, "ifrs-full_BusinessCombinationsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "BusinessCombinationsDomain", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Business combinations [domain]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used." } } }, "auth_ref": [ "r151", "r153", "r257" ] }, "dei_BusinessContactMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "BusinessContactMember", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Business Contact [Member]", "documentation": "Business contact for the entity" } } }, "auth_ref": [ "r384", "r385" ] }, "country_CA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2025", "localname": "CA", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "CANADA", "terseLabel": "Canada" } } }, "auth_ref": [] }, "nvs_COPDMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "COPDMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "COPD [member]" } } }, "auth_ref": [] }, "nvs_CSLMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "CSLMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "CSL [member]", "terseLabel": "CSL" } } }, "auth_ref": [] }, "nvs_CanadaAndLatinAmericaMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "CanadaAndLatinAmericaMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Canada and Latin America [member]" } } }, "auth_ref": [] }, "nvs_CardiovascularRenalAndMetabolicMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "CardiovascularRenalAndMetabolicMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Cardiovascular, renal and metabolic [member]" } } }, "auth_ref": [] }, "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r5", "r10", "r50", "r54", "r59", "r60", "r61", "r62", "r63", "r152", "r163", "r164", "r215", "r220", "r237", "r241", "r244", "r245", "r246", "r247", "r248", "r258", "r261", "r262" ] }, "ifrs-full_CarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CarryingAmountMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Carrying amount [member]" } } }, "auth_ref": [ "r10", "r54", "r59", "r61", "r62", "r152", "r163", "r164", "r220", "r241", "r244", "r246", "r247", "r258", "r261", "r262" ] }, "nvs_CarryingReportedAmountFairValueDisclosure1Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "CarryingReportedAmountFairValueDisclosure1Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Carrying reported amount fair value disclosure [member]", "terseLabel": "Balance sheet" } } }, "auth_ref": [] }, "nvs_CarryingValueOfTheDivestedBusiness": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CarryingValueOfTheDivestedBusiness", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Carrying value of the divested business" } } }, "auth_ref": [] }, "ifrs-full_Cash": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Cash", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureMarketableSecuritiesDetails2": { "parentTag": "ifrs-full_CashAndCashEquivalents", "weight": 1.0, "order": 1.0 } }, "lang": { "en-us": { "role": { "terseLabel": "Current accounts", "label": "Cash" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]" } } }, "auth_ref": [ "r403" ] }, "nvs_CashAcquiredMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "CashAcquiredMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Cash acquired [member]", "terseLabel": "Cash acquired" } } }, "auth_ref": [] }, "nvs_CashAcquiredRecognizedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CashAcquiredRecognizedAsOfAcquisitionDate", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Cash acquired recognized as of acquisition date" } } }, "auth_ref": [] }, "nvs_CashAcquiredRecognizedAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CashAcquiredRecognizedAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails3Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Cash acquired recognized as of acquisition date through acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "ifrs-full_CashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashAndCashEquivalents", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners", "weight": 1.0, "order": 5.0 }, "http://novartis.com/20260630/role/DisclosureMarketableSecuritiesDetails2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet", "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "totalLabel": "Total cash and cash equivalents", "periodStartLabel": "Cash and cash equivalents at beginning of period", "periodEndLabel": "Cash and cash equivalents at end of period" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } } }, "auth_ref": [ "r79", "r109", "r203", "r297" ] }, "nvs_CashAndCashEquivalents1Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "CashAndCashEquivalents1Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents [member]" } } }, "auth_ref": [] }, "nvs_CashAndCashEquivalentsAcquiredThroughAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CashAndCashEquivalentsAcquiredThroughAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents acquired through acquisitions applying the optional concentration test", "negatedTerseLabel": "dup_1_Acquisitions applying optional concentration test" } } }, "auth_ref": [] }, "ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents in subsidiary or businesses acquired or disposed" } }, "en": { "role": { "documentation": "The amount of cash and cash equivalents in subsidiaries or other businesses over which control is obtained or lost. [Refer: Total for all subsidiaries [member]; Cash and cash equivalents]" } } }, "auth_ref": [ "r75" ] }, "ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashAndCashEquivalentsRecognisedAsOfAcquisitionDate", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents recognised as of acquisition date", "terseLabel": "Cash and cash equivalents", "negatedTerseLabel": "Acquired cash and cash equivalents" } }, "en": { "role": { "documentation": "The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Total for all business combinations [member]]" } } }, "auth_ref": [ "r404" ] }, "nvs_CashAndCashEquivalentsRecognisedAsOfAcquisitionDateMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "CashAndCashEquivalentsRecognisedAsOfAcquisitionDateMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents recognised as of acquisition date [member]", "terseLabel": "Cash and cash equivalents recognised as of acquisition date" } } }, "auth_ref": [] }, "nvs_CashAndCashEquivalentsRecognisedAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CashAndCashEquivalentsRecognisedAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails3Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents recognised as of acquisition date through acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "ifrs-full_CashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashEquivalents", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureMarketableSecuritiesDetails2": { "parentTag": "ifrs-full_CashAndCashEquivalents", "weight": 1.0, "order": 2.0 } }, "lang": { "en-us": { "role": { "terseLabel": "Time deposits and short term investments with original maturity less than 90 days", "label": "Cash equivalents" } }, "en": { "role": { "documentation": "The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value." } } }, "auth_ref": [ "r403" ] }, "nvs_CashFlowFromNetIdentifiableAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CashFlowFromNetIdentifiableAssets", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Net identifiable assets (acquired) or divested", "negatedTerseLabel": "Total purchase consideration for acquisitions of businesses", "terseLabel": "Total purchase consideration for acquisitions of businesses" } } }, "auth_ref": [] }, "nvs_CashFlowsArisingFromAcquisitionsAndDivestmentsOfBusinessesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://novartis.com/20260630", "localname": "CashFlowsArisingFromAcquisitionsAndDivestmentsOfBusinessesTableTextBlock", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsTablesQ" ], "lang": { "en-us": { "role": { "label": "Cash flows arising from acquisitions and divestments of businesses [table text block]", "terseLabel": "Cash flows related to acquisitions of businesses" } } }, "auth_ref": [] }, "nvs_CashFlowsBeforeWorkingCapitalAndProvisionChanges": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CashFlowsBeforeWorkingCapitalAndProvisionChanges", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Cash flows before working capital and provision changes", "totalLabel": "Net cash flows from operating activities before working capital and provision changes" } } }, "auth_ref": [] }, "nvs_CashFlowsFromChangesInWorkingCapitalAndOtherOperatingItemsIncludedInOperatingCashFlowFromContinuingOperationsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://novartis.com/20260630", "localname": "CashFlowsFromChangesInWorkingCapitalAndOtherOperatingItemsIncludedInOperatingCashFlowFromContinuingOperationsTableTextBlock", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsTablesQ" ], "lang": { "en-us": { "role": { "label": "Cash flows from changes in working capital and other operating items included in operating cash flow from continuing operations [table text block]", "terseLabel": "Cash flows from changes in working capital and other operating items included in operating cash flow from continuing operations" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": 1.0, "order": 3.7 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Cash flows from losing control of subsidiaries or other businesses, classified as investing activities", "terseLabel": "Divestments of businesses, net", "negatedTerseLabel": "Divestments of businesses, net" } }, "en": { "role": { "documentation": "The aggregate cash flows arising from losing control of subsidiaries or other businesses, classified as investing activities. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r72" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) financing activities", "totalLabel": "Net cash flows from/(used in) financing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations." } } }, "auth_ref": [ "r64", "r80" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Net cash flows used in financing activities from continuing operations", "label": "Cash flows from (used in) financing activities, continuing operations" } }, "en": { "role": { "documentation": "The cash flows from (used in) the entity's financing activities, related to continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Cash flows from (used in) financing activities]" } } }, "auth_ref": [ "r157" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Net cash flows from financing activities from discontinued operations", "label": "Cash flows from (used in) financing activities, discontinued operations" } }, "en": { "role": { "documentation": "The cash flows from (used in) the entity's financing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) financing activities]" } } }, "auth_ref": [ "r157" ] }, "ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) increase (decrease) in current borrowings", "terseLabel": "Change in current financial debts", "negatedTerseLabel": "Change in current financial debts", "totalLabel": "Financial debts cash flows from continuing operations" } }, "en": { "role": { "documentation": "The cash inflow (outflow) due to an increase (decrease) in current borrowings. [Refer: Current borrowings]" } } }, "auth_ref": [ "r398" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) investing activities", "totalLabel": "Net cash flows (used in)/from investing activities", "terseLabel": "Total net cash flows (used in)/from investing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations." } } }, "auth_ref": [ "r64", "r80" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) investing activities, continuing operations", "totalLabel": "Cash flows used in investing activities from continuing operations", "terseLabel": "Net cash flows (used in)/from investing activities from continuing operations" } }, "en": { "role": { "documentation": "The cash flows from (used in) the entity's investing activities, related to continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Cash flows from (used in) investing activities]" } } }, "auth_ref": [ "r157" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) investing activities, discontinued operations", "terseLabel": "Cash flows used in/from investing activities from discontinued operations", "totalLabel": "Cash flows used in/from investing activities from discontinued operations", "verboseLabel": "Net cash flows used in investing activities from discontinued operations" } }, "en": { "role": { "documentation": "The cash flows from (used in) the entity's investing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) investing activities]" } } }, "auth_ref": [ "r157" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivities", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 3.0 }, "http://novartis.com/20260630/role/StatementsOfCashFlowCalc2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) operating activities", "totalLabel": "Net cash flows from operating activities" } } }, "auth_ref": [ "r64", "r80" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 2.5 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) operating activities, continuing operations", "totalLabel": "Net cash flows from operating activities from continuing operations" } }, "en": { "role": { "documentation": "The cash flows from (used in) the entity's operating activities, related to continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Cash flows from (used in) operating activities]" } } }, "auth_ref": [ "r157" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlowCalc2": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 1.0 }, "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) operating activities, discontinued operations", "terseLabel": "Net cash flows from operating activities from discontinued operations" } }, "en": { "role": { "documentation": "The cash flows from (used in) the entity's operating activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) operating activities]" } } }, "auth_ref": [ "r157" ] }, "ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": -1.0, "order": 3.5 } }, "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q", "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities", "terseLabel": "Acquisitions of businesses", "negatedTotalLabel": "Net cash flows", "negatedTerseLabel": "Acquisitions of businesses" } }, "en": { "role": { "documentation": "The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r72" ] }, "nvs_CashInflowOutflowFromNetIdentifiableAssetsDivestedAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CashInflowOutflowFromNetIdentifiableAssetsDivestedAcquired", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Cash inflow outflow from net identifiable assets divested acquired" } } }, "auth_ref": [] }, "nvs_CashOfferPerADS": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CashOfferPerADS", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Cash offer per ADS", "documentation": "This expresses the amount of cash Novartis paid to the owners of AAA per ADS." } } }, "auth_ref": [] }, "nvs_CashOfferPerOrdinaryShare": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CashOfferPerOrdinaryShare", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Cash offer per ordinary share", "documentation": "This expresses the amount of cash Novartis paid to the owners of AAA per ordinary share." } } }, "auth_ref": [] }, "nvs_CashOfferPerOutstandingShareForAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CashOfferPerOutstandingShareForAcquisitionsApplyingTheOptionalConcentrationTest", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Cash offer per outstanding share for acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "nvs_CashOutflowsDueToDerecognizedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CashOutflowsDueToDerecognizedCashAndCashEquivalents", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Cash outflows due to derecognized cash and cash equivalents", "terseLabel": "dup_3_Divested business" } } }, "auth_ref": [] }, "ifrs-full_CashTransferred": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CashTransferred", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Cash transferred" } }, "en": { "role": { "documentation": "The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Total for all business combinations [member]]" } } }, "auth_ref": [ "r142", "r252" ] }, "nvs_ChangeInCashSettledShareBasedPaymentsLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ChangeInCashSettledShareBasedPaymentsLiabilities", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Change in cash settled share based payments liabilities" } } }, "auth_ref": [] }, "nvs_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 1.0 }, "http://novartis.com/20260630/role/StatementsOfCashFlowCalc2": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails1Q", "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Changes in working capital and other operating cash flow items", "totalLabel": "Total" } } }, "auth_ref": [] }, "nvs_ChangeOverPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "ChangeOverPeriodAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Change over period [axis]" } } }, "auth_ref": [] }, "nvs_ChangeOverPriorPeriodMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ChangeOverPriorPeriodMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Change over prior period [member]" } } }, "auth_ref": [] }, "ifrs-full_ChangesInEquity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ChangesInEquity", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in equity", "terseLabel": "Movement in the year", "totalLabel": "Total of other equity movements" } }, "en": { "role": { "documentation": "The increase (decrease) in equity. [Refer: Equity]" } } }, "auth_ref": [ "r286" ] }, "nvs_ChinookTherapeuticsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ChinookTherapeuticsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Chinook Therapeutics [member]", "terseLabel": "Chinook Therapeutics" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CityAreaCode", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ifrs-full_ClassesOfAssetsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfAssetsAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ", "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Classes of assets [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r38", "r40", "r122", "r133", "r191", "r229", "r269" ] }, "ifrs-full_ClassesOfAssetsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfAssetsDomain", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ", "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Classes of assets [domain]" } }, "en": { "role": { "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used." } } }, "auth_ref": [ "r38", "r122", "r133", "r191", "r229", "r269" ] }, "nvs_ClassesOfIPRDProgramsAxis": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "ClassesOfIPRDProgramsAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Classes of IPR&D programs [axis]" } } }, "auth_ref": [] }, "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfIntangibleAssetsAndGoodwillAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Classes of intangible assets and goodwill [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r394" ] }, "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfIntangibleAssetsAndGoodwillDomain", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Classes of intangible assets and goodwill [domain]" } }, "en": { "role": { "documentation": "This member stands for intangible assets and goodwill. It also represents the standard value for the 'Classes of intangible assets and goodwill' axis if no other member is used. [Refer: Goodwill; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r394" ] }, "ifrs-full_ClassesOfLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfLiabilitiesAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Classes of liabilities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r122", "r269" ] }, "ifrs-full_ClassesOfLiabilitiesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfLiabilitiesDomain", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Classes of liabilities [domain]" } }, "en": { "role": { "documentation": "This member stands for a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of liabilities' axis if no other member is used. [Refer: Liabilities]" } } }, "auth_ref": [ "r122", "r269" ] }, "ifrs-full_ClassesOfOtherProvisionsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfOtherProvisionsDomain", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Classes of other provisions [domain]" } }, "en": { "role": { "documentation": "This member stands for provisions other than provisions for employee benefits. It also represents the standard value for the 'Classes of other provisions' axis if no other member is used. [Refer: Provisions]" } } }, "auth_ref": [ "r48", "r235" ] }, "ifrs-full_ClassesOfProvisionsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfProvisionsAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Classes of other provisions [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r48", "r235" ] }, "ifrs-full_ClassesOfShareCapitalAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfShareCapitalAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ", "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Classes of share capital [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r201", "r271", "r313" ] }, "ifrs-full_ClassesOfShareCapitalDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ClassesOfShareCapitalDomain", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ", "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Classes of share capital [domain]" } }, "en": { "role": { "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used." } } }, "auth_ref": [ "r201", "r271", "r313" ] }, "ifrs-full_CommercialPapersIssued": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CommercialPapersIssued", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsDetails": { "parentTag": "ifrs-full_OtherCurrentFinancialLiabilities", "weight": 1.0, "order": 1.0 } }, "lang": { "en-us": { "role": { "label": "Commercial papers issued", "terseLabel": "Commercial paper" } }, "en": { "role": { "documentation": "The amount of commercial paper issued by the entity." } } }, "auth_ref": [ "r410" ] }, "nvs_CommitmentForRepurchaseOwnShares": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CommitmentForRepurchaseOwnShares", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetails1Q" ], "lang": { "en-us": { "role": { "label": "Commitment for repurchase own shares", "negatedTerseLabel": "Commitment for repurchase own shares" } } }, "auth_ref": [] }, "nvs_Commodities": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "Commodities", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureMarketableSecuritiesDetails": { "parentTag": "ifrs-full_OtherCurrentFinancialAssets", "weight": 1.0, "order": 5.0 } }, "lang": { "en-us": { "role": { "label": "Commodities" } } }, "auth_ref": [] }, "ifrs-full_ComponentsOfEquityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComponentsOfEquityAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ", "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Components of equity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r287" ] }, "ifrs-full_ComponentsOfEquityDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComponentsOfEquityDomain", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ", "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Components of equity [domain]" } }, "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "auth_ref": [ "r287" ] }, "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract", "presentation": [ "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]", "terseLabel": "Other comprehensive income - Items that are or may be recycled into the consolidated income statement" } } }, "auth_ref": [] }, "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract", "presentation": [ "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]", "terseLabel": "Items that will never be recycled into the consolidated income statement" } } }, "auth_ref": [] }, "ifrs-full_ComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComprehensiveIncome", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfComprehensiveIncomeCalc2": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://novartis.com/20260630/role/StatementOfComprehensiveIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity", "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive income", "totalLabel": "Total comprehensive income" } }, "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } } }, "auth_ref": [ "r92", "r94", "r105", "r228", "r250", "r281", "r316", "r344" ] }, "ifrs-full_ComprehensiveIncomeAttributableToAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComprehensiveIncomeAttributableToAbstract", "presentation": [ "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive income attributable to [abstract]", "terseLabel": "Total comprehensive income for the period attributable to:" } } }, "auth_ref": [] }, "ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComprehensiveIncomeAttributableToNoncontrollingInterests", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive income, attributable to non-controlling interests", "terseLabel": "Non-controlling interests" } }, "en": { "role": { "documentation": "The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]" } } }, "auth_ref": [ "r281", "r319" ] }, "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComprehensiveIncomeAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive income, attributable to owners of parent", "terseLabel": "Shareholders of Novartis AG" } }, "en": { "role": { "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]" } } }, "auth_ref": [ "r281", "r320" ] }, "ifrs-full_ComprehensiveIncomeFromContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComprehensiveIncomeFromContinuingOperations", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfComprehensiveIncome": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income from continuing operations" } }, "en": { "role": { "documentation": "The comprehensive income from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Comprehensive income]" } } }, "auth_ref": [ "r405" ] }, "ifrs-full_ComprehensiveIncomeFromDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ComprehensiveIncomeFromDiscontinuedOperations", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfComprehensiveIncome": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income from discontinued operations", "terseLabel": "Other comprehensive income from discontinued operations, net of taxes" } }, "en": { "role": { "documentation": "The comprehensive income from discontinued operations. [Refer: Discontinued operations [member]; Comprehensive income]" } } }, "auth_ref": [ "r405" ] }, "nvs_ConsiderationPaidForShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ConsiderationPaidForShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Consideration paid for share capital tendered at the subsequent offering period of the tender offer" } } }, "auth_ref": [] }, "ifrs-full_ConsiderationPaidReceived": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ConsiderationPaidReceived", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Consideration paid (received)", "terseLabel": "Net cash inflows from divestment" } }, "en": { "role": { "documentation": "The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r73" ] }, "nvs_ConsumerHealthMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ConsumerHealthMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOperatingSegmentsQ" ], "lang": { "en-us": { "role": { "label": "Consumer Health [member]", "terseLabel": "Consumer Health" } } }, "auth_ref": [] }, "nvs_ContactLensesMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ContactLensesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Contact Lenses [member]" } } }, "auth_ref": [] }, "dei_ContactPersonnelFaxNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "ContactPersonnelFaxNumber", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Fax Number", "documentation": "Fax Number of contact personnel." } } }, "auth_ref": [ "r384" ] }, "dei_ContactPersonnelName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "ContactPersonnelName", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Name", "documentation": "Name of contact personnel" } } }, "auth_ref": [] }, "nvs_ContingentConsiderationCurrentPortion": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ContingentConsiderationCurrentPortion", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails": { "parentTag": "ifrs-full_OtherCurrentNonfinancialLiabilities", "weight": 1.0, "order": 12.0 } }, "lang": { "en-us": { "role": { "label": "Contingent consideration, current portion", "terseLabel": "Contingent consideration" } } }, "auth_ref": [] }, "nvs_ContingentConsiderationNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ContingentConsiderationNonCurrent", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails": { "parentTag": "ifrs-full_OtherNoncurrentNonfinancialLiabilities", "weight": 1.0, "order": 6.0 } }, "lang": { "en-us": { "role": { "label": "Contingent consideration" } } }, "auth_ref": [] }, "nvs_ContingentConsiderationPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ContingentConsiderationPaid", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Contingent consideration paid" } } }, "auth_ref": [] }, "nvs_ContingentConsiderationPayablesMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ContingentConsiderationPayablesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Contingent consideration liabilities [member]", "terseLabel": "Contingent consideration payables [member]" } } }, "auth_ref": [] }, "nvs_ContingentConsiderationReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ContingentConsiderationReceivable", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails": { "parentTag": "ifrs-full_NoncurrentFinancialAssets", "weight": 1.0, "order": 7.0 } }, "lang": { "en-us": { "role": { "label": "Contingent Consideration Receivable", "terseLabel": "Contingent consideration receivables" } } }, "auth_ref": [] }, "nvs_ContingentConsiderationReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ContingentConsiderationReceivableCurrent", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureOtherCurrentAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentNonfinancialAssets", "weight": 1.0, "order": 7.0 } }, "lang": { "en-us": { "role": { "label": "Contingent consideration receivable, current", "terseLabel": "Contingent consideration receivable" } } }, "auth_ref": [] }, "nvs_ContingentConsiderationReceivablesMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ContingentConsiderationReceivablesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Current contingent consideration receivables [member]", "terseLabel": "Current contingent consideration receivables [member]" } } }, "auth_ref": [] }, "nvs_ContingentConsiderationReceivablesShorttermMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ContingentConsiderationReceivablesShorttermMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Contingent consideration receivables short-term [member]" } } }, "auth_ref": [] }, "ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ContingentConsiderationRecognisedAsOfAcquisitionDate", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Contingent consideration recognised as of acquisition date" } }, "en": { "role": { "documentation": "The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Total for all business combinations [member]]" } } }, "auth_ref": [ "r144", "r254" ] }, "ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ContingentLiabilitiesRecognisedAsOfAcquisitionDate", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Contingent liabilities recognised as of acquisition date" } }, "en": { "role": { "documentation": "The amount of contingent liabilities recognised as of the acquisition date in a business combination. [Refer: Classes of contingent liabilities [domain]; Total for all business combinations [member]]" } } }, "auth_ref": [ "r353", "r355", "r367" ] }, "nvs_ContingentValueRightAmountForAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ContingentValueRightAmountForAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Contingent value right amount for acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "nvs_ContingentValueRightPerShareForAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ContingentValueRightPerShareForAcquisitionsApplyingTheOptionalConcentrationTest", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Contingent value right per share for acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "ifrs-full_ContinuingAndDiscontinuedOperationsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ContinuingAndDiscontinuedOperationsAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails1Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ", "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Continuing and discontinued operations [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r159" ] }, "ifrs-full_ContinuingOperationsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ContinuingOperationsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails1Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ", "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Continuing operations [member]", "terseLabel": "Continuing operations" } }, "en": { "role": { "documentation": "This member stands for components of the entity that are not discontinued operations. A component of an entity comprises operations and cash flows that can be clearly distinguished, operationally and for financial reporting purposes, from the rest of the entity. This meaning may be overridden for line items which are either intrinsically related to discontinued operations (or disposal groups held for sale), or which are typically reported for the aggregate of continuing and discontinued. This member also represents the standard value for the 'Continuing and discontinued operations' axis if no other member is used. [Refer: Discontinued operations [member]; Aggregate continuing and discontinued operations [member]]" } } }, "auth_ref": [ "r159" ] }, "nvs_ContractManufacturingMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ContractManufacturingMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "Contract manufacturing [member]" } } }, "auth_ref": [] }, "nvs_ContractRightOfFirstNegotiationTerm": { "xbrltype": "decimalItemType", "nsuri": "http://novartis.com/20260630", "localname": "ContractRightOfFirstNegotiationTerm", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Contract right of first negotiation term" } } }, "auth_ref": [] }, "ifrs-full_ContractualCommitmentsForAcquisitionOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ContractualCommitmentsForAcquisitionOfIntangibleAssets", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureCommitmentsAndContingenciesDetails2": { "parentTag": "nvs_ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments", "weight": 1.0, "order": 1.5 } }, "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails4Q" ], "lang": { "en-us": { "role": { "label": "Contractual commitments for acquisition of intangible assets", "terseLabel": "Commitments under long-term research and development agreements" } }, "en": { "role": { "documentation": "The amount of contractual commitments for the acquisition of intangible assets." } } }, "auth_ref": [ "r55", "r242" ] }, "nvs_CoreTherapeuticAreaAndEstablishedBrandsAxis": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "CoreTherapeuticAreaAndEstablishedBrandsAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Core therapeutic area and established brands [axis]" } } }, "auth_ref": [] }, "nvs_CoreTherapeuticAreaAndEstablishedBrandsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "CoreTherapeuticAreaAndEstablishedBrandsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Core therapeutic area and established brands [member]" } } }, "auth_ref": [] }, "nvs_Corporate1Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "Corporate1Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOperatingSegmentsQ", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails4Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Corporate [member]", "terseLabel": "Corporate" } } }, "auth_ref": [] }, "nvs_CosentyxMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "CosentyxMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Cosentyx [member]" } } }, "auth_ref": [] }, "ifrs-full_CostOfSales": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CostOfSales", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": "ifrs-full_GrossProfit", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Cost of sales", "negatedTerseLabel": "Cost of goods sold" } } }, "auth_ref": [ "r280", "r328" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CountryRegion", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "nvs_CurrentAndNonCurrentLeaseLiabilitiesAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CurrentAndNonCurrentLeaseLiabilitiesAsOfAcquisitionDate", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Current and non current lease liabilities as of acquisition date", "negatedTerseLabel": "Current and non-current lease liabilities" } } }, "auth_ref": [] }, "nvs_CurrentAndNonCurrentLeaseLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "CurrentAndNonCurrentLeaseLiabilitiesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Current and non-current lease liabilities [member]", "terseLabel": "Current and non-current lease liabilities" } } }, "auth_ref": [] }, "nvs_CurrentAndNonCurrentLeaseLiabilitiesThroughAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CurrentAndNonCurrentLeaseLiabilitiesThroughAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Current and non-current lease liabilities through acquisitions applying the optional concentration test", "negatedTerseLabel": "Current and non-current lease liabilities through acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "nvs_CurrentAndNonCurrentLiabilitiesRecognisedAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CurrentAndNonCurrentLiabilitiesRecognisedAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Current and non-current liabilities recognised as of acquisition date through acquisitions applying the optional concentration test", "negatedTerseLabel": "Current and non-current liabilities recognised as of acquisition date through acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "ifrs-full_CurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentAssets", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Current assets", "totalLabel": "Total current assets" } }, "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } } }, "auth_ref": [ "r101", "r308", "r344" ] }, "ifrs-full_CurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentAssetsAbstract", "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Current assets [abstract]" } } }, "auth_ref": [] }, "nvs_CurrentAssetsDivested": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CurrentAssetsDivested", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Current assets divested" } } }, "auth_ref": [] }, "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 17.2 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners", "totalLabel": "Total current assets without disposal group" } }, "en": { "role": { "documentation": "The amount of current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners. [Refer: Current assets; Disposal groups classified as held for sale [member]; Non-current assets or disposal groups classified as held for sale; Non-current assets or disposal groups classified as held for distribution to owners]" } } }, "auth_ref": [ "r308" ] }, "nvs_CurrentFinancialLiabilitiesAtFairValueMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "CurrentFinancialLiabilitiesAtFairValueMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Current financial liabilities at fair value [member]" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "ifrs-full_CurrentInterestPayable": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentInterestPayable", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails": { "parentTag": "ifrs-full_OtherCurrentNonfinancialLiabilities", "weight": 1.0, "order": 5.0 } }, "lang": { "en-us": { "role": { "label": "Current interest payable", "terseLabel": "Accrued interests on financial debt" } }, "en": { "role": { "documentation": "The amount of current interest payable. [Refer: Interest payable]" } } }, "auth_ref": [ "r410" ] }, "ifrs-full_CurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Current lease liabilities", "terseLabel": "Lease liabilities", "negatedTerseLabel": "Less current lease liabilities" } }, "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r128" ] }, "ifrs-full_CurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentLiabilities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Current liabilities", "totalLabel": "Total current liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } } }, "auth_ref": [ "r103", "r309", "r344" ] }, "ifrs-full_CurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentLiabilitiesAbstract", "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Current liabilities [abstract]" } } }, "auth_ref": [] }, "nvs_CurrentLiabilitiesDivested": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CurrentLiabilitiesDivested", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Current liabilities divested" } } }, "auth_ref": [] }, "nvs_CurrentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "CurrentLiabilitiesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Current liabilities [member]" } } }, "auth_ref": [] }, "ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Current liabilities other than liabilities included in disposal groups classified as held for sale", "totalLabel": "Total current liabilities without disposal group" } }, "en": { "role": { "documentation": "The amount of current liabilities other than liabilities included in disposal groups classified as held for sale. [Refer: Current liabilities; Disposal groups classified as held for sale [member]; Liabilities included in disposal groups classified as held for sale]" } } }, "auth_ref": [ "r309" ] }, "ifrs-full_CurrentLiabilitiesRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentLiabilitiesRecognisedAsOfAcquisitionDate", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Current liabilities recognised as of acquisition date", "negatedTerseLabel": "Current liabilities" } }, "en": { "role": { "documentation": "The amount recognised as of the acquisition date for current liabilities assumed in a business combination. [Refer: Current liabilities; Total for all business combinations [member]]" } } }, "auth_ref": [ "r404" ] }, "ifrs-full_CurrentPortionOfLongtermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentPortionOfLongtermBorrowings", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsDetails": { "parentTag": "ifrs-full_OtherCurrentFinancialLiabilities", "weight": 1.0, "order": 3.0 } }, "lang": { "en-us": { "role": { "label": "Current portion of non-current borrowings", "terseLabel": "Current portion of non-current financial debt", "verboseLabel": "Less current portion of non-current financial debt", "negatedTerseLabel": "Less current portion of non-current financial debt" } }, "en": { "role": { "documentation": "The current portion of non-current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r412" ] }, "nvs_CurrentPrepaidExpensesAssociatedCompanies": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CurrentPrepaidExpensesAssociatedCompanies", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureOtherCurrentAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentNonfinancialAssets", "weight": 1.0, "order": 1.0 } }, "lang": { "en-us": { "role": { "label": "Current prepaid expenses associated companies", "terseLabel": "Prepaid expenses - associated companies" } } }, "auth_ref": [] }, "ifrs-full_CurrentPrepayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentPrepayments", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureOtherCurrentAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentNonfinancialAssets", "weight": 1.0, "order": 2.5 } }, "lang": { "en-us": { "role": { "label": "Current prepayments", "terseLabel": "Prepaid expenses - third party" } }, "en": { "role": { "documentation": "The amount of current prepayments. [Refer: Prepayments]" } } }, "auth_ref": [ "r369", "r375" ] }, "ifrs-full_CurrentRefundsProvision": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentRefundsProvision", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails": { "parentTag": "ifrs-full_OtherCurrentNonfinancialLiabilities", "weight": 1.0, "order": 15.0 } }, "lang": { "en-us": { "role": { "label": "Current refunds provision", "terseLabel": "Provisions for deductions from revenue", "periodStartLabel": "Provisions for deductions from revenue, at beginning of period", "periodEndLabel": "Provisions for deductions from revenue, at end of period" } }, "en": { "role": { "documentation": "The amount of current provision for refunds. [Refer: Refunds provision]" } } }, "auth_ref": [ "r335", "r337" ] }, "ifrs-full_CurrentTaxAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentTaxAssetsCurrent", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Current tax assets, current", "terseLabel": "Income tax receivables" } }, "en": { "role": { "documentation": "The current amount of current tax assets. [Refer: Current tax assets]" } } }, "auth_ref": [ "r299" ] }, "ifrs-full_CurrentTaxLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentTaxLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Current tax liabilities, current", "terseLabel": "Current income tax liabilities" } }, "en": { "role": { "documentation": "The current amount of current tax liabilities. [Refer: Current tax liabilities]" } } }, "auth_ref": [ "r299" ] }, "ifrs-full_CurrentTradeReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentTradeReceivables", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Trade receivables", "terseLabel": "Total trade receivables, net", "periodStartLabel": "Provisions at beginning of period", "periodEndLabel": "Provisions at end of period", "verboseLabel": "Trade receivables" } }, "en": { "role": { "documentation": "The amount of current trade receivables. [Refer: Trade receivables]" } } }, "auth_ref": [ "r369", "r374", "r375" ] }, "ifrs-full_CurrentValueAddedTaxReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "CurrentValueAddedTaxReceivables", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureOtherCurrentAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentNonfinancialAssets", "weight": 1.0, "order": 3.0 } }, "lang": { "en-us": { "role": { "label": "Current value added tax receivables", "terseLabel": "VAT Receivable" } }, "en": { "role": { "documentation": "The amount of current value added tax receivables. [Refer: Value added tax receivables]" } } }, "auth_ref": [ "r413" ] }, "nvs_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Currently marketed products intangible assets recognised as of acquisition date", "terseLabel": "Currently marketed products" } } }, "auth_ref": [] }, "nvs_CurrentlyMarketedProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "CurrentlyMarketedProductsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Currently marketed products [member]", "terseLabel": "Currently marketed products" } } }, "auth_ref": [] }, "nvs_CustomaryPurchasePriceAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "CustomaryPurchasePriceAdjustment", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Customary purchase price adjustment" } } }, "auth_ref": [] }, "nvs_DM1Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "DM1Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "DM1 [member]" } } }, "auth_ref": [] }, "nvs_DTxPharmaInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "DTxPharmaInc.Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "DTx Pharma Inc. [member]", "terseLabel": "DTx Pharma Inc." } } }, "auth_ref": [] }, "nvs_DebtAndEquitySecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "DebtAndEquitySecuritiesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Debt and equity securities [member]" } } }, "auth_ref": [] }, "ifrs-full_DebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DebtSecuritiesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Debt securities [member]", "terseLabel": "Debt securities" } }, "en": { "role": { "documentation": "This member stands for instruments held by the entity that represent indebtedness." } } }, "auth_ref": [ "r345", "r346" ] }, "nvs_DeferredCompensationPlansAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "DeferredCompensationPlansAssets", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails2": { "parentTag": "ifrs-full_OtherNoncurrentAssets", "weight": 1.0, "order": 1.0 } }, "lang": { "en-us": { "role": { "label": "Deferred compensation plans assets" } } }, "auth_ref": [] }, "nvs_DeferredSalePriceAndOtherAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "DeferredSalePriceAndOtherAdjustments", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Deferred sale price and other adjustments", "terseLabel": "dup_1_Divested business" } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DeferredTaxAssets", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Deferred tax assets", "terseLabel": "Deferred tax assets", "negatedTerseLabel": "Deferred tax assets" } }, "en": { "role": { "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } } }, "auth_ref": [ "r4", "r214", "r300", "r305" ] }, "nvs_DeferredTaxAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "DeferredTaxAssetsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Deferred tax assets [member]", "terseLabel": "Deferred tax assets" } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxAssetsRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DeferredTaxAssetsRecognisedAsOfAcquisitionDate", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Deferred tax assets recognised as of acquisition date", "terseLabel": "Deferred tax assets" } }, "en": { "role": { "documentation": "The amount recognised as of the acquisition date for deferred tax assets acquired in a business combination. [Refer: Deferred tax assets; Total for all business combinations [member]]" } } }, "auth_ref": [ "r404" ] }, "nvs_DeferredTaxAssetsRecognisedAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "DeferredTaxAssetsRecognisedAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Deferred tax assets recognised as of acquisition date through acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Deferred tax liabilities", "terseLabel": "Deferred tax liabilities", "negatedTerseLabel": "Deferred tax liabilities", "negatedLabel": "Deferred tax liabilities" } }, "en": { "role": { "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]" } } }, "auth_ref": [ "r4", "r214", "r300", "r305" ] }, "ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Deferred tax liabilities recognised as of acquisition date", "negatedTerseLabel": "Deferred tax liabilities" } }, "en": { "role": { "documentation": "The amount recognised as of the acquisition date for deferred tax liabilities assumed in a business combination. [Refer: Deferred tax liabilities; Total for all business combinations [member]]" } } }, "auth_ref": [ "r404" ] }, "ifrs-full_DeferredTaxLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DeferredTaxLiabilityAsset", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Deferred tax liability (asset)", "negatedTotalLabel": "Net deferred tax balance", "negatedPeriodStartLabel": "Net deferred tax balance at beginning of period", "negatedPeriodEndLabel": "Net deferred tax balance at end of period", "totalLabel": "Net deferred tax balance", "negatedTerseLabel": "Net deferred tax balance at beginning of period continuing operations" } }, "en": { "role": { "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]" } } }, "auth_ref": [ "r4", "r214" ] }, "ifrs-full_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]", "terseLabel": "Depreciation, amortization and impairments on:" } } }, "auth_ref": [] }, "ifrs-full_DepreciationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DepreciationPropertyPlantAndEquipment", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Depreciation, property, plant and equipment", "terseLabel": "Depreciation charge", "negatedTerseLabel": "Property, plant and equipment depreciation charge" } } }, "auth_ref": [ "r9", "r12", "r219" ] }, "ifrs-full_DepreciationRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DepreciationRightofuseAssets", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Depreciation, right-of-use assets", "terseLabel": "Depreciation charge", "negatedTerseLabel": "Right-of-use assets depreciation charge" } } }, "auth_ref": [ "r129", "r187" ] }, "ifrs-full_DerivativeFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DerivativeFinancialAssets", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureMarketableSecuritiesDetails": { "parentTag": "ifrs-full_OtherCurrentFinancialAssets", "weight": 1.0, "order": 7.0 } }, "lang": { "en-us": { "role": { "terseLabel": "Derivative financial instruments", "label": "Derivative financial assets" } }, "en": { "role": { "documentation": "The amount of financial assets classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r412" ] }, "nvs_DerivativeFinancialInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "DerivativeFinancialInstrumentsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q", "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Derivative financial instruments [member]" } } }, "auth_ref": [] }, "ifrs-full_DerivativeFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DerivativeFinancialLiabilities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsDetails": { "parentTag": "ifrs-full_OtherCurrentFinancialLiabilities", "weight": 1.0, "order": 4.0 } }, "lang": { "en-us": { "role": { "label": "Derivative financial liabilities", "terseLabel": "Derivative financial instruments" } }, "en": { "role": { "documentation": "The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r412" ] }, "ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Description of arrangement for contingent consideration arrangements and indemnification assets" } }, "en": { "role": { "documentation": "The description of the contingent consideration arrangements and the arrangements for indemnification assets." } } }, "auth_ref": [ "r145", "r255" ] }, "ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations", "presentation": [ "http://novartis.com/20260630/role/DisclosureSelectedCriticalAccountingPoliciesPoliciesQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of expected impact of initial application of new standards or interpretations [text block]", "terseLabel": "Impact of adopting significant new IFRS standards" } } }, "auth_ref": [ "r85", "r208" ] }, "ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Growth rate used to extrapolate cash flow projections", "terseLabel": "Terminal Growth Rate" } }, "en": { "role": { "documentation": "The growth rate used to extrapolate cash flow projections beyond the period covered by the most recent budgets/forecasts for a cash-generating unit (group of units). [Refer: Total for all cash-generating units [member]]" } } }, "auth_ref": [ "r44", "r46", "r231", "r233" ] }, "ifrs-full_DescriptionOfReasonsForTransfersOutOfLevel3OfFairValueHierarchyAssets": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DescriptionOfReasonsForTransfersOutOfLevel3OfFairValueHierarchyAssets", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Description of reasons for transfers out of Level 3 of fair value hierarchy, assets" } }, "en": { "role": { "documentation": "The description of the reasons for transfers of assets out of Level 3 of the fair value hierarchy. [Refer: Level 3 of fair value hierarchy [member]]" } } }, "auth_ref": [ "r120" ] }, "nvs_DetailedInformationAboutSignificantTransaction": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "DetailedInformationAboutSignificantTransaction", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Detailed information about significant transaction" } } }, "auth_ref": [] }, "ifrs-full_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Difference between carrying amount of dividends payable and carrying amount of non-cash assets distributed", "terseLabel": "Gain on distribution", "verboseLabel": "Difference between net assets and distribution liability" } } }, "auth_ref": [ "r88" ] }, "nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": "ifrs-full_ProfitLossFromDiscontinuedOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ", "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Difference between carrying amount of dividends payable and carrying amount of non-cash assets distributed, Net", "terseLabel": "Gain on distribution of Sandoz Group AG to Novartis AG shareholders" } } }, "auth_ref": [] }, "nvs_DifferenceBetweenFairValueOfDistributionLiabilityAndNetAssetsAtTheDateOfDistribution": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "DifferenceBetweenFairValueOfDistributionLiabilityAndNetAssetsAtTheDateOfDistribution", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Difference between fair value of distribution liability and net assets at the date of distribution" } } }, "auth_ref": [] }, "ifrs-full_DilutedEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DilutedEarningsLossPerShare", "calculation": { "http://novartis.com/20260630/role/DisclosureEarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Diluted earnings (loss) per share", "totalLabel": "Total diluted earnings per share", "terseLabel": "Diluted earnings per share" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r34", "r35" ] }, "ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DilutedEarningsLossPerShareFromContinuingOperations", "calculation": { "http://novartis.com/20260630/role/DisclosureEarningsPerShareDetails": { "parentTag": "ifrs-full_DilutedEarningsLossPerShare", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Diluted earnings (loss) per share from continuing operations", "terseLabel": "Diluted earnings per share, Continuing operations", "verboseLabel": "Continuing operations" } }, "en": { "role": { "documentation": "Diluted earnings (loss) per share from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Diluted earnings (loss) per share]" } } }, "auth_ref": [ "r34", "r35" ] }, "ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DilutedEarningsLossPerShareFromDiscontinuedOperations", "calculation": { "http://novartis.com/20260630/role/DisclosureEarningsPerShareDetails": { "parentTag": "ifrs-full_DilutedEarningsLossPerShare", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Diluted earnings (loss) per share from discontinued operations", "terseLabel": "Diluted earnings per share, Discontinued operations", "verboseLabel": "Discontinued operations" } }, "en": { "role": { "documentation": "Diluted earnings (loss) per share from discontinued operations. [Refer: Diluted earnings (loss) per share; Discontinued operations [member]]" } } }, "auth_ref": [ "r35", "r36" ] }, "ifrs-full_DilutedEarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DilutedEarningsPerShareAbstract", "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Diluted earnings per share [abstract]" } } }, "auth_ref": [] }, "nvs_DiovanGroupMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "DiovanGroupMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Diovan Group [member]" } } }, "auth_ref": [] }, "nvs_DisclosureOfAdditionsExcludingTheImpactOfBusinessAcquisitionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://novartis.com/20260630", "localname": "DisclosureOfAdditionsExcludingTheImpactOfBusinessAcquisitionsTableTextBlock", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresTablesQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of additions excluding the impact of business acquisitions [table text block]", "terseLabel": "dup_1_Disclosure of other income and expense" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "presentation": [ "http://novartis.com/20260630/role/DisclosureBasisOfPreparationQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of basis of preparation of financial statements [text block]", "terseLabel": "Basis of preparation" } } }, "auth_ref": [ "r408" ] }, "ifrs-full_DisclosureOfBusinessCombinationsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfBusinessCombinationsAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about business combination [abstract]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfBusinessCombinationsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfBusinessCombinationsExplanatory", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of business combinations [text block]", "terseLabel": "Acquisition of businesses" } }, "en": { "role": { "documentation": "The entire disclosure for business combinations." } } }, "auth_ref": [ "r154" ] }, "ifrs-full_DisclosureOfBusinessCombinationsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfBusinessCombinationsLineItems", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about business combination [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfBusinessCombinationsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfBusinessCombinationsTable", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about business combination [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of business combinations." } } }, "auth_ref": [ "r151", "r257" ] }, "ifrs-full_DisclosureOfCashFlowStatementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfCashFlowStatementExplanatory", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsQ" ], "lang": { "en-us": { "role": { "terseLabel": "Details to the consolidated statements of cash flows", "label": "Disclosure of cash flow statement [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for a statement of cash flows." } } }, "auth_ref": [ "r81" ] }, "ifrs-full_DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory", "presentation": [ "http://novartis.com/20260630/role/DisclosureSelectedCriticalAccountingPoliciesPoliciesQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of changes in accounting policies, accounting estimates and errors [text block]" } } }, "auth_ref": [ "r87" ] }, "ifrs-full_DisclosureOfClassesOfShareCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of classes of share capital [abstract]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalLineItems", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetails1Q", "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of classes of share capital [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfClassesOfShareCapitalTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalTable", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetails1Q", "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of classes of share capital [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to classes of share capital." } } }, "auth_ref": [ "r201", "r271", "r313" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [abstract]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails2Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [text block]", "terseLabel": "Disclosure of detailed information about borrowings" } }, "en": { "role": { "documentation": "The disclosure of detailed information about borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r407" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails2Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails2Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of borrowings." } } }, "auth_ref": [ "r407" ] }, "nvs_DisclosureOfDetailedInformationAboutBorrowingsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://novartis.com/20260630", "localname": "DisclosureOfDetailedInformationAboutBorrowingsTableTextBlock", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresTablesQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [table text block]", "terseLabel": "Disclosure of detailed information about borrowings" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about financial instruments [text block]", "terseLabel": "Financial instruments" } }, "en": { "role": { "documentation": "The disclosure of detailed information about financial instruments. [Refer: Classes of financial instruments [domain]]" } } }, "auth_ref": [ "r162", "r165", "r168", "r259" ] }, "nvs_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about provisions and non-current liabilities [abstract]" } } }, "auth_ref": [] }, "nvs_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of details to the consolidated statements of cash flows [abstract]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfEntitysReportableSegmentsExplanatory", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of entity's operating segments [text block]", "terseLabel": "Operating segment" } }, "en": { "role": { "documentation": "The entire disclosure for operating segments." } } }, "auth_ref": [ "r182" ] }, "nvs_DisclosureOfEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "DisclosureOfEquityAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of equity [abstract]" } } }, "auth_ref": [] }, "nvs_DisclosureOfEquityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://novartis.com/20260630", "localname": "DisclosureOfEquityTextBlock", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of equity [text block]", "terseLabel": "Equity", "verboseLabel": "Summary of equity attributable to Novartis AG shareholders" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory", "presentation": [ "http://novartis.com/20260630/role/DisclosureSubsequentEventsQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of events after reporting period [text block]", "terseLabel": "Events subsequent to the December 31 consolidated balance sheet date" } }, "en": { "role": { "documentation": "The entire disclosure for events after the reporting period." } } }, "auth_ref": [ "r0" ] }, "ifrs-full_DisclosureOfFairValueMeasurementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFairValueMeasurementExplanatory", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsTablesQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement [text block]", "terseLabel": "Fair value by hierarchy" } }, "en": { "role": { "documentation": "The entire disclosure for fair value measurement." } } }, "auth_ref": [ "r123" ] }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfAssetsLineItems", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of assets [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfAssetsTable", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the fair value measurement of assets." } } }, "auth_ref": [ "r122", "r269" ] }, "ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of liabilities [abstract]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfLiabilitiesLineItems", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of liabilities [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfLiabilitiesTable", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of liabilities [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the fair value measurement of liabilities." } } }, "auth_ref": [ "r122", "r269" ] }, "ifrs-full_DisclosureOfFinancialAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfFinancialAssetsAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of financial assets [abstract]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresTablesQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of impairment loss and reversal of impairment loss [text block]" } } }, "auth_ref": [ "r38", "r229" ] }, "nvs_DisclosureOfLeasingCommitmentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://novartis.com/20260630", "localname": "DisclosureOfLeasingCommitmentsTableTextBlock", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresTablesQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of Leasing commitments [table text block]", "terseLabel": "Research and development commitments" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfMaterialAccountingPolicyInformationExplanatory", "presentation": [ "http://novartis.com/20260630/role/DisclosureSelectedCriticalAccountingPoliciesQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of material accounting policy information [text block]" } }, "en": { "role": { "documentation": "The entire disclosure of material accounting policy information applied by the entity." } } }, "auth_ref": [ "r204", "r273", "r289" ] }, "nvs_DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://novartis.com/20260630", "localname": "DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresTablesQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of net sales, by segements and regions [table text block]", "terseLabel": "Net sales by region" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of non-adjusting events after reporting period [abstract]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOperatingSegmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfOperatingSegmentsAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of operating segments [abstract]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOperatingSegmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfOperatingSegmentsLineItems", "presentation": [ "http://novartis.com/20260630/role/DisclosureOperatingSegmentsQ", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails4Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of operating segments [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "nvs_DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://novartis.com/20260630", "localname": "DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresTablesQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of operating segments, net sales of Top 20 products [table text block]", "terseLabel": "Net sales of Top 20 products" } } }, "auth_ref": [] }, "nvs_DisclosureOfOperatingSegmentsNetSalesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://novartis.com/20260630", "localname": "DisclosureOfOperatingSegmentsNetSalesTableTextBlock", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresTablesQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of operating segments, net sales [table text block]", "terseLabel": "Net sales" } } }, "auth_ref": [] }, "nvs_DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://novartis.com/20260630", "localname": "DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresTablesQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of operating segments, other revenue [table text block]", "terseLabel": "Other revenue" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOperatingSegmentsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfOperatingSegmentsTable", "presentation": [ "http://novartis.com/20260630/role/DisclosureOperatingSegmentsQ", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails4Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of operating segments [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to operating segments." } } }, "auth_ref": [ "r173" ] }, "nvs_DisclosureOfOtherInterimDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "DisclosureOfOtherInterimDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of other interim disclosures [abstract]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOtherProvisionsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfOtherProvisionsLineItems", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Disclosure of other provisions [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOtherProvisionsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfOtherProvisionsTable", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Disclosure of other provisions [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to other provisions." } } }, "auth_ref": [ "r48", "r235" ] }, "ifrs-full_DisclosureOfRevenueExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DisclosureOfRevenueExplanatory", "presentation": [ "http://novartis.com/20260630/role/DisclosureRevenuesAndGeographicInformationQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of revenue [text block]", "terseLabel": "Revenues and geographic information" } }, "en": { "role": { "documentation": "The entire disclosure for revenue." } } }, "auth_ref": [ "r408" ] }, "nvs_DisclosureOfRevenuesAndGeographicInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "DisclosureOfRevenuesAndGeographicInformationAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of revenues and geographic information [abstract]" } } }, "auth_ref": [] }, "nvs_DisclosureOfSignificantAccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "DisclosureOfSignificantAccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of significant accounting policies [abstract]" } } }, "auth_ref": [] }, "nvs_DisclosureOfSignificantTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "DisclosureOfSignificantTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Disclosure of significant transactions [abstract]" } } }, "auth_ref": [] }, "nvs_DisclosureOfSignificantTransactionsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://novartis.com/20260630", "localname": "DisclosureOfSignificantTransactionsTextBlock", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsQ" ], "lang": { "en-us": { "role": { "label": "Disclosure of Significant transactions [text block]", "terseLabel": "Significant acquisitions of businesses" } } }, "auth_ref": [] }, "ifrs-full_DiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DiscontinuedOperationsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails1Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ", "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Discontinued operations [member]", "terseLabel": "Discontinued operations" } }, "en": { "role": { "documentation": "This member stands for a component of an entity that either has been disposed of or is classified as held for sale, and that: (a) represents a separate major line of business or geographical area of operations; (b) is part of a single co-ordinated plan to dispose of a separate major line of business or geographical area of operations; or (c) is a subsidiary acquired exclusively with a view to resale. A component of an entity comprises operations and cash flows that can be clearly distinguished, operationally and for financial reporting purposes, from the rest of the entity. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r159" ] }, "ifrs-full_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Discount rate used in current measurement of fair value less costs of disposal", "terseLabel": "Discount Rate (post-tax)" } }, "en": { "role": { "documentation": "The discount rate used in the current measurement of fair value less costs of disposal." } } }, "auth_ref": [ "r42" ] }, "nvs_DistributionOfDividendBearingSharesToConsolidatedFoundations": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "DistributionOfDividendBearingSharesToConsolidatedFoundations", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Distribution of dividend to dividend bearing shares to consolidated foundations", "terseLabel": "Shares obtained through consolidated foundation" } } }, "auth_ref": [] }, "nvs_DivestmentCostToSell": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "DivestmentCostToSell", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Divestment cost to sell" } } }, "auth_ref": [] }, "nvs_DivestmentDateFairValueOfTotalConsiderationTransferred": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "DivestmentDateFairValueOfTotalConsiderationTransferred", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Consideration transferred, divestment-date fair value" } } }, "auth_ref": [] }, "nvs_DivestmentFairValueOfContingentConsiderationReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "DivestmentFairValueOfContingentConsiderationReceived", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Fair value of contingent consideration received" } } }, "auth_ref": [] }, "nvs_DivestmentsAquisitionsOfInterestsInAssociatedCompanies": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "DivestmentsAquisitionsOfInterestsInAssociatedCompanies", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Divestments aquisitions of interests in associated companies", "terseLabel": "Acquisitions and divestments of interests in associated companies, net" } } }, "auth_ref": [] }, "nvs_DivestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "DivestmentsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q", "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Divestments [member]", "terseLabel": "Divestments" } } }, "auth_ref": [] }, "nvs_DividendPaidNoncashAssetsDistribution": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "DividendPaidNoncashAssetsDistribution", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Dividend paid, non-cash assets distribution", "negatedTerseLabel": "Dividend in kind" } } }, "auth_ref": [] }, "ifrs-full_DividendsPaid": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DividendsPaid", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ", "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Dividends recognised as distributions to owners", "negatedTerseLabel": "Dividends" } }, "en": { "role": { "documentation": "The amount of dividends recognised as distributions to owners." } } }, "auth_ref": [ "r199", "r272", "r288" ] }, "ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Dividends paid to shareholders of Novartis AG", "label": "Dividends paid to equity holders of parent, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow for dividends paid to equity holders of the parent, classified as financing activities." } } }, "auth_ref": [ "r398" ] }, "ifrs-full_DividendsPayable": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DividendsPayable", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend in kind distribution liability", "label": "Dividends payable, non-cash assets distributions", "verboseLabel": "Derecognition of distribution liability" } }, "en": { "role": { "documentation": "The amount of dividends payable by means of the distribution of non-cash assets to owners." } } }, "auth_ref": [ "r89" ] }, "ifrs-full_DividendsReceivedClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "DividendsReceivedClassifiedAsOperatingActivities", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlowCalc2": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends received from associated companies and others", "label": "Dividends received, classified as operating activities" } }, "en": { "role": { "documentation": "The cash inflow from dividends received, classified as operating activities. [Refer: Dividends received]" } } }, "auth_ref": [ "r70" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentAccountingStandard", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r384" ] }, "nvs_DocumentAndEntityInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "DocumentAndEntityInformationAbstract", "lang": { "en-us": { "role": { "label": "Document and Entity Information" } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentAnnualReport", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r383", "r384", "r385" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r383", "r384", "r385", "r387" ] }, "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Restatement Recovery Analysis [Flag]", "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)." } } }, "auth_ref": [ "r383", "r384", "r385", "r387" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentInformationLineItems", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentInformationTable", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodEndDate", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentRegistrationStatement", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r379" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentShellCompanyReport", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r384" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentTransitionReport", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r386" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentType", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Effect of exchange rate changes on cash and cash equivalents" } }, "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r68", "r69" ] }, "nvs_EffectOfTheSettlementOfShareBasedCompensationPlans": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "EffectOfTheSettlementOfShareBasedCompensationPlans", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Effect of the settlement of share based compensation plans" } } }, "auth_ref": [] }, "nvs_EffectOfWriteoffOfDeferredTaxAssets": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "EffectOfWriteoffOfDeferredTaxAssets", "calculation": { "http://novartis.com/20260630/role/DisclosureTaxesDetails3": { "parentTag": "ifrs-full_AverageEffectiveTaxRate", "weight": 1.0, "order": 9.0 } }, "lang": { "en-us": { "role": { "label": "Tax rate, effect of write-off of deferred tax assets", "terseLabel": "Effect of derecognition and reversals of derecognition of deferred tax assets" } } }, "auth_ref": [] }, "nvs_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions", "calculation": { "http://novartis.com/20260630/role/DisclosureTaxesDetails3": { "parentTag": "ifrs-full_AverageEffectiveTaxRate", "weight": 1.0, "order": 12.0 } }, "lang": { "en-us": { "role": { "label": "Effective income tax rate reconciliation change in uncertain tax positions" } } }, "auth_ref": [] }, "nvs_EliLillyAndCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "EliLillyAndCompanyMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Eli Lilly and Company [member]", "terseLabel": "Eli Lilly and Company" } } }, "auth_ref": [] }, "nvs_EmergingGrowthMarketsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "EmergingGrowthMarketsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Emerging Growth Markets [member]" } } }, "auth_ref": [] }, "nvs_EncoreVisionIncMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "EncoreVisionIncMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Encore Vision, Inc [member]", "terseLabel": "Encore Vision, Inc." } } }, "auth_ref": [] }, "nvs_EndocyteMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "EndocyteMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Endocyte [member]", "terseLabel": "Endocyte" } } }, "auth_ref": [] }, "nvs_EnoxaparinMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "EnoxaparinMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Enoxaparin [member]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine1", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCityOrTown", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCountry", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r381" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityDomain", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails2Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails5Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r381" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFileNumber", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFilerCategory", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r381" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r388" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r381" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityShellCompany", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r381" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityVoluntaryFilers", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r389" ] }, "nvs_EntrestoMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "EntrestoMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Entresto [member]" } } }, "auth_ref": [] }, "nvs_EnvironmentalRemediationProvisionNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "EnvironmentalRemediationProvisionNoncurrent", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails": { "parentTag": "ifrs-full_OtherNoncurrentNonfinancialLiabilities", "weight": 1.0, "order": 4.0 } }, "lang": { "en-us": { "role": { "periodEndLabel": "Non-current environmental remediation provisions at end of period", "terseLabel": "Environmental remediation provisions", "label": "Environmental remediation provisions, non-current" } } }, "auth_ref": [] }, "ifrs-full_Equity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Equity", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet", "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ", "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Equity", "totalLabel": "Total equity", "periodEndLabel": "Equity at end of period", "periodStartLabel": "Equity at beginning of period" } }, "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } } }, "auth_ref": [ "r91", "r93", "r118", "r119", "r121", "r227", "r249", "r267", "r268", "r275", "r304", "r311" ] }, "ifrs-full_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAbstract", "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Equity [abstract]" } } }, "auth_ref": [] }, "ifrs-full_EquityAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAndLiabilities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Equity and liabilities", "totalLabel": "Total equity and liabilities" } }, "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } } }, "auth_ref": [ "r304" ] }, "ifrs-full_EquityAndLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAndLiabilitiesAbstract", "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Equity and liabilities [abstract]" } } }, "auth_ref": [] }, "ifrs-full_EquityAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Equity attributable to owners of parent", "totalLabel": "Equity attributable to Novartis AG shareholders" } }, "en": { "role": { "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest." } } }, "auth_ref": [ "r303" ] }, "ifrs-full_EquityAttributableToOwnersOfParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EquityAttributableToOwnersOfParentMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ", "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Equity attributable to owners of parent [member]" } }, "en": { "role": { "documentation": "This member stands for equity attributable to the owners of the parent." } } }, "auth_ref": [ "r287" ] }, "nvs_EquityBasedCompensationPlansAndEmployeeTransactionsEquityImpact": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "EquityBasedCompensationPlansAndEmployeeTransactionsEquityImpact", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Equity-based compensation plans and employee transactions, equity impact" } } }, "auth_ref": [] }, "nvs_EquityBasedCompensationPlansAndEmployeeTransactionsShares": { "xbrltype": "sharesItemType", "nsuri": "http://novartis.com/20260630", "localname": "EquityBasedCompensationPlansAndEmployeeTransactionsShares", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Equity-based compensation plans and employee transactions, shares" } } }, "auth_ref": [] }, "nvs_EquityBasedCompensationShares": { "xbrltype": "sharesItemType", "nsuri": "http://novartis.com/20260630", "localname": "EquityBasedCompensationShares", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Equity based compensation shares" } } }, "auth_ref": [] }, "nvs_EquitySecurities1Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "EquitySecurities1Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Equity securities [member]" } } }, "auth_ref": [] }, "nvs_EquitySecuritiesCurrentMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "EquitySecuritiesCurrentMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Current debt and equity securities [member]" } } }, "auth_ref": [] }, "nvs_EstablishedBrandsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "EstablishedBrandsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Established Brands [member]" } } }, "auth_ref": [] }, "nvs_EstablishedMarketsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "EstablishedMarketsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Established Markets [member]" } } }, "auth_ref": [] }, "ifrs-full_EstimatedFinancialEffectOfContingentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "EstimatedFinancialEffectOfContingentLiabilities", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Estimated financial effect of contingent liabilities" } }, "en": { "role": { "documentation": "The amount of the estimated financial effect of contingent liabilities. [Refer: Classes of contingent liabilities [domain]]" } } }, "auth_ref": [ "r49", "r236" ] }, "nvs_EstimatedFinancialEffectOfContingentLiabilitiesCompensationForMoralDamages": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "EstimatedFinancialEffectOfContingentLiabilitiesCompensationForMoralDamages", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Estimated financial effect of contingent liabilities, compensation for moral damages" } } }, "auth_ref": [] }, "nvs_EstimatedFinancialEffectOfContingentLiabilitiesDamagesClaimed": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "EstimatedFinancialEffectOfContingentLiabilitiesDamagesClaimed", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Estimated financial effect of contingent liabilities, damages claimed" } } }, "auth_ref": [] }, "nvs_EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Estimated financial effect of contingent liabilities, maximum fine", "documentation": "This expresses a maximal amount." } } }, "auth_ref": [] }, "srt_EuropeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "EuropeMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Europe [member]" } } }, "auth_ref": [] }, "nvs_ExcelergyInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ExcelergyInc.Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails5Q" ], "lang": { "en-us": { "role": { "label": "Excelergy, Inc. [member]", "terseLabel": "dup_2_AveXis, Inc." } } }, "auth_ref": [] }, "nvs_ExcellergyInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ExcellergyInc.Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Excellergy, Inc. [member]", "terseLabel": "Excellergy, Inc." } } }, "auth_ref": [] }, "nvs_ExelonExelonPatchMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ExelonExelonPatchMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Exelon/Exelon Patch [member]" } } }, "auth_ref": [] }, "nvs_ExerciseOfOptionsAndEmployeeTransactionsShares": { "xbrltype": "sharesItemType", "nsuri": "http://novartis.com/20260630", "localname": "ExerciseOfOptionsAndEmployeeTransactionsShares", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Exercise of options and employee transactions shares" } } }, "auth_ref": [] }, "nvs_ExforgeGroupMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ExforgeGroupMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Exforge Group [member]" } } }, "auth_ref": [] }, "nvs_ExjadeJadenuMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ExjadeJadenuMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Exjade/Jadenu [member]" } } }, "auth_ref": [] }, "ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ExpenseDueToUnwindingOfDiscountOnProvisions", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails": { "parentTag": "ifrs-full_InterestExpense", "weight": 1.0, "order": 3.0 } }, "lang": { "en-us": { "role": { "label": "Expense due to unwinding of discount on provisions", "negatedTerseLabel": "Expense arising from discounting long-term liabilities" } } }, "auth_ref": [ "r410" ] }, "nvs_FHoffmanLaRocheAGAndRocheSpAMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "FHoffmanLaRocheAGAndRocheSpAMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "F Hoffman La Roche AG and Roche SpA [member]" } } }, "auth_ref": [] }, "country_FR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2025", "localname": "FR", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "FRANCE", "terseLabel": "France" } } }, "auth_ref": [] }, "nvs_FabhaltaMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "FabhaltaMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Fabhalta [member]" } } }, "auth_ref": [] }, "nvs_FairValueAdjustmentsOnFinancialAssetsSold": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "FairValueAdjustmentsOnFinancialAssetsSold", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Value adjustments related to financial assets sold and divestments", "negatedTerseLabel": "Value adjustments related to financial assets sold and divestments", "terseLabel": "Fair value adjustments on equity securities sold, reclassified to retained earnings" } } }, "auth_ref": [] }, "nvs_FairValueAdjustmentsRelatedToDivestments": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "FairValueAdjustmentsRelatedToDivestments", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Fair value adjustments related to divestments" } } }, "auth_ref": [] }, "nvs_FairValueByMeasurementBasis1Axis": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "FairValueByMeasurementBasis1Axis", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Fair value by measurement basis [axis]" } } }, "auth_ref": [] }, "nvs_FairValueByMeasurementBasisMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "FairValueByMeasurementBasisMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Fair value by measurement basis [member]" } } }, "auth_ref": [] }, "nvs_FairValueDisclosureItemAmountsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "FairValueDisclosureItemAmountsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Fair value disclosure item amounts [member]", "terseLabel": "Fair values" } } }, "auth_ref": [] }, "nvs_FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://novartis.com/20260630", "localname": "FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsTablesQ" ], "lang": { "en-us": { "role": { "label": "Fair value of assets and liabilities arising from acquisitions [table text block]", "terseLabel": "Fair value of assets and liabilities acquired through business combinations" } } }, "auth_ref": [] }, "nvs_FairValueOfOtherFinancialAssetsSold": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "FairValueOfOtherFinancialAssetsSold", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Fair value of other financial assets sold" } } }, "auth_ref": [] }, "ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinanceCostsPaidClassifiedAsOperatingActivities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlowCalc2": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Finance costs paid, classified as operating activities", "negatedTerseLabel": "Other financial payments" } } }, "auth_ref": [ "r402" ] }, "ifrs-full_FinanceIncomeReceivedClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinanceIncomeReceivedClassifiedAsOperatingActivities", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlowCalc2": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Finance income received, classified as operating activities", "terseLabel": "Other financial receipts" } } }, "auth_ref": [ "r402" ] }, "nvs_FinancialAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "FinancialAndOtherAssets", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Other non-current assets as of acquisition date" } } }, "auth_ref": [] }, "nvs_FinancialAndOtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "FinancialAndOtherLiabilities", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Other non-current liabilities as of acquisition date", "negatedTerseLabel": "Other non-current liabilities as of acquisition date" } } }, "auth_ref": [] }, "ifrs-full_FinancialAssetsAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinancialAssetsAtFairValue", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Financial assets, at fair value" } }, "en": { "role": { "documentation": "The fair value of financial assets. [Refer: At fair value [member]; Financial assets]" } } }, "auth_ref": [ "r161" ] }, "ifrs-full_FinancialAssetsImpairedMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinancialAssetsImpairedMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Financial assets impaired [member]", "terseLabel": "Financial assets" } }, "en": { "role": { "documentation": "This member stands for financial assets that have been impaired. [Refer: Financial assets]" } } }, "auth_ref": [ "r279" ] }, "nvs_FinancialDebtToThirdParties": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "FinancialDebtToThirdParties", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Financial debt to third parties" } } }, "auth_ref": [] }, "ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinancialEffectOfChangesInAccountingPolicyMember", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) due to changes in accounting policy [member]" } }, "en": { "role": { "documentation": "This member stands for the financial effect of changes in accounting policy." } } }, "auth_ref": [ "r82", "r84", "r205", "r207" ] }, "nvs_FinancialInstrumentsAdditionalDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "FinancialInstrumentsAdditionalDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Financial Instruments - additional disclosure [abstract]" } } }, "auth_ref": [] }, "nvs_FinancialInvestmentsAndOtherReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "FinancialInvestmentsAndOtherReceivable", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Financial investments and other receivable" } } }, "auth_ref": [] }, "ifrs-full_FinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinancialLiabilities", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Financial liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r161" ] }, "ifrs-full_FinancialLiabilitiesAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FinancialLiabilitiesAtFairValue", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q", "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Financial liabilities, at fair value", "negatedTerseLabel": "Financial liabilities, at fair value" } }, "en": { "role": { "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]" } } }, "auth_ref": [ "r161" ] }, "ifrs-full_FixedInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FixedInterestRateMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails2Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Fixed interest rate [member]" } }, "en": { "role": { "documentation": "This member stands for a fixed interest rate. [Refer: Interest rate risk [member]]" } } }, "auth_ref": [ "r406" ] }, "ifrs-full_FloatingInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "FloatingInterestRateMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails2Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Floating interest rate [member]" } }, "en": { "role": { "documentation": "This member stands for a non-fixed interest rate. [Refer: Interest rate risk [member]]" } } }, "auth_ref": [ "r406" ] }, "nvs_FundInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "FundInvestmentsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Fund investments [member]" } } }, "auth_ref": [] }, "nvs_FuturePutOptionToSellBusiness": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "FuturePutOptionToSellBusiness", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Future put option to sell business" } } }, "auth_ref": [] }, "country_GR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2025", "localname": "GR", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "GREECE", "terseLabel": "Greece" } } }, "auth_ref": [] }, "nvs_GSKConsumerHealthcareMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "GSKConsumerHealthcareMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "GSK Consumer Healthcare [member]", "terseLabel": "GSK Consumer Healthcare" } } }, "auth_ref": [] }, "nvs_GSKOncologyProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "GSKOncologyProductsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "GSK Oncology Products [member]", "terseLabel": "GSK Oncology Products" } } }, "auth_ref": [] }, "nvs_GSKTotalTransactionMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "GSKTotalTransactionMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "GSK Total Transaction [member]", "terseLabel": "GSK Total Transaction" } } }, "auth_ref": [] }, "nvs_GSKVaccinesMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "GSKVaccinesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "GSK Vaccines [member]", "terseLabel": "GSK Vaccines" } } }, "auth_ref": [] }, "nvs_GainLossOnSaleOfOtherFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "GainLossOnSaleOfOtherFinancialAssets", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Gain (loss) on sale of other financial assets", "terseLabel": "Other financial assets sold" } } }, "auth_ref": [] }, "ifrs-full_GainLossRecognisedAsResultOfRemeasuringToFairValueEquityInterestInAcquireeHeldByAcquirerBeforeBusinessCombination": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GainLossRecognisedAsResultOfRemeasuringToFairValueEquityInterestInAcquireeHeldByAcquirerBeforeBusinessCombination", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Gain (loss) recognised as result of remeasuring to fair value equity interest in acquiree held by acquirer before business combination" } }, "en": { "role": { "documentation": "The gain (loss) recognised as result of remeasuring to fair value the equity interest in the acquiree held by the acquirer before the business combination. [Refer: Total for all business combinations [member]]" } } }, "auth_ref": [ "r149" ] }, "nvs_GainOnDivestmentOfInterestsInAssociatedCompanies": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "GainOnDivestmentOfInterestsInAssociatedCompanies", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Gain on divestment of interests in associated companies", "terseLabel": "Gain on divestment" } } }, "auth_ref": [] }, "ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GainsLossesOnAvailableforsaleFinancialAssets", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails2": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": 1.0, "order": 3.0 } }, "lang": { "en-us": { "role": { "terseLabel": "Net capital losses on available-for-sale securities", "label": "Gains (losses) on available-for-sale financial assets" } }, "en": { "role": { "documentation": "The gains (losses) on available-for-sale financial assets. [Refer: Financial assets available-for-sale]" } } }, "auth_ref": [ "r278" ] }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails2": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": 1.0, "order": 8.0 } }, "lang": { "en-us": { "role": { "label": "Foreign exchange gain (loss)", "terseLabel": "Currency result, net" } }, "en": { "role": { "documentation": "The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Classes of financial instruments [domain]]" } } }, "auth_ref": [ "r16", "r222", "r291" ] }, "ifrs-full_GainsLossesOnNetMonetaryPosition": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GainsLossesOnNetMonetaryPosition", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails2": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": 1.0, "order": 7.0 } }, "lang": { "en-us": { "role": { "label": "Gains (losses) on net monetary position", "terseLabel": "Monetary loss from hyperinflation accounting" } }, "en": { "role": { "documentation": "The gains (losses) representing the difference resulting from the restatement of non-monetary assets, owners' equity and items in the statement of comprehensive income and the adjustment of index linked assets and liabilities in hyperinflationary reporting." } } }, "auth_ref": [ "r32" ] }, "nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "GainsLossesOnValueAdjustmentOnComprehensiveIncome", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "lang": { "en-us": { "role": { "label": "Gains (losses) on value adjustment on comprehensive income", "totalLabel": "Total value adjustments" } } }, "auth_ref": [] }, "nvs_GalvusGroupMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "GalvusGroupMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Galvus Group [member]" } } }, "auth_ref": [] }, "ifrs-full_GeographicalAreasAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GeographicalAreasAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Geographical areas [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r181", "r329", "r348", "r351", "r364" ] }, "ifrs-full_GeographicalAreasDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GeographicalAreasDomain", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Geographical areas [domain]" } }, "en": { "role": { "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used." } } }, "auth_ref": [ "r181", "r329", "r348", "r351", "r364" ] }, "nvs_GilenyaMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "GilenyaMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Gilenya [member]" } } }, "auth_ref": [] }, "nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "GlaxoSmithKline Consumer Healthcare Holdings Ltd. [member]", "terseLabel": "GlaxoSmithKline Consumer Healthcare Holdings Ltd., UK" } } }, "auth_ref": [] }, "nvs_GlaxoSmithKlinePlcGSKMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "GlaxoSmithKlinePlcGSKMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "GlaxoSmithKline plc (GSK) [member]", "terseLabel": "GlaxoSmithKline plc (GSK)" } } }, "auth_ref": [] }, "nvs_GlaxosmithklineConsumerHealthcareHoldingsLimitedBrentfordMiddlesexMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "GlaxosmithklineConsumerHealthcareHoldingsLimitedBrentfordMiddlesexMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Glaxosmithkline Consumer Healthcare Holdings Limited, Brentford, Middlesex [member]", "terseLabel": "Glaxosmithkline Consumer Healthcare Holdings Limited, Brentford, Middlesex" } } }, "auth_ref": [] }, "nvs_GleevecGlivecMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "GleevecGlivecMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Gleevec/Glivec [member]" } } }, "auth_ref": [] }, "nvs_GleevecMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "GleevecMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Gleevec [member]" } } }, "auth_ref": [] }, "ifrs-full_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Goodwill" } }, "en": { "role": { "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]]" } } }, "auth_ref": [ "r43", "r47", "r152", "r230", "r234", "r258", "r293" ] }, "ifrs-full_GoodwillExpectedDeductibleForTaxPurposes": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GoodwillExpectedDeductibleForTaxPurposes", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Goodwill expected to be deductible for tax purposes" } }, "en": { "role": { "documentation": "The amount of goodwill in a business combination that is expected to be deductible for tax purposes. [Refer: Goodwill; Total for all business combinations [member]]" } } }, "auth_ref": [ "r146" ] }, "ifrs-full_GoodwillMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GoodwillMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Goodwill [member]", "terseLabel": "Goodwill" } }, "en": { "role": { "documentation": "This member stands for goodwill. [Refer: Goodwill]" } } }, "auth_ref": [ "r333", "r366" ] }, "ifrs-full_GoodwillRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GoodwillRecognisedAsOfAcquisitionDate", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Goodwill recognised as of acquisition date", "terseLabel": "Goodwill" } }, "en": { "role": { "documentation": "The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Total for all business combinations [member]]" } } }, "auth_ref": [ "r354", "r355", "r368" ] }, "ifrs-full_GrossCarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GrossCarryingAmountMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Gross carrying amount [member]", "terseLabel": "Gross carrying amount" } } }, "auth_ref": [ "r5", "r50", "r60", "r63", "r152", "r164", "r166", "r215", "r237", "r245", "r248", "r262", "r263", "r356" ] }, "ifrs-full_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Gross profit", "totalLabel": "Gross profit" } } }, "auth_ref": [ "r372" ] }, "nvs_GroupsOfFinancialAssetsLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "GroupsOfFinancialAssetsLiabilitiesAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q", "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Groups of financial assets/liabilities [axis]" } } }, "auth_ref": [] }, "nvs_GroupsOfFinancialAssetsLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "GroupsOfFinancialAssetsLiabilitiesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q", "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Groups of financial assets/liabilities [member]" } } }, "auth_ref": [] }, "nvs_GyroscopeTherapeuticsHoldingsPlcMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "GyroscopeTherapeuticsHoldingsPlcMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Gyroscope Therapeutics Holdings plc. [member]", "terseLabel": "Gyroscope Therapeutics Holdings plc." } } }, "auth_ref": [] }, "nvs_IFMTreInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "IFMTreInc.Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "IFM Tre, Inc. [member]", "terseLabel": "IFM Tre, Inc." } } }, "auth_ref": [] }, "nvs_IPRDProgramsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "IPRDProgramsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "IPR&D programs [member]" } } }, "auth_ref": [] }, "country_IT": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2025", "localname": "IT", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "ITALY", "terseLabel": "Italy" } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r383", "r384", "r385" ] }, "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IdentifiableAssetsAcquiredLiabilitiesAssumed", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Identifiable assets acquired (liabilities assumed)", "terseLabel": "Net identifiable assets acquired", "negatedTerseLabel": "Net identifiable assets acquired" } }, "en": { "role": { "documentation": "The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Total for all business combinations [member]]" } } }, "auth_ref": [ "r353", "r355", "r367" ] }, "nvs_IdentifiableNetAssetsAcquiredThroughAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "IdentifiableNetAssetsAcquiredThroughAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Identifiable net assets acquired through acquisitions applying the optional concentration test", "totalLabel": "Identifiable net assets acquired through acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "nvs_IdentifiableNetAssetsAcquiredThroughAcquisitionsApplyingTheOptionalConcentrationTestTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://novartis.com/20260630", "localname": "IdentifiableNetAssetsAcquiredThroughAcquisitionsApplyingTheOptionalConcentrationTestTableTextBlock", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsTablesQ" ], "lang": { "en-us": { "role": { "label": "Identifiable net assets acquired through acquisitions applying the optional concentration test [table text block]", "terseLabel": "Identifiable net assets acquired through acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "nvs_IlarisMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "IlarisMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Ilaris [member]" } } }, "auth_ref": [] }, "nvs_ImmunologyMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ImmunologyMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Immunology [member]" } } }, "auth_ref": [] }, "nvs_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment charges and fair value gains on financial assets, net", "label": "Impairment charges and fair value gains on financial assets, net", "negatedTerseLabel": "Impairment charges and fair value gains on financial assets, net" } } }, "auth_ref": [] }, "ifrs-full_ImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ImpairmentLoss", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Impairment loss" } }, "en": { "role": { "documentation": "The amount recognised as a reduction of the carrying amount of an asset or cash-generating unit to its recoverable amount. [Refer: Carrying amount [member]]" } } }, "auth_ref": [ "r39", "r40" ] }, "nvs_ImpairmentLossOnCommoditiesAndAvailableforsaleSecuritiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ImpairmentLossOnCommoditiesAndAvailableforsaleSecuritiesNet", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails2": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": -1.0, "order": 5.5 } }, "lang": { "en-us": { "role": { "label": "Impairment loss on commodities and available-for-sale securities, net", "negatedTerseLabel": "Impairment of commodities and available-for-sale securities, net" } } }, "auth_ref": [] }, "ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Impairment loss recognised in profit or loss, intangible assets and goodwill", "terseLabel": "Impairment charge", "negatedLabel": "Impairment loss recognised in profit or loss, intangible assets and goodwill", "negatedTerseLabel": "Intangible assets impairment charges" } } }, "auth_ref": [ "r393" ] }, "ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment charge", "label": "Impairment loss recognised in profit or loss, property, plant and equipment", "negatedTerseLabel": "Property, plant and equipment impairment charges" } } }, "auth_ref": [ "r7", "r217", "r326" ] }, "ifrs-full_ImpairmentLossRecognisedInProfitOrLossRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ImpairmentLossRecognisedInProfitOrLossRightofuseAssets", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Impairment loss recognised in profit or loss, right-of-use assets", "terseLabel": "Impairment loss recognised in profit or loss, right of use assets", "negatedTerseLabel": "Impairment loss recognised in profit or loss, right of use assets" } } }, "auth_ref": [ "r391" ] }, "ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Impairment loss (reversal of impairment loss) recognised in profit or loss", "negatedTerseLabel": "Impairment loss (reversal of impairment loss) recognised in profit or loss", "negatedLabel": "Impairment (loss) reversal of impairment loss recognised in profit or loss" } } }, "auth_ref": [ "r198", "r328" ] }, "nvs_IncomeOnForwardContractsAndOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "IncomeOnForwardContractsAndOptions", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails2": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": 1.0, "order": 4.0 } }, "lang": { "en-us": { "role": { "label": "Income on forward contracts and options" } } }, "auth_ref": [] }, "ifrs-full_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Profit or loss [abstract]", "terseLabel": "Consolidated income statements [abstract]" } } }, "auth_ref": [] }, "nvs_IncomeStatementLocation1Axis": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "IncomeStatementLocation1Axis", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Income statement location [axis]" } } }, "auth_ref": [] }, "nvs_IncomeStatementLocationMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "IncomeStatementLocationMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Income statement location [member]" } } }, "auth_ref": [] }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncomeTaxExpenseContinuingOperations", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": "ifrs-full_ProfitLossFromContinuingOperations", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ", "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Tax expense (income), continuing operations", "terseLabel": "Income tax expense", "negatedTerseLabel": "Income taxes", "negatedLabel": "Income tax expense from continuing operations", "verboseLabel": "Income taxes" } } }, "auth_ref": [ "r1", "r2", "r3", "r26", "r114", "r172", "r211", "r212", "r213", "r322" ] }, "ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncomeTaxesPaidRefundClassifiedAsOperatingActivities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlowCalc2": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Income taxes paid (refund), classified as operating activities", "terseLabel": "Taxes paid", "negatedTerseLabel": "Income taxes paid", "negatedLabel": "Income taxes refund/(paid), classified as operating activities" } }, "en": { "role": { "documentation": "The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]" } } }, "auth_ref": [ "r71", "r339" ] }, "ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) due to changes in accounting policy and corrections of prior period errors [member]" } }, "en": { "role": { "documentation": "This member stands for the financial effect of changes in accounting policy and corrections of prior period errors." } } }, "auth_ref": [ "r82", "r84", "r86", "r205", "r207", "r210", "r282" ] }, "ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) due to changes in accounting policy required by IFRSs [member]" } } }, "auth_ref": [ "r82", "r83", "r205", "r206" ] }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseInCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in cash and cash equivalents", "totalLabel": "Net change in cash and cash equivalents" } }, "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } } }, "auth_ref": [ "r79", "r203" ] }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Net change in cash and cash equivalents before effect of exchange rate changes", "label": "Increase (decrease) in cash and cash equivalents before effect of exchange rate changes" } }, "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } } }, "auth_ref": [ "r79", "r203" ] }, "ifrs-full_IncreaseDecreaseInDividendsPayableThroughChangeInFairValueOfNoncashAssetsHeldForDistributionToOwners": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseInDividendsPayableThroughChangeInFairValueOfNoncashAssetsHeldForDistributionToOwners", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in dividends payable through change in fair value of non-cash assets held for distribution to owners", "terseLabel": "Decrease of distribution liability" } }, "en": { "role": { "documentation": "The increase (decrease) in dividends payable through a change in the fair value of non-cash assets held for distribution to owners." } } }, "auth_ref": [ "r90" ] }, "nvs_IncreaseDecreaseInNoncontrolingInterests": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "IncreaseDecreaseInNoncontrolingInterests", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ", "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in non-controling interests", "terseLabel": "Changes in non-controlling interests" } } }, "auth_ref": [] }, "nvs_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ", "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Increase/decrease of treasury share repurchase obligation under a share buyback trading plan", "terseLabel": "(Increase)/decrease of treasury share repurchase obligation under a share buyback trading plan", "negatedTerseLabel": "Increase/decrease of treasury share repurchase obligation under a share buyback trading plan" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through changes in ownership interests in subsidiaries that do not result in loss of control, equity", "negatedTerseLabel": "Impact of change in ownership of consolidated entities", "terseLabel": "Impact of change in ownership of consolidated entities" } }, "en": { "role": { "documentation": "The increase (decrease) in equity through changes in ownership interests in subsidiaries that do not result in loss of control. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r285" ] }, "nvs_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesWithoutLossOfControl": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesWithoutLossOfControl", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Increase/decrease through changes in ownership interests in subsidiaries without loss of control" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughExerciseOfOptions", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ", "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through exercise of options, equity", "terseLabel": "Exercise of options and employee transactions, equity impact" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the exercise of options." } } }, "auth_ref": [ "r409" ] }, "nvs_IncreaseDecreaseThroughOtherChangesInEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "IncreaseDecreaseThroughOtherChangesInEquity", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Increase/decrease through other changes in equity" } } }, "auth_ref": [] }, "nvs_IncreaseDecreaseThroughOtherChangesInEquityShares": { "xbrltype": "sharesItemType", "nsuri": "http://novartis.com/20260630", "localname": "IncreaseDecreaseThroughOtherChangesInEquityShares", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Increase/decrease through other changes in equity, shares" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "Equity-based compensation plans", "terseLabel": "Equity-based compensation, equity impact", "label": "Increase (decrease) through share-based payment transactions, equity" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } } }, "auth_ref": [ "r285" ] }, "ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IncreaseDecreaseThroughTransfersAndOtherChangesEquity", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through other changes, equity", "terseLabel": "Other movements" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Equity]" } } }, "auth_ref": [ "r286" ] }, "nvs_IncreaseDecreaseThroughTransfersAndOtherMovementsEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "IncreaseDecreaseThroughTransfersAndOtherMovementsEquity", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Increase decrease through transfers and other movements equity", "terseLabel": "Other movements" } } }, "auth_ref": [] }, "nvs_IncreaseDecreaseThroughTransfersAndOtherMovementsEquityShares": { "xbrltype": "sharesItemType", "nsuri": "http://novartis.com/20260630", "localname": "IncreaseDecreaseThroughTransfersAndOtherMovementsEquityShares", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Increase decrease through transfers and other movements equity, shares", "terseLabel": "dup_1_Total movements" } } }, "auth_ref": [] }, "nvs_InnovativeMedicinesMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "InnovativeMedicinesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOperatingSegmentsQ", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails4Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Innovative Medicines [member]", "terseLabel": "Innovative Medicines" } } }, "auth_ref": [] }, "ifrs-full_IntangibleAssetsAndGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IntangibleAssetsAndGoodwill", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Intangible assets and goodwill", "periodStartLabel": "Intangible assets and goodwill at beginning of period", "periodEndLabel": "Intangible assets and goodwill at end of period", "terseLabel": "Net book value" } }, "en": { "role": { "documentation": "The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r412" ] }, "nvs_IntangibleAssetsAndGoodwillMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "IntangibleAssetsAndGoodwillMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q", "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Intangible assets and goodwill [member]", "terseLabel": "Intangible assets", "verboseLabel": "Intangible assets [member]" } } }, "auth_ref": [] }, "ifrs-full_IntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Intangible assets other than goodwill" } }, "en": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]" } } }, "auth_ref": [ "r54", "r241", "r293" ] }, "nvs_IntangibleAssetsOtherThanGoodwillForAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "IntangibleAssetsOtherThanGoodwillForAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Intangible assets other than goodwill for acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IntangibleAssetsOtherThanGoodwillMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Intangible assets other than goodwill [member]", "terseLabel": "Intangible Assets other than Goodwill" } }, "en": { "role": { "documentation": "This member stands for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r333", "r349", "r365", "r366" ] }, "nvs_InterestBearningAccountsOfAssociatesPayableOnDemand": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "InterestBearningAccountsOfAssociatesPayableOnDemand", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsDetails": { "parentTag": "ifrs-full_OtherCurrentFinancialLiabilities", "weight": 1.0, "order": 5.0 } }, "lang": { "en-us": { "role": { "label": "Interest bearning accounts of associates payable on demand" } } }, "auth_ref": [] }, "nvs_InterestExchanged": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "InterestExchanged", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Interest exchanged" } } }, "auth_ref": [] }, "ifrs-full_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 1.0 }, "http://novartis.com/20260630/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Interest expense", "totalLabel": "Total Interest Expense", "negatedTerseLabel": "Interest expense", "negatedTotalLabel": "Total interest expense" } }, "en": { "role": { "documentation": "The amount of expense arising from interest." } } }, "auth_ref": [ "r113", "r170", "r178" ] }, "nvs_InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails": { "parentTag": "ifrs-full_InterestExpense", "weight": 1.0, "order": 1.0 } }, "lang": { "en-us": { "role": { "label": "Interest expense, gross", "negatedTerseLabel": "Interest expense" } } }, "auth_ref": [] }, "ifrs-full_InterestExpenseOnLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InterestExpenseOnLeaseLiabilities", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails": { "parentTag": "ifrs-full_InterestExpense", "weight": 1.0, "order": 2.0 } }, "lang": { "en-us": { "role": { "label": "Interest expense on lease liabilities", "negatedTerseLabel": "Interest expense on lease liabilities" } } }, "auth_ref": [ "r130", "r188" ] }, "ifrs-full_InterestPaidClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InterestPaidClassifiedAsOperatingActivities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlowCalc2": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Interest paid, classified as operating activities", "negatedTerseLabel": "Interest paid" } }, "en": { "role": { "documentation": "The cash outflow for interest paid, classified as operating activities." } } }, "auth_ref": [ "r70" ] }, "ifrs-full_InterestReceivable": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InterestReceivable", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureMarketableSecuritiesDetails": { "parentTag": "ifrs-full_OtherCurrentFinancialAssets", "weight": 1.0, "order": 8.0 } }, "lang": { "en-us": { "role": { "label": "Interest receivable", "terseLabel": "Accrued interest on debt securities and time deposits" } }, "en": { "role": { "documentation": "The amount of interest recognised as a receivable." } } }, "auth_ref": [ "r410" ] }, "ifrs-full_InterestReceivedClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InterestReceivedClassifiedAsOperatingActivities", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlowCalc2": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Interest received, classified as operating activities", "terseLabel": "Interest received" } }, "en": { "role": { "documentation": "The cash inflow from interest received, classified as operating activities." } } }, "auth_ref": [ "r70" ] }, "ifrs-full_Inventories": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Inventories", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Current inventories", "terseLabel": "Inventories", "verboseLabel": "Inventory" } }, "en": { "role": { "documentation": "The amount of current inventories. [Refer: Inventories]" } } }, "auth_ref": [ "r15", "r202", "r296", "r374" ] }, "ifrs-full_InventoryRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InventoryRecognisedAsOfAcquisitionDate", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Inventory recognised as of acquisition date", "terseLabel": "Inventories" } }, "en": { "role": { "documentation": "The amount recognised as of the acquisition date for inventory acquired in a business combination. [Refer: Inventories; Total for all business combinations [member]]" } } }, "auth_ref": [ "r353", "r355", "r367" ] }, "ifrs-full_InvestmentAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InvestmentAccountedForUsingEquityMethod", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Investments accounted for using equity method", "terseLabel": "Investments in associated companies", "verboseLabel": "Balance sheet value" } }, "en": { "role": { "documentation": "The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]" } } }, "auth_ref": [ "r115", "r174", "r266", "r295" ] }, "ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "InvestmentsInSubsidiariesJointVenturesAndAssociates", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Investments in subsidiaries, joint ventures and associates" } }, "en": { "role": { "documentation": "The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Total for all associates [member]; Total for all joint ventures [member]; Total for all subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]" } } }, "auth_ref": [ "r27" ] }, "ifrs-full_IssuedCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IssuedCapital", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 1.0 }, "http://novartis.com/20260630/role/DisclosureEquityDetails": { "parentTag": "nvs_OutstandingShareCapital", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Issued capital", "terseLabel": "Share capital", "periodStartLabel": "Share capital at beginning of period", "periodEndLabel": "Share capital at end of period" } }, "en": { "role": { "documentation": "The nominal value of capital issued." } } }, "auth_ref": [ "r370", "r376" ] }, "ifrs-full_IssuedCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "IssuedCapitalMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ", "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Issued capital [member]", "terseLabel": "Share capital" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } } }, "auth_ref": [ "r287" ] }, "nvs_IssuedCapitalMovement": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "IssuedCapitalMovement", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureEquityDetails": { "parentTag": "nvs_OutstandingShareCapitalMovement", "weight": 1.0, "order": 2.0 } }, "lang": { "en-us": { "role": { "label": "Issued capital, movement", "terseLabel": "Share capital movement of period" } } }, "auth_ref": [] }, "country_JP": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2025", "localname": "JP", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "JAPAN", "terseLabel": "Japan" } } }, "auth_ref": [] }, "nvs_JakaviMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "JakaviMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Jakavi [member]" } } }, "auth_ref": [] }, "country_KR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2025", "localname": "KR", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "KOREA, REPUBLIC OF", "terseLabel": "South Korea" } } }, "auth_ref": [] }, "nvs_KateTherapeuticsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "KateTherapeuticsIncMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Kate Therapeutics, Inc. [member]", "terseLabel": "Kate Therapeutics, Inc." } } }, "auth_ref": [] }, "nvs_KesimptaMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "KesimptaMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Kesimpta [member]" } } }, "auth_ref": [] }, "ifrs-full_KeyManagementPersonnelCompensation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "KeyManagementPersonnelCompensation", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureTransactionsWithRelatedPartiesDetails2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "lang": { "en-us": { "role": { "label": "Key management personnel compensation", "totalLabel": "Total" } } }, "auth_ref": [ "r22", "r225" ] }, "ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "KeyManagementPersonnelCompensationPostemploymentBenefits", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureTransactionsWithRelatedPartiesDetails2": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 2.0 } }, "lang": { "en-us": { "role": { "label": "Key management personnel compensation, post-employment benefits", "terseLabel": "Post-employment benefits" } } }, "auth_ref": [ "r20" ] }, "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "KeyManagementPersonnelCompensationSharebasedPayment", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureTransactionsWithRelatedPartiesDetails2": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 3.0 } }, "lang": { "en-us": { "role": { "label": "Key management personnel compensation, share-based payment", "terseLabel": "Equity-based compensation" } } }, "auth_ref": [ "r21" ] }, "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureTransactionsWithRelatedPartiesDetails2": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 1.5 } }, "lang": { "en-us": { "role": { "terseLabel": "Benefits other than equity-based compensation", "label": "Key management personnel compensation, short-term employee benefits" } } }, "auth_ref": [ "r19" ] }, "nvs_KisqaliMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "KisqaliMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Kisqali [member]" } } }, "auth_ref": [] }, "nvs_KymriahMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "KymriahMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Kymriah [member]" } } }, "auth_ref": [] }, "nvs_LaterThanFiveYearsAndNotLaterThanSixYearsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "LaterThanFiveYearsAndNotLaterThanSixYearsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails4Q" ], "lang": { "en-us": { "role": { "label": "Later than five years and not later than six years [member]", "terseLabel": "Later than five years and not later than six years" } } }, "auth_ref": [] }, "ifrs-full_LaterThanFiveYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LaterThanFiveYearsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails4Q" ], "lang": { "en-us": { "role": { "label": "Later than five years [member]", "terseLabel": "Later than five years" } }, "en": { "role": { "documentation": "This member stands for a time band of later than five years." } } }, "auth_ref": [ "r134", "r135", "r140", "r193", "r196", "r357", "r358", "r360" ] }, "ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LaterThanFourYearsAndNotLaterThanFiveYearsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails4Q" ], "lang": { "en-us": { "role": { "label": "Later than four years and not later than five years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than four years and not later than five years." } } }, "auth_ref": [ "r134", "r135", "r140", "r357", "r360", "r410" ] }, "ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LaterThanOneYearAndNotLaterThanTwoYearsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails4Q" ], "lang": { "en-us": { "role": { "label": "Later than one year and not later than two years [member]", "terseLabel": "Later than one year and not later than two years" } }, "en": { "role": { "documentation": "This member stands for a time band of later than one year and not later than two years." } } }, "auth_ref": [ "r134", "r135", "r140", "r357", "r360", "r410" ] }, "nvs_LaterThanSixYearsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "LaterThanSixYearsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails4Q" ], "lang": { "en-us": { "role": { "label": "Later than six years [member]", "terseLabel": "Later than six years" } } }, "auth_ref": [] }, "ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LaterThanThreeYearsAndNotLaterThanFourYearsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails4Q" ], "lang": { "en-us": { "role": { "label": "Later than three years and not later than four years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than three years and not later than four years." } } }, "auth_ref": [ "r134", "r135", "r140", "r357", "r360", "r410" ] }, "ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LaterThanTwoYearsAndNotLaterThanThreeYearsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails4Q" ], "lang": { "en-us": { "role": { "label": "Later than two years and not later than three years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than two years and not later than three years." } } }, "auth_ref": [ "r134", "r135", "r140", "r357", "r360", "r410" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LegalEntityAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails2Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails5Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "ifrs-full_LegalProceedingsProvisionMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LegalProceedingsProvisionMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Legal proceedings provision [member]" } }, "en": { "role": { "documentation": "This member stands for a provision for legal proceedings. [Refer: Classes of other provisions [domain]]" } } }, "auth_ref": [ "r335", "r336" ] }, "nvs_LegalProceedingsUpdateAbstract": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "LegalProceedingsUpdateAbstract", "lang": { "en-us": { "role": { "label": "Legal proceedings update [abstract]" } } }, "auth_ref": [] }, "nvs_LegalProceedingsUpdateTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://novartis.com/20260630", "localname": "LegalProceedingsUpdateTextBlock", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateQ" ], "lang": { "en-us": { "role": { "label": "Legal proceedings update [text block]", "terseLabel": "Legal proceedings update" } } }, "auth_ref": [] }, "nvs_LeqvioMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "LeqvioMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Leqvio [member]" } } }, "auth_ref": [] }, "ifrs-full_Level1OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Level1OfFairValueHierarchyMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q", "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Level 1 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date." } } }, "auth_ref": [ "r14", "r41", "r45", "r119", "r232", "r268" ] }, "ifrs-full_Level2OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Level2OfFairValueHierarchyMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q", "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Level 2 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly." } } }, "auth_ref": [ "r41", "r45", "r119", "r232", "r268" ] }, "ifrs-full_Level3OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Level3OfFairValueHierarchyMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q", "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Level 3 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability." } } }, "auth_ref": [ "r41", "r45", "r119", "r232", "r268" ] }, "ifrs-full_LevelsOfFairValueHierarchyAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LevelsOfFairValueHierarchyAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q", "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Levels of fair value hierarchy [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r14", "r119", "r268" ] }, "ifrs-full_LevelsOfFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LevelsOfFairValueHierarchyDomain", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q", "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Levels of fair value hierarchy [domain]" } }, "en": { "role": { "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used." } } }, "auth_ref": [ "r14", "r119", "r268" ] }, "ifrs-full_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total liabilities", "negatedLabel": "Total liabilities", "negatedTotalLabel": "Total liabilities" } }, "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r118", "r119", "r121", "r173", "r177", "r267", "r268", "r304" ] }, "ifrs-full_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LiabilitiesAbstract", "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Liabilities [abstract]" } } }, "auth_ref": [] }, "ifrs-full_LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Liabilities in subsidiary or businesses acquired or disposed" } }, "en": { "role": { "documentation": "The amount of liabilities in subsidiaries or other businesses over which control is obtained or lost. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r76" ] }, "ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Liabilities included in disposal groups classified as held for sale", "terseLabel": "Liabilities of disposal group held for sale" } }, "en": { "role": { "documentation": "The amount of liabilities included in disposal groups classified as held for sale. [Refer: Liabilities; Disposal groups classified as held for sale [member]]" } } }, "auth_ref": [ "r158", "r301" ] }, "nvs_LiabilitiesToBanksAndOtherInstitutions": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "LiabilitiesToBanksAndOtherInstitutions", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureNonCurrentFinancialDebtDetails": { "parentTag": "ifrs-full_Borrowings", "weight": 1.0, "order": 4.0 } }, "lang": { "en-us": { "role": { "label": "Liabilities to banks and other institutions", "negatedTerseLabel": "Liabilities to banks and other financial institutions" } } }, "auth_ref": [] }, "nvs_LiabilityRelatedToEmployeeSharePlansForAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "LiabilityRelatedToEmployeeSharePlansForAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Liability related to employee share plans for acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "nvs_LocalBilateralFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "LocalBilateralFacilitiesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Local bilateral facilities [member]" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LocalPhoneNumber", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "nvs_LongTermFinancialInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "LongTermFinancialInvestmentsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Long-term financial investments [member]" } } }, "auth_ref": [] }, "nvs_LongTermLoansAdvancesAndSecurityDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "LongTermLoansAdvancesAndSecurityDeposits", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails": { "parentTag": "ifrs-full_NoncurrentFinancialAssets", "weight": 1.0, "order": 8.5 } }, "lang": { "en-us": { "role": { "label": "Long-term loans, advances and security deposits", "terseLabel": "dup_1_Contingent consideration receivables" } } }, "auth_ref": [] }, "nvs_LongTermReceivablesFromFinanceSubleases": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "LongTermReceivablesFromFinanceSubleases", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails": { "parentTag": "ifrs-full_NoncurrentFinancialAssets", "weight": 1.0, "order": 9.0 } }, "lang": { "en-us": { "role": { "label": "Long term receivables from finance subleases" } } }, "auth_ref": [] }, "nvs_LongtermFinancialDebtWithACarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "LongtermFinancialDebtWithACarryingAmount", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Carrying amount of long-term financial debt designated as hedge instruments", "terseLabel": "Long-term financial debt with a carrying amount" } } }, "auth_ref": [] }, "nvs_LongtermFinancialInvestmentsAtFairValueMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "LongtermFinancialInvestmentsAtFairValueMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Long- term financial investments at fair value [member]" } } }, "auth_ref": [] }, "nvs_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Long-term loans and receivables from customers and finance lease, advances, security deposits [member]" } } }, "auth_ref": [] }, "nvs_LucentisMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "LucentisMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Lucentis [member]" } } }, "auth_ref": [] }, "nvs_LutatheraMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "LutatheraMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Lutathera [member]" } } }, "auth_ref": [] }, "nvs_MarianaOncologyInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "MarianaOncologyInc.Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Mariana Oncology, Inc. [member]", "terseLabel": "Mariana Oncology, Inc." } } }, "auth_ref": [] }, "nvs_MarketableSecuritiesRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "MarketableSecuritiesRecognisedAsOfAcquisitionDate", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Marketable securities recognised as of acquisition date", "negatedTerseLabel": "Marketable securities recognised as of acquisition date" } } }, "auth_ref": [] }, "nvs_MarketableSecuritiesTimeDepositsAndShorttermInvestmentsWithOriginalMaturityMoreThan90DaysAndAccruedInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "MarketableSecuritiesTimeDepositsAndShorttermInvestmentsWithOriginalMaturityMoreThan90DaysAndAccruedInterestMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Marketable securities, time deposits and short-term investments with original maturity more than 90 days and accrued interest [member]" } } }, "auth_ref": [] }, "nvs_MarketingRelatedIntangibleAssets1Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "MarketingRelatedIntangibleAssets1Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Marketing related intangible assets [member]", "terseLabel": "Marketing know-how" } } }, "auth_ref": [] }, "ifrs-full_MaterialReconcilingItemsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "MaterialReconcilingItemsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails4Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Material reconciling items [member]" } }, "en": { "role": { "documentation": "This member stands for material adjustments used to reconcile items in the entity's financial statements." } } }, "auth_ref": [ "r179" ] }, "nvs_MatureOphthaMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "MatureOphthaMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "Mature Ophtha [member]" } } }, "auth_ref": [] }, "ifrs-full_MaturityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "MaturityAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails4Q" ], "lang": { "en-us": { "role": { "label": "Maturity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r125", "r134", "r135", "r136", "r137", "r139", "r140", "r160", "r167", "r184", "r186", "r194", "r197", "r260", "r307", "r331", "r357" ] }, "ifrs-full_MaturityDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "MaturityDomain", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails4Q" ], "lang": { "en-us": { "role": { "label": "Maturity [domain]" } }, "en": { "role": { "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used." } } }, "auth_ref": [ "r125", "r134", "r135", "r136", "r137", "r139", "r140", "r160", "r184", "r186", "r194", "r197", "r260", "r307", "r331", "r357", "r359" ] }, "nvs_MaximalAmountOfShareBuybackProgramm": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "MaximalAmountOfShareBuybackProgramm", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetails1Q" ], "lang": { "en-us": { "role": { "label": "Maximal amount of share buyback programm" } } }, "auth_ref": [] }, "nvs_MayzentMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "MayzentMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "Mayzent [member]" } } }, "auth_ref": [] }, "ifrs-full_MeasurementAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "MeasurementAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q", "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Measurement [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r58", "r62", "r118", "r247", "r267" ] }, "ifrs-full_MeasurementDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "MeasurementDomain", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q", "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Measurement [domain]" } }, "en": { "role": { "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used." } } }, "auth_ref": [ "r58", "r62", "r118", "r247", "r267" ] }, "nvs_MilestoneIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "MilestoneIncome", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails4Q" ], "lang": { "en-us": { "role": { "label": "Milestone income" } } }, "auth_ref": [] }, "nvs_MilestonePaymentAlreadyReceived": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "MilestonePaymentAlreadyReceived", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Milestone payment already received" } } }, "auth_ref": [] }, "nvs_MorphoSysAGMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "MorphoSysAGMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "MorphoSys AG [member]", "terseLabel": "MorphoSys AG" } } }, "auth_ref": [] }, "nvs_MyforticMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "MyforticMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "Myfortic [member]" } } }, "auth_ref": [] }, "nvs_MyricxBioMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "MyricxBioMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails5Q" ], "lang": { "en-us": { "role": { "label": "Myricx Bio [member]", "terseLabel": "dup_3_AveXis, Inc." } } }, "auth_ref": [] }, "nvs_NAGAndNovartisPharmaSpAMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "NAGAndNovartisPharmaSpAMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "NAG and Novartis Pharma SpA [member]" } } }, "auth_ref": [] }, "nvs_NAGMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "NAGMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "NAG [member]" } } }, "auth_ref": [] }, "nvs_NPCAndOthersMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "NPCAndOthersMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "NPC and others [member]" } } }, "auth_ref": [] }, "nvs_NeoralSandimmunEMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "NeoralSandimmunEMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Neoral/Sandimmun(e) [member]" } } }, "auth_ref": [] }, "nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Net Cash Flows Used In Acquisitions And Divestments Of Businesses Classified As Investing Activities", "negatedTerseLabel": "Acquisitions and divestments of businesses, net", "terseLabel": "Acquisitions and divestments of businesses, net", "totalLabel": "Cash flows used for acquisitions and divestments of businesses, net" } } }, "auth_ref": [] }, "nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivitiesFromContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivitiesFromContinuingOperations", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Net cash flows used in acquisitions and divestments of businesses classified as investing activities from continuing operations" } } }, "auth_ref": [] }, "nvs_NetCashOutflowsFromDivestments": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "NetCashOutflowsFromDivestments", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Net cash outflows from divestments" } } }, "auth_ref": [] }, "nvs_NetDividendPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "NetDividendPaid", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Net dividend paid", "negatedTerseLabel": "Net dividend paid" } } }, "auth_ref": [] }, "nvs_NetIdentifiableAssetsOfDivestedBusiness": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "NetIdentifiableAssetsOfDivestedBusiness", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Net identifiable assets of divested business" } } }, "auth_ref": [] }, "nvs_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": "ifrs-full_ProfitLossFromDiscontinuedOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Net loss from discontinued operations before gain on distribution", "terseLabel": "Net income from discontinued operations before gain on distribution" } } }, "auth_ref": [] }, "nvs_NetInvestmentHedgeRecognizedInTheConsolidatedIncomeStatement": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "NetInvestmentHedgeRecognizedInTheConsolidatedIncomeStatement", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Net investment hedge recognized in the consolidated income statement" } } }, "auth_ref": [] }, "nvs_NeuroscienceMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "NeuroscienceMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Neuroscience [member]" } } }, "auth_ref": [] }, "nvs_NonControllingInterestsForAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "NonControllingInterestsForAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Non-controlling interests for acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "nvs_NonCurrentContingentConsiderationReceivablesMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "NonCurrentContingentConsiderationReceivablesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Non-current contingent consideration receivables [member]" } } }, "auth_ref": [] }, "nvs_NonCurrentFinancialAndOtherAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "NonCurrentFinancialAndOtherAssetsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Non-current financial and other assets [member]", "terseLabel": "Non-current financial and other assets" } } }, "auth_ref": [] }, "nvs_NonCurrentFinancialAndOtherAssetsThroughAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "NonCurrentFinancialAndOtherAssetsThroughAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Non-current financial and other assets through acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Non-controlling interest in acquiree recognised at acquisition date", "negatedTerseLabel": "Non-controlling interests", "terseLabel": "Non-controlling interests" } }, "en": { "role": { "documentation": "The amount of non-controlling interest in the acquiree recognised at the acquisition date for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: Total for all business combinations [member]]" } } }, "auth_ref": [ "r147", "r256" ] }, "ifrs-full_NoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncontrollingInterests", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Non-controlling interests" } }, "en": { "role": { "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r95", "r98", "r302" ] }, "ifrs-full_NoncontrollingInterestsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncontrollingInterestsMember", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Non-controlling interests [member]" } }, "en": { "role": { "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent." } } }, "auth_ref": [ "r287" ] }, "nvs_NoncurrentAndCurrentLiabilitiesDivested": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "NoncurrentAndCurrentLiabilitiesDivested", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Non-current and current liabilities divested" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentAssets", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Non-current assets", "totalLabel": "Total non-current assets" } }, "en": { "role": { "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]" } } }, "auth_ref": [ "r102", "r308", "r344" ] }, "ifrs-full_NoncurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentAssetsAbstract", "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Non-current assets [abstract]" } } }, "auth_ref": [] }, "nvs_NoncurrentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "NoncurrentAssetsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Non-current assets [member]" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 10.2 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Non-current assets or disposal groups classified as held for sale", "terseLabel": "Assets of disposal group held for sale" } }, "en": { "role": { "documentation": "The amount of non-current assets or disposal groups classified as held for sale. [Refer: Disposal groups classified as held for sale [member]]" } } }, "auth_ref": [ "r158" ] }, "nvs_NoncurrentContingentConsiderationLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "NoncurrentContingentConsiderationLiabilitiesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Non-current contingent consideration liabilities [member]" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentFinanceLeaseReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentFinanceLeaseReceivables", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails": { "parentTag": "ifrs-full_NoncurrentFinancialAssets", "weight": 1.0, "order": 6.0 } }, "lang": { "en-us": { "role": { "label": "Non-current finance lease receivables", "terseLabel": "Minimum lease payments from finance lease agreements" } }, "en": { "role": { "documentation": "The amount of non-current finance lease receivables. [Refer: Finance lease receivables]" } } }, "auth_ref": [ "r412" ] }, "ifrs-full_NoncurrentFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentFinancialAssets", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 6.0 }, "http://novartis.com/20260630/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Financial assets", "label": "Non-current financial assets", "totalLabel": "Total financial assets" } }, "en": { "role": { "documentation": "The amount of non-current financial assets. [Refer: Financial assets]" } } }, "auth_ref": [ "r161" ] }, "nvs_NoncurrentFinancialAssetsEquityInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "NoncurrentFinancialAssetsEquityInvestments", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails": { "parentTag": "nvs_NoncurrentFinancialAssetsTotalFinancialInvestments", "weight": 1.0, "order": 1.0 } }, "lang": { "en-us": { "role": { "label": "Non-current financial assets, equity securities" } } }, "auth_ref": [] }, "nvs_NoncurrentFinancialAssetsFundInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "NoncurrentFinancialAssetsFundInvestments", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails": { "parentTag": "nvs_NoncurrentFinancialAssetsTotalFinancialInvestments", "weight": 1.0, "order": 3.0 } }, "lang": { "en-us": { "role": { "label": "Non-current financial assets, fund investments" } } }, "auth_ref": [] }, "nvs_NoncurrentFinancialAssetsTotalFinancialInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "NoncurrentFinancialAssetsTotalFinancialInvestments", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails": { "parentTag": "ifrs-full_NoncurrentFinancialAssets", "weight": 1.0, "order": 4.0 } }, "lang": { "en-us": { "role": { "label": "Non-current financial assets, total financial investments", "totalLabel": "Non-current financial assets, total financial investments" } } }, "auth_ref": [] }, "nvs_NoncurrentFinancialAsstetsDebtSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "NoncurrentFinancialAsstetsDebtSecurities", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails": { "parentTag": "nvs_NoncurrentFinancialAssetsTotalFinancialInvestments", "weight": 1.0, "order": 2.0 } }, "lang": { "en-us": { "role": { "label": "Non-current financial asstets debt securities" } } }, "auth_ref": [] }, "nvs_NoncurrentFinancialLiabilitiesAtFairValueMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "NoncurrentFinancialLiabilitiesAtFairValueMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Non-current financial liabilities at fair value [member]" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Non-current lease liabilities", "terseLabel": "Lease liabilities" } }, "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r128" ] }, "ifrs-full_NoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentLiabilities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current liabilities", "label": "Non-current liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]" } } }, "auth_ref": [ "r104", "r309", "r344" ] }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentLiabilitiesAbstract", "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Non-current liabilities [abstract]" } } }, "auth_ref": [] }, "nvs_NoncurrentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "NoncurrentLiabilitiesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Non-current liabilities [member]" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentRecognisedLiabilitiesDefinedBenefitPlan", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails": { "parentTag": "ifrs-full_OtherNoncurrentNonfinancialLiabilities", "weight": 1.0, "order": 1.0 } }, "lang": { "en-us": { "role": { "label": "Non-current net defined benefit liability", "terseLabel": "Defined benefit pension plans" } }, "en": { "role": { "documentation": "The amount of non-current net defined benefit liability. [Refer: Net defined benefit liability]" } } }, "auth_ref": [ "r412" ] }, "ifrs-full_NoncurrentTradeReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NoncurrentTradeReceivables", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails": { "parentTag": "ifrs-full_NoncurrentFinancialAssets", "weight": 1.0, "order": 5.0 } }, "lang": { "en-us": { "role": { "label": "Non-current trade receivables", "terseLabel": "Long-term receivables from customers" } }, "en": { "role": { "documentation": "The amount of non-current trade receivables. [Refer: Trade receivables]" } } }, "auth_ref": [ "r369", "r375" ] }, "ifrs-full_NotLaterThanOneYearMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NotLaterThanOneYearMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails4Q" ], "lang": { "en-us": { "role": { "label": "Not later than one year [member]", "terseLabel": "Not later than one year" } }, "en": { "role": { "documentation": "This member stands for a time band of not later than one year." } } }, "auth_ref": [ "r134", "r135", "r140", "r192", "r195", "r306", "r357", "r360" ] }, "ifrs-full_NotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NotionalAmount", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Notional amount" } }, "en": { "role": { "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument." } } }, "auth_ref": [ "r410" ] }, "nvs_NovartisHellasS.A.C.I.MetamorphosisAthensMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "NovartisHellasS.A.C.I.MetamorphosisAthensMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Novartis (Hellas) S.A.C.I., Metamorphosis/Athens [member]" } } }, "auth_ref": [] }, "nvs_NovartisNCMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "NovartisNCMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Novartis NC [member]" } } }, "auth_ref": [] }, "nvs_NovartisPharmaKKMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "NovartisPharmaKKMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Novartis Pharma K.K. [member]" } } }, "auth_ref": [] }, "nvs_NumberOfAcquisitionsApplyingTheOptionalConcentrationTestMethod": { "xbrltype": "integerItemType", "nsuri": "http://novartis.com/20260630", "localname": "NumberOfAcquisitionsApplyingTheOptionalConcentrationTestMethod", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails3Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Number of acquisitions applying the optional concentration test method" } } }, "auth_ref": [] }, "nvs_NumberOfAcquisitionsOfBusinessesApplyingTheBusinessCombinationAcquisitionMethod": { "xbrltype": "integerItemType", "nsuri": "http://novartis.com/20260630", "localname": "NumberOfAcquisitionsOfBusinessesApplyingTheBusinessCombinationAcquisitionMethod", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Number of acquisitions of businesses applying the business combination acquisition method" } } }, "auth_ref": [] }, "nvs_NumberOfBearerShares": { "xbrltype": "sharesItemType", "nsuri": "http://novartis.com/20260630", "localname": "NumberOfBearerShares", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Number of bearer shares" } } }, "auth_ref": [] }, "nvs_NumberOfBrandsInPortfolioToAcquire": { "xbrltype": "decimalItemType", "nsuri": "http://novartis.com/20260630", "localname": "NumberOfBrandsInPortfolioToAcquire", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Number of brands in portfolio to acquire" } } }, "auth_ref": [] }, "nvs_NumberOfBusinessUnits": { "xbrltype": "integerItemType", "nsuri": "http://novartis.com/20260630", "localname": "NumberOfBusinessUnits", "presentation": [ "http://novartis.com/20260630/role/DisclosureOperatingSegmentsQ" ], "lang": { "en-us": { "role": { "label": "Number of Business Units" } } }, "auth_ref": [] }, "nvs_NumberOfCentersThatFiledADRProceedings": { "xbrltype": "integerItemType", "nsuri": "http://novartis.com/20260630", "localname": "NumberOfCentersThatFiledADRProceedings", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Number of centers that filed ADR proceedings" } } }, "auth_ref": [] }, "nvs_NumberOfCommercialOrganizationalUnits": { "xbrltype": "integerItemType", "nsuri": "http://novartis.com/20260630", "localname": "NumberOfCommercialOrganizationalUnits", "presentation": [ "http://novartis.com/20260630/role/DisclosureOperatingSegmentsQ" ], "lang": { "en-us": { "role": { "label": "Number of commercial organizational units" } } }, "auth_ref": [] }, "nvs_NumberOfContingentValuePerShareIssuedForAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "decimalItemType", "nsuri": "http://novartis.com/20260630", "localname": "NumberOfContingentValuePerShareIssuedForAcquisitionsApplyingTheOptionalConcentrationTest", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Number of contingent value per share issued for acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "nvs_NumberOfEmployeesAssociatedWithTheProductTransfer": { "xbrltype": "decimalItemType", "nsuri": "http://novartis.com/20260630", "localname": "NumberOfEmployeesAssociatedWithTheProductTransfer", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Number of employees associated with the product transfer" } } }, "auth_ref": [] }, "nvs_NumberOfFranchises": { "xbrltype": "integerItemType", "nsuri": "http://novartis.com/20260630", "localname": "NumberOfFranchises", "presentation": [ "http://novartis.com/20260630/role/DisclosureOperatingSegmentsQ" ], "lang": { "en-us": { "role": { "label": "Number of Franchises" } } }, "auth_ref": [] }, "nvs_NumberOfMarketsForTheAcquiredBrands": { "xbrltype": "decimalItemType", "nsuri": "http://novartis.com/20260630", "localname": "NumberOfMarketsForTheAcquiredBrands", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Number of markets for the acquired brands" } } }, "auth_ref": [] }, "nvs_NumberOfOptionsRepurchased": { "xbrltype": "pureItemType", "nsuri": "http://novartis.com/20260630", "localname": "NumberOfOptionsRepurchased", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetails1Q" ], "lang": { "en-us": { "role": { "label": "Number of options repurchased" } } }, "auth_ref": [] }, "nvs_NumberOfOrdinarySharePerADS": { "xbrltype": "decimalItemType", "nsuri": "http://novartis.com/20260630", "localname": "NumberOfOrdinarySharePerADS", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Number of ordinary share per ADS" } } }, "auth_ref": [] }, "nvs_NumberOfOrganizationalUnits": { "xbrltype": "integerItemType", "nsuri": "http://novartis.com/20260630", "localname": "NumberOfOrganizationalUnits", "presentation": [ "http://novartis.com/20260630/role/DisclosureOperatingSegmentsQ" ], "lang": { "en-us": { "role": { "label": "Number of organizational units" } } }, "auth_ref": [] }, "nvs_NumberOfOtherShareSales": { "xbrltype": "sharesItemType", "nsuri": "http://novartis.com/20260630", "localname": "NumberOfOtherShareSales", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Number of other share sales", "terseLabel": "Other share sales" } } }, "auth_ref": [] }, "nvs_NumberOfProductsInPortfolioToBeSold": { "xbrltype": "decimalItemType", "nsuri": "http://novartis.com/20260630", "localname": "NumberOfProductsInPortfolioToBeSold", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Number of products in portfolio to be sold" } } }, "auth_ref": [] }, "nvs_NumberOfReportableOperatingSegments": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "NumberOfReportableOperatingSegments", "presentation": [ "http://novartis.com/20260630/role/DisclosureOperatingSegmentsQ" ], "lang": { "en-us": { "role": { "label": "Number of Reportable Segments" } } }, "auth_ref": [] }, "ifrs-full_NumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfSharesIssued", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Number of shares issued", "periodStartLabel": "Number of shares issued at beginning of period", "periodEndLabel": "Number of shares issued at end of period" } }, "en": { "role": { "documentation": "The number of shares issued by the entity." } } }, "auth_ref": [ "r409" ] }, "ifrs-full_NumberOfSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "NumberOfSharesOutstanding", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Number of shares outstanding", "periodStartLabel": "Number of shares outstanding at beginning of period", "periodEndLabel": "Number of shares outstanding at end of period" } }, "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } } }, "auth_ref": [ "r200", "r270", "r312" ] }, "nvs_NumberOfTreasuryShares": { "xbrltype": "sharesItemType", "nsuri": "http://novartis.com/20260630", "localname": "NumberOfTreasuryShares", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Number of treasury shares", "periodStartLabel": "Number of treasury shares at beginning of period", "periodEndLabel": "Number of treasury shares at end of period" } } }, "auth_ref": [] }, "nvs_OnbrezBreezhalerMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "OnbrezBreezhalerMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "Onbrez Breezhaler [member]" } } }, "auth_ref": [] }, "nvs_OncologyMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "OncologyMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Oncology [member]" } } }, "auth_ref": [] }, "nvs_OperatingIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "OperatingIncomeMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Operating income [member]" } } }, "auth_ref": [] }, "ifrs-full_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OperatingSegmentsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails4Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Operating segments [member]" } } }, "auth_ref": [ "r179" ] }, "ifrs-full_OrdinarySharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OrdinarySharesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Ordinary shares [member]", "terseLabel": "Total Novartis shares" } }, "en": { "role": { "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments." } } }, "auth_ref": [ "r415" ] }, "nvs_OrdinarySharesNominalValueCHF0.49PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "OrdinarySharesNominalValueCHF0.49PerShareMember", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Ordinary shares, nominal value CHF 0.49 per share [member]", "terseLabel": "Ordinary shares, nominal value CHF 0.49 per share*" } } }, "auth_ref": [] }, "nvs_OrdinarySharesNominalValueCHF0.50PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "OrdinarySharesNominalValueCHF0.50PerShareMember", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Ordinary shares, nominal value CHF 0.50 per share [member]", "terseLabel": "Ordinary shares, nominal value CHF 0.50 per share*" } } }, "auth_ref": [] }, "ifrs-full_OtherAdjustmentsForNoncashItems": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherAdjustmentsForNoncashItems", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Other adjustments for non-cash items", "terseLabel": "Other" } } }, "auth_ref": [ "r400" ] }, "ifrs-full_OtherAdjustmentsToReconcileProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherAdjustmentsToReconcileProfitLoss", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Other adjustments to reconcile profit (loss)", "terseLabel": "Other adjustments, net" } } }, "auth_ref": [ "r66" ] }, "ifrs-full_OtherBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherBorrowings", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Other borrowings", "terseLabel": "Other bonds" } }, "en": { "role": { "documentation": "The amount of borrowings that the entity does not separately disclose in the same statement or note. [Refer: Borrowings]" } } }, "auth_ref": [ "r410" ] }, "nvs_OtherBorrowingsAxis": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherBorrowingsAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Other borrowings [axis]" } } }, "auth_ref": [] }, "nvs_OtherBorrowingsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherBorrowingsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Other borrowings [member]" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherComprehensiveIncome", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfComprehensiveIncome": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 1.5 } }, "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ", "http://novartis.com/20260630/role/StatementOfChangesInEquity", "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income", "terseLabel": "Total other comprehensive income", "totalLabel": "Total other comprehensive income" } } }, "auth_ref": [ "r108", "r284", "r315", "r325" ] }, "ifrs-full_OtherComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherComprehensiveIncomeAbstract", "presentation": [ "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income [abstract]" } } }, "auth_ref": [] }, "nvs_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails4": { "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "weight": 1.0, "order": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other comprehensive income, before taxes, gains (losses) on remeasurements of defined benefit plans", "terseLabel": "Defined benefit pension plans before tax" } } }, "auth_ref": [] }, "nvs_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails4": { "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "weight": 1.0, "order": 2.0 } }, "lang": { "en-us": { "role": { "label": "Other comprehensive income, before taxes, gains (losses) on remeasurements of other post-employment benefit plans", "terseLabel": "Other post-employment benefit plans before tax" } } }, "auth_ref": [] }, "nvs_OtherComprehensiveIncomeEquitySecuritiesNetOfTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherComprehensiveIncomeEquitySecuritiesNetOfTaxes", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails": { "parentTag": "nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome", "weight": 1.0, "order": 8.0 } }, "lang": { "en-us": { "role": { "label": "Other comprehensive income, equity securities", "terseLabel": "Fair value adjustments on equity securities, net of taxes" } } }, "auth_ref": [] }, "nvs_OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails4": { "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "weight": 1.0, "order": 3.0 } }, "lang": { "en-us": { "role": { "label": "Other comprehensive income, gains (losses) on remeasurements of defined and other post-employment benefit plans, taxation", "terseLabel": "Taxation on above items" } } }, "auth_ref": [] }, "nvs_OtherComprehensiveIncomeMaketableSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherComprehensiveIncomeMaketableSecurities", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income, maketable securities", "terseLabel": "Available-for-sale marketable securities" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfComprehensiveIncome": { "parentTag": "nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income, net of tax, available-for-sale financial assets", "terseLabel": "Fair value adjustments on marketable securities, net of taxes", "verboseLabel": "Available-for-sale marketable securities" } } }, "auth_ref": [ "r276", "r277" ] }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxCashFlowHedges": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherComprehensiveIncomeNetOfTaxCashFlowHedges", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfComprehensiveIncome": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 0.0 }, "http://novartis.com/20260630/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails": { "parentTag": "nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value adjustments on deferred cash flow hedges, net of taxes", "label": "Other comprehensive income, net of tax, fair value adjustments on deferred cash flow hedges", "verboseLabel": "Cash flow hedge, net of taxes" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to cash flow hedges. [Refer: Cash flow hedges [member]; Other comprehensive income]" } } }, "auth_ref": [ "r310", "r325" ] }, "nvs_OtherComprehensiveIncomeNetOfTaxDebtSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherComprehensiveIncomeNetOfTaxDebtSecurities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfComprehensiveIncome": { "parentTag": "nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments", "weight": 1.0, "order": 3.0 }, "http://novartis.com/20260630/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails": { "parentTag": "nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income, net of tax, debt securities", "terseLabel": "Fair value adjustments on debt securities, net of taxes", "verboseLabel": "Available-for-sale debt securities" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfComprehensiveIncome": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 1.0 }, "http://novartis.com/20260630/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails": { "parentTag": "nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income, net of tax, exchange differences on translation", "terseLabel": "Currency translation effects, net of taxes" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r310", "r325" ] }, "nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherComprehensiveIncomeNetOfTaxFinancialInstruments", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfComprehensiveIncome": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 3.0 }, "http://novartis.com/20260630/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails": { "parentTag": "nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income, net of tax, financial instruments", "totalLabel": "Total fair value adjustments on financial instruments, net of taxes", "terseLabel": "Fair value adjustments on financial instruments", "verboseLabel": "Fair value adjustments during the year" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfComprehensiveIncome": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value adjustments on equity securities, net of taxes", "label": "Other comprehensive income, net of tax, gains (losses) from investments in equity instruments" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, related to gains (losses) from changes in the fair value of investments in equity instruments that the entity has designated at fair value through other comprehensive income applying paragraph 5.7.5 of IFRS 9. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r310", "r325" ] }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfComprehensiveIncome": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 1.0 }, "http://novartis.com/20260630/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails": { "parentTag": "nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome", "weight": 1.0, "order": 10.0 }, "http://novartis.com/20260630/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails4": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans", "terseLabel": "Actuarial gains/losses from defined benefit plans, net of taxes", "verboseLabel": "Net actuarial gains/losses from defined benefit plans, net of taxes", "totalLabel": "Remeasurements from defined benefit plans, total after tax" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [domain]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]" } } }, "auth_ref": [ "r310", "r325", "r392" ] }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfComprehensiveIncome": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 4.0 }, "http://novartis.com/20260630/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails": { "parentTag": "nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income, net of tax, hedges of net investments in foreign operations", "terseLabel": "Net investment hedge, net of taxes" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to hedges of net investments in foreign operations. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r57", "r183", "r325" ] }, "nvs_OtherComprehensiveIncomeRecycledIntoTheConsolidatedIncomeStatement": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherComprehensiveIncomeRecycledIntoTheConsolidatedIncomeStatement", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income recycled into the consolidated income statement" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfComprehensiveIncome": { "parentTag": "ifrs-full_OtherComprehensiveIncome", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income that will be reclassified to profit or loss, net of tax", "totalLabel": "Total of items that are or may be recycled" } }, "en": { "role": { "documentation": "The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r377", "r378" ] }, "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfComprehensiveIncome": { "parentTag": "ifrs-full_OtherComprehensiveIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income that will not be reclassified to profit or loss, net of tax", "terseLabel": "Total of items that will never be recycled" } }, "en": { "role": { "documentation": "The amount of other comprehensive income that will not be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r377", "r378" ] }, "nvs_OtherCurrentAndNonCurrentAssetsRecognisedAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherCurrentAndNonCurrentAssetsRecognisedAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Other current and non-current assets recognised as of acquisition date through acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "ifrs-full_OtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherCurrentAssets", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureOtherCurrentAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentNonfinancialAssets", "weight": 1.0, "order": 4.8 } }, "lang": { "en-us": { "role": { "label": "Other current assets" } }, "en": { "role": { "documentation": "The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]" } } }, "auth_ref": [ "r412" ] }, "nvs_OtherCurrentAssetsRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherCurrentAssetsRecognisedAsOfAcquisitionDate", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Other current assets recognised as of acquisition date", "negatedTerseLabel": "Other current assets recognised as of acquisition date" } } }, "auth_ref": [] }, "nvs_OtherCurrentAssetsRecognisedAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherCurrentAssetsRecognisedAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Other current assets recognised as of acquisition date through acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "ifrs-full_OtherCurrentFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherCurrentFinancialAssets", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners", "weight": 1.0, "order": 4.0 }, "http://novartis.com/20260630/role/DisclosureMarketableSecuritiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Other current financial assets", "terseLabel": "Marketable securities, time deposits and derivative financial instruments", "totalLabel": "Total marketable securities, time deposits and derivative financial instruments" } }, "en": { "role": { "documentation": "The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]" } } }, "auth_ref": [ "r294" ] }, "ifrs-full_OtherCurrentFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherCurrentFinancialLiabilities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale", "weight": 1.0, "order": 1.0 }, "http://novartis.com/20260630/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Other current financial liabilities", "terseLabel": "Financial debts and derivative financial instruments", "totalLabel": "Total current financial debt and derivative financial instruments", "negatedTerseLabel": "Current financial debt" } }, "en": { "role": { "documentation": "The amount of current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities; Current financial liabilities]" } } }, "auth_ref": [ "r110", "r298" ] }, "ifrs-full_OtherCurrentNonfinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherCurrentNonfinancialAssets", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners", "weight": 1.0, "order": 6.0 }, "http://novartis.com/20260630/role/DisclosureOtherCurrentAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total other current assets", "label": "Other current non-financial assets", "terseLabel": "Other current assets" } }, "en": { "role": { "documentation": "The amount of current non-financial assets that the entity does not separately disclose in the same statement or note. [Refer: Financial assets]" } } }, "auth_ref": [ "r412" ] }, "ifrs-full_OtherCurrentNonfinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherCurrentNonfinancialLiabilities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale", "weight": 1.0, "order": 3.0 }, "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Other current non-financial liabilities", "terseLabel": "Provisions and other current liabilities", "totalLabel": "Total provisions and other current liabilities" } }, "en": { "role": { "documentation": "The amount of current non-financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]" } } }, "auth_ref": [ "r412" ] }, "ifrs-full_OtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherCurrentPayables", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails": { "parentTag": "ifrs-full_OtherCurrentNonfinancialLiabilities", "weight": 1.0, "order": 14.0 } }, "lang": { "en-us": { "role": { "label": "Other current payables", "terseLabel": "Other provisions and other current liabilities" } }, "en": { "role": { "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r412" ] }, "ifrs-full_OtherCurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherCurrentReceivables", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureOtherCurrentAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentNonfinancialAssets", "weight": 1.0, "order": 4.6 } }, "lang": { "en-us": { "role": { "label": "Other current receivables" } }, "en": { "role": { "documentation": "The amount of current other receivables. [Refer: Other receivables]" } } }, "auth_ref": [ "r369", "r375" ] }, "nvs_OtherEquityShareholdingsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherEquityShareholdingsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Other equity shareholdings [member]", "terseLabel": "Other equity shareholdings" } } }, "auth_ref": [] }, "ifrs-full_OtherExpenseByFunction": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherExpenseByFunction", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 1.5 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other expense", "label": "Other expense, by function", "negatedTotalLabel": "Total other expense" } } }, "auth_ref": [ "r25", "r328", "r372" ] }, "nvs_OtherExpenseRelatedToLegalMatters": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherExpenseRelatedToLegalMatters", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Other expense related to legal matters" } } }, "auth_ref": [] }, "ifrs-full_OtherFinanceCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherFinanceCost", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails2": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": -1.0, "order": 11.0 } }, "lang": { "en-us": { "role": { "label": "Other finance cost", "negatedTerseLabel": "Financial expense" } } }, "auth_ref": [ "r410" ] }, "nvs_OtherFinanceCostsPaidClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherFinanceCostsPaidClassifiedAsOperatingActivities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlowCalc2": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 10.5 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Other finance costs paid classified as operating activities", "negatedTerseLabel": "Other financial payments" } } }, "auth_ref": [] }, "ifrs-full_OtherFinanceIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherFinanceIncome", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails2": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": 1.0, "order": 10.5 } }, "lang": { "en-us": { "role": { "label": "Other finance income" } } }, "auth_ref": [ "r410" ] }, "ifrs-full_OtherFinanceIncomeCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherFinanceIncomeCost", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 4.0 }, "http://novartis.com/20260630/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Other financial income and expense", "totalLabel": "Total other financial income and expense", "terseLabel": "Other financial income and expense", "negatedTerseLabel": "Other financial income and expense" } } }, "auth_ref": [ "r416" ] }, "nvs_OtherFinanceIncomeReceivedClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherFinanceIncomeReceivedClassifiedAsOperatingActivities", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlowCalc2": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 9.5 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Other Finance income received, classified as operating activities", "terseLabel": "Other financial receipts" } } }, "auth_ref": [] }, "nvs_OtherFinancialLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherFinancialLiabilitiesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Other financial liabilities [member]" } } }, "auth_ref": [] }, "nvs_OtherHematologyMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherHematologyMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "Other Hematology [member]" } } }, "auth_ref": [] }, "ifrs-full_OtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherIncome", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Other income", "totalLabel": "Total other income" } } }, "auth_ref": [ "r24", "r371", "r372" ] }, "ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Other financing cash flows, net", "label": "Other inflows (outflows) of cash, classified as financing activities", "negatedTerseLabel": "Dividends paid to non-controlling interests and other financing cash flows", "verboseLabel": "Transaction cost payments" } }, "en": { "role": { "documentation": "Inflows (outflows) of cash, classified as financing activities, that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r67" ] }, "ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": 1.0, "order": 15.8 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Other cash flows used in investing activities, net", "label": "Other inflows (outflows) of cash, classified as investing activities", "verboseLabel": "Other investing cash flows, net" } }, "en": { "role": { "documentation": "Inflows (outflows) of cash, classified as investing activities, that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r67" ] }, "ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Other inflows (outflows) of cash", "terseLabel": "Change in other net current assets and other operating cash flow items" } }, "en": { "role": { "documentation": "Inflows (outflows) of cash, classified as operating activities, that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r65" ] }, "ifrs-full_OtherIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherIntangibleAssetsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Other intangible assets [member]", "terseLabel": "Other intangible assets" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r395" ] }, "nvs_OtherIntangibleAssetsRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherIntangibleAssetsRecognisedAsOfAcquisitionDate", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Other intangible assets recognised as of acquisition date", "terseLabel": "Other intangible assets" } } }, "auth_ref": [] }, "nvs_OtherIntangiblePurchaseCommitments": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherIntangiblePurchaseCommitments", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureCommitmentsAndContingenciesDetails2": { "parentTag": "nvs_ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments", "weight": 1.0, "order": 2.0 } }, "lang": { "en-us": { "role": { "label": "Other intangible asset purchase commitments" } } }, "auth_ref": [] }, "nvs_OtherInterimDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherInterimDisclosuresTextBlock", "presentation": [ "http://novartis.com/20260630/role/OtherInterimDisclosuresQ" ], "lang": { "en-us": { "role": { "label": "Other interim disclosures [text block]", "terseLabel": "dup_1_Equity", "verboseLabel": "dup_1_Summary of equity attributable to Novartis AG shareholders" } } }, "auth_ref": [] }, "nvs_OtherLongtermEmployeeBenefitsAndDeferredCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherLongtermEmployeeBenefitsAndDeferredCompensation", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails": { "parentTag": "ifrs-full_OtherNoncurrentNonfinancialLiabilities", "weight": 1.0, "order": 2.0 } }, "lang": { "en-us": { "role": { "label": "Other long-term employee benefits and deferred compensation" } } }, "auth_ref": [] }, "nvs_OtherNetAssetsForAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherNetAssetsForAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Other net assets for acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "nvs_OtherNetAssetsLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherNetAssetsLiabilities", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Other net assets liabilities" } } }, "auth_ref": [] }, "nvs_OtherNetCashInflowsFromDivestments": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherNetCashInflowsFromDivestments", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Other net cash inflows from divestments", "terseLabel": "dup_2_Divested business" } } }, "auth_ref": [] }, "nvs_OtherNetLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherNetLiabilities", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Other net liabilities" } } }, "auth_ref": [] }, "ifrs-full_OtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherNoncurrentAssets", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 7.0 }, "http://novartis.com/20260630/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Other non-current assets", "totalLabel": "Total other non-current assets" } }, "en": { "role": { "documentation": "The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]" } } }, "auth_ref": [ "r412" ] }, "nvs_OtherNoncurrentFinancialDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherNoncurrentFinancialDebt", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureNonCurrentFinancialDebtDetails": { "parentTag": "ifrs-full_Borrowings", "weight": 1.0, "order": 5.0 } }, "lang": { "en-us": { "role": { "label": "Other non-current financial debt", "terseLabel": "Others" } } }, "auth_ref": [] }, "ifrs-full_OtherNoncurrentFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherNoncurrentFinancialLiabilities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Other non-current financial liabilities", "terseLabel": "Financial debts", "totalLabel": "Total non-current financial debts", "negatedTerseLabel": "Non-current financial debts" } }, "en": { "role": { "documentation": "The amount of non-current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]" } } }, "auth_ref": [ "r111", "r298" ] }, "ifrs-full_OtherNoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherNoncurrentLiabilities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails": { "parentTag": "ifrs-full_OtherNoncurrentNonfinancialLiabilities", "weight": 1.0, "order": 7.0 } }, "lang": { "en-us": { "role": { "label": "Other non-current liabilities" } }, "en": { "role": { "documentation": "The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]" } } }, "auth_ref": [ "r412" ] }, "ifrs-full_OtherNoncurrentNonfinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherNoncurrentNonfinancialAssets", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails2": { "parentTag": "ifrs-full_OtherNoncurrentAssets", "weight": 1.0, "order": 2.0 } }, "lang": { "en-us": { "role": { "label": "Other non-current non-financial assets", "terseLabel": "Other non-current assets" } }, "en": { "role": { "documentation": "The amount of non-current non-financial assets that the entity does not separately disclose in the same statement or note. [Refer: Financial assets]" } } }, "auth_ref": [ "r412" ] }, "ifrs-full_OtherNoncurrentNonfinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherNoncurrentNonfinancialLiabilities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 6.0 }, "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Other non-current non-financial liabilities", "terseLabel": "Provisions and other non-current liabilities", "totalLabel": "Total provisions and other non-current liabilities" } }, "en": { "role": { "documentation": "The amount of non-current non-financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]" } } }, "auth_ref": [ "r412" ] }, "ifrs-full_OtherNoncurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherNoncurrentReceivables", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails": { "parentTag": "ifrs-full_NoncurrentFinancialAssets", "weight": 1.0, "order": 10.0 } }, "lang": { "en-us": { "role": { "label": "Other non-current receivables", "terseLabel": "Other long-term receivables" } }, "en": { "role": { "documentation": "The amount of non-current other receivables. [Refer: Other receivables]" } } }, "auth_ref": [ "r369", "r375" ] }, "nvs_OtherPaymentsAndDeferredConsiderationNet": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherPaymentsAndDeferredConsiderationNet", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Other payments and deferred consideration, net", "terseLabel": "Payments, deferred consideration and other adjustments, net", "negatedTerseLabel": "Payments, deferred consideration and other adjustments, net" } } }, "auth_ref": [] }, "nvs_OtherPostemploymentBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherPostemploymentBenefits", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails": { "parentTag": "ifrs-full_OtherNoncurrentNonfinancialLiabilities", "weight": 1.0, "order": 3.0 } }, "lang": { "en-us": { "role": { "label": "Other post-employment benefits" } } }, "auth_ref": [] }, "nvs_OtherProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherProductsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "Other [member]" } } }, "auth_ref": [] }, "nvs_OtherPromotedBrandsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherPromotedBrandsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Other Promoted Brands [member]" } } }, "auth_ref": [] }, "ifrs-full_OtherReserves": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherReserves", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Other reserves", "terseLabel": "Reserves" } }, "en": { "role": { "documentation": "A component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]" } } }, "auth_ref": [ "r370", "r376" ] }, "nvs_OtherRespiratoryMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherRespiratoryMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "Other Respiratory [member]" } } }, "auth_ref": [] }, "ifrs-full_OtherRevenue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherRevenue", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": "ifrs-full_GrossProfit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails4Q", "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Other revenue", "terseLabel": "Other revenues", "verboseLabel": "Total other revenues" } } }, "auth_ref": [ "r410" ] }, "nvs_OtherRevenueOther": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherRevenueOther", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails4Q" ], "lang": { "en-us": { "role": { "label": "Other revenue, other", "terseLabel": "Other" } } }, "auth_ref": [] }, "nvs_OtherSharePurchases": { "xbrltype": "sharesItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherSharePurchases", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Other share purchases" } } }, "auth_ref": [] }, "nvs_OtherSharePurchasesValue": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherSharePurchasesValue", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Other share purchases, equity impact", "negatedTerseLabel": "Other share purchases, equity impact" } } }, "auth_ref": [] }, "nvs_OtherShareSales": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherShareSales", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Other share sales", "negativeLabel": "Other share sales" } } }, "auth_ref": [] }, "nvs_OtherSolidTumorMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "OtherSolidTumorMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "Other Solid Tumor [member]" } } }, "auth_ref": [] }, "ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome", "calculation": { "http://novartis.com/20260630/role/DisclosureTaxesDetails3": { "parentTag": "ifrs-full_AverageEffectiveTaxRate", "weight": 1.0, "order": 13.0 } }, "lang": { "en-us": { "role": { "terseLabel": "Effect of other items", "label": "Other tax rate effects for reconciliation between accounting profit and tax expense (income)" } }, "en": { "role": { "documentation": "Tax rate effects, in aggregate, on the reconciliation between the average effective tax rate and the applicable tax rate that the entity does not separately disclose in the reconciliation. [Refer: Average effective tax rate; Applicable tax rate]" } } }, "auth_ref": [ "r3", "r213" ] }, "nvs_OthersAssociatesMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "OthersAssociatesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Others associates [member]", "terseLabel": "Others" } } }, "auth_ref": [] }, "nvs_OutstandingShareCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OutstandingShareCapital", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureEquityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "lang": { "en-us": { "role": { "label": "Outstanding share capital", "periodStartLabel": "Total outstanding share capital at beginning of period", "periodEndLabel": "Total outstanding share capital at end of period" } } }, "auth_ref": [] }, "nvs_OutstandingShareCapitalMovement": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "OutstandingShareCapitalMovement", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureEquityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "lang": { "en-us": { "role": { "label": "Outstanding share capital, movement", "terseLabel": "Total shares outstanding movement of period" } } }, "auth_ref": [] }, "nvs_PaymentPutOption": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "PaymentPutOption", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Payment put option" } } }, "auth_ref": [] }, "nvs_PaymentToTheFormerRemainingMinorityShareholders": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "PaymentToTheFormerRemainingMinorityShareholders", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Payment to the former remaining minority shareholders" } } }, "auth_ref": [] }, "ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PaymentsFromChangesInOwnershipInterestsInSubsidiaries", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Payments from changes in ownership interests in subsidiaries that do not result in loss of control", "negatedTerseLabel": "Payments from changes in ownership interests in consolidated subsidiaries", "terseLabel": "Payments from changes in ownership interests in consolidated subsidiaries" } }, "en": { "role": { "documentation": "The cash outflow for changes in ownership interests in subsidiaries that do not result in a loss of control. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r77", "r78" ] }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payments of lease liabilities", "label": "Payments of lease liabilities, classified as financing activities", "terseLabel": "Repayment of lease liability", "verboseLabel": "Payments of lease liabilities, net" } }, "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r343" ] }, "nvs_PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 2.0 }, "http://novartis.com/20260630/role/StatementsOfCashFlowCalc2": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Payments out of provisions and other net cash movements in non-current liabilities", "negatedTerseLabel": "Payments out of provisions and other net cash movements in non-current liabilities" } } }, "auth_ref": [] }, "ifrs-full_PaymentsToAcquireOrRedeemEntitysShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PaymentsToAcquireOrRedeemEntitysShares", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Payments to acquire or redeem entity's shares", "negatedTerseLabel": "Purchases of treasury shares" } }, "en": { "role": { "documentation": "The cash outflow to acquire or redeem entity's shares." } } }, "auth_ref": [ "r342" ] }, "nvs_PercentageOfEquityInterestSharesReceived": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "PercentageOfEquityInterestSharesReceived", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Percentage of equity interest shares received" } } }, "auth_ref": [] }, "nvs_PercentageOfShareCapitalInTenderOffer": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "PercentageOfShareCapitalInTenderOffer", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Percentage of Share capital in tender offer" } } }, "auth_ref": [] }, "nvs_PercentageOfShareCapitalOwned": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "PercentageOfShareCapitalOwned", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Percentage of share capital owned" } } }, "auth_ref": [] }, "nvs_PercentageOfShareCapitalPurchasedByTheCompanyDuringTheTenderOffer": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "PercentageOfShareCapitalPurchasedByTheCompanyDuringTheTenderOffer", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Percentage of share capital purchased by the company during the tender offer" } } }, "auth_ref": [] }, "nvs_PercentageOfShareCapitalPurchasedByTheCompanyOutsideTheTenderOffer": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "PercentageOfShareCapitalPurchasedByTheCompanyOutsideTheTenderOffer", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Percentage of share capital purchased by the company outside the tender offer" } } }, "auth_ref": [] }, "nvs_PercentageOfShareCapitalTenderedAfterTheExpirationOfTheTenderOffer": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "PercentageOfShareCapitalTenderedAfterTheExpirationOfTheTenderOffer", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Percentage of share capital tendered after the expiration of the tender offer" } } }, "auth_ref": [] }, "nvs_PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Percentage of share capital tendered at the expiration of the tender offer" } } }, "auth_ref": [] }, "nvs_PercentageOfShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "PercentageOfShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Percentage of share capital tendered at the subsequent offering period of the tender offer" } } }, "auth_ref": [] }, "ifrs-full_PercentageOfVotingEquityInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PercentageOfVotingEquityInterestsAcquired", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Percentage of voting equity interests acquired" } }, "en": { "role": { "documentation": "The percentage of voting equity interests acquired in a business combination. [Refer: Total for all business combinations [member]]" } } }, "auth_ref": [ "r141", "r251" ] }, "nvs_PercentageOfVotingEquityInterestsContributed": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "PercentageOfVotingEquityInterestsContributed", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Percentage of voting equity interests contributed" } } }, "auth_ref": [] }, "nvs_PikavationTherapeuticsInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "PikavationTherapeuticsInc.Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Pikavation Therapeutics, Inc. [member]", "terseLabel": "Pikavation Therapeutics, Inc." } } }, "auth_ref": [] }, "nvs_PiqrayVijoiceMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "PiqrayVijoiceMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "Piqray/Vijoice [member]" } } }, "auth_ref": [] }, "nvs_PluvictoMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "PluvictoMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Pluvicto [member]" } } }, "auth_ref": [] }, "nvs_PoPChangeMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "PoPChangeMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Change over period [member]" } } }, "auth_ref": [] }, "nvs_PoPYEChangeMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "PoPYEChangeMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Change to prior year-end [member]" } } }, "auth_ref": [] }, "nvs_PortionOfConsiderationPaidConsistingOfCashAndCashEquivalentsForAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "PortionOfConsiderationPaidConsistingOfCashAndCashEquivalentsForAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Portion of consideration paid consisting of cash and cash equivalents for acquisitions applying the optional concentration test", "negatedTerseLabel": "Portion of consideration paid consisting of cash and cash equivalents for acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Portion of consideration paid (received) consisting of cash and cash equivalents", "negatedTerseLabel": "Portion of consideration paid (received) consisting of cash and cash equivalents" } }, "en": { "role": { "documentation": "The portion of consideration paid or received, consisting of cash and cash equivalents, in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Total for all subsidiaries [member]; Cash and cash equivalents; Consideration paid (received)]" } } }, "auth_ref": [ "r74" ] }, "nvs_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Portion of consideration paid (received) consisting of cash and cash equivalents upfront payment", "negatedTerseLabel": "Portion of consideration paid consisting of cash and cash equivalents upfront payment" } } }, "auth_ref": [] }, "nvs_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPaymentForAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPaymentForAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails5Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Portion of consideration paid received consisting of cash and cash equivalents upfront payment for acquisitions applying the optional concentration test", "negatedTerseLabel": "Portion of consideration paid received consisting of cash and cash equivalents upfront payment for acquisitions applying the optional concentration test", "terseLabel": "Upfront payment" } } }, "auth_ref": [] }, "nvs_PotentialMilestoneMaximumPaymentForAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "PotentialMilestoneMaximumPaymentForAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Potential milestone maximum payment for acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "nvs_PotentialMilestoneMaximumPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "PotentialMilestoneMaximumPayments", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails5Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Potential milestone maximum payments", "terseLabel": "Additional payments" } } }, "auth_ref": [] }, "nvs_PotentialMilestoneMaximumReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "PotentialMilestoneMaximumReceived", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Potential milestone maximum received" } } }, "auth_ref": [] }, "nvs_PotentialReceivableFromDivestment": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "PotentialReceivableFromDivestment", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Potential receivable from divestment" } } }, "auth_ref": [] }, "nvs_PotentiallyRefundableConsiderationFromAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "PotentiallyRefundableConsiderationFromAcquisition", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Potentially refundable consideration from acquisition" } } }, "auth_ref": [] }, "nvs_PowerVisionInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "PowerVisionInc.Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "PowerVision, Inc. [member]", "terseLabel": "PowerVision, Inc." } } }, "auth_ref": [] }, "nvs_PreTaxProfitLossFromDivestmentOfBusiness": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "PreTaxProfitLossFromDivestmentOfBusiness", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Pre tax profit (loss) from divestment of business" } } }, "auth_ref": [] }, "nvs_PrepaidPostemploymentBenefitPlansAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "PrepaidPostemploymentBenefitPlansAssets", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails2": { "parentTag": "ifrs-full_OtherNoncurrentAssets", "weight": 1.0, "order": 3.0 } }, "lang": { "en-us": { "role": { "label": "Prepaid post-employment benefit plans assets", "terseLabel": "Prepaid post-employment benefit plans" } } }, "auth_ref": [] }, "ifrs-full_PreviouslyStatedMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PreviouslyStatedMember", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Previously stated [member]" } }, "en": { "role": { "documentation": "This member stands for the information previously stated in the financial statements (ie before retrospective application or retrospective restatement)." } } }, "auth_ref": [ "r82", "r84", "r86", "r205", "r207", "r210", "r282" ] }, "nvs_PrivateClinicalStageBiotechCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "PrivateClinicalStageBiotechCompanyMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Private clinical-stage biotech company [member]", "terseLabel": "Private clinical-stage biotech company" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Proceeds from disposal of non-current assets or disposal groups classified as held for sale and discontinued operations" } }, "en": { "role": { "documentation": "The cash inflow from the disposal of non-current assets or disposal groups classified as held for sale and discontinued operations. [Refer: Discontinued operations [member]; Disposal groups classified as held for sale [member]; Non-current assets or disposal groups classified as held for sale]" } } }, "auth_ref": [ "r397" ] }, "nvs_ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Proceeds from exercise of options and other treasury share transactions", "terseLabel": "Proceeds from exercised options and other treasury share transactions, net" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromNoncurrentBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProceedsFromNoncurrentBorrowings", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from non-current financial debts", "label": "Proceeds from non-current borrowings", "verboseLabel": "Proceeds from non-current financial debts", "negatedTerseLabel": "Proceeds from non-current financial debts" } }, "en": { "role": { "documentation": "The cash inflow from non-current borrowings obtained. [Refer: Borrowings]" } } }, "auth_ref": [ "r398" ] }, "ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Proceeds from sales of other long-term assets, classified as investing activities", "terseLabel": "Proceeds from sale of other non-current assets" } }, "en": { "role": { "documentation": "The cash inflow from sales of long-term assets that the entity does not separately disclose in the same statement or note, classified as investing activities. [Refer: Assets]" } } }, "auth_ref": [ "r341" ] }, "ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Proceeds from sales of intangible assets, classified as investing activities", "terseLabel": "Proceeds from sale of intangible assets" } }, "en": { "role": { "documentation": "The cash inflow from sales of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r341" ] }, "ifrs-full_ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Proceeds from sales of investments other than investments accounted for using equity method", "terseLabel": "Proceeds from sale of financial assets" } }, "en": { "role": { "documentation": "The cash inflow from sales of investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method; Investments other than investments accounted for using equity method]" } } }, "auth_ref": [ "r397" ] }, "ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Proceeds from sales of property, plant and equipment", "terseLabel": "Proceeds from sale of property, plant and equipment" } }, "en": { "role": { "documentation": "The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r341" ] }, "ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": 1.0, "order": 15.7 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from time deposits and from sale of marketable securities", "label": "Proceeds from sales or maturity of financial instruments, classified as investing activities" } }, "en": { "role": { "documentation": "The cash inflow from sales or maturity of financial instruments, classified as investing activities. [Refer: Classes of financial instruments [domain]]" } } }, "auth_ref": [ "r397" ] }, "nvs_ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases": { "xbrltype": "integerItemType", "nsuri": "http://novartis.com/20260630", "localname": "ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Product liability contingency, loss exposure not accrued, number of cases" } } }, "auth_ref": [] }, "nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails5": { "parentTag": null, "weight": null, "order": null, "root": true } }, "lang": { "en-us": { "role": { "label": "Product liability, government investigations, other legal matters provisions", "periodStartLabel": "Product liabilities government investigations other legal matters provisions at beginning of period", "periodEndLabel": "Product liabilities government investigations other legal matters provisions at end of period" } } }, "auth_ref": [] }, "nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails5": { "parentTag": "nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions", "weight": 1.0, "order": 1.0 } }, "lang": { "en-us": { "role": { "label": "Product liability, government investigations, other legal matters provisions, current", "terseLabel": "Provisions for product liabilities, governmental investigations and other legal matters", "negatedTerseLabel": "Less current provision" } } }, "auth_ref": [] }, "nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails5": { "parentTag": "nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions", "weight": 1.0, "order": 2.0 }, "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails": { "parentTag": "ifrs-full_OtherNoncurrentNonfinancialLiabilities", "weight": 1.0, "order": 5.0 } }, "lang": { "en-us": { "role": { "label": "Product liability, government investigations, other legal matters provisions, non-current", "terseLabel": "Provisions for product liability, government investigations, other legal matters provisions", "periodEndLabel": "Non-current product liabilities, governmental investigations and other legal matters provisions at end of period" } } }, "auth_ref": [] }, "nvs_ProductPortfolioAxis": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "ProductPortfolioAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Product portfolio [axis]" } } }, "auth_ref": [] }, "nvs_ProductPortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ProductPortfolioMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Product portfolio [member]" } } }, "auth_ref": [] }, "ifrs-full_ProductsAndServicesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProductsAndServicesAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Products and services [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r180", "r347", "r363" ] }, "ifrs-full_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProductsAndServicesDomain", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Products and services [domain]" } }, "en": { "role": { "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used." } } }, "auth_ref": [ "r180", "r347", "r363" ] }, "ifrs-full_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlowCalc2": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 3.8 }, "http://novartis.com/20260630/role/StatementOfComprehensiveIncome": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 5.0 }, "http://novartis.com/20260630/role/StatementOfIncomeCalc2": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ", "http://novartis.com/20260630/role/StatementOfChangesInEquity", "http://novartis.com/20260630/role/StatementOfComprehensiveIncome", "http://novartis.com/20260630/role/StatementOfIncome", "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Profit (loss)", "totalLabel": "Net income", "terseLabel": "Net income" } }, "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r92", "r94", "r173", "r175", "r228", "r250", "r283", "r314", "r344", "r350" ] }, "ifrs-full_ProfitLossAttributableToAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossAttributableToAbstract", "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Profit (loss), attributable to [abstract]", "terseLabel": "Attributable to" } } }, "auth_ref": [] }, "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossAttributableToNoncontrollingInterests", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncomeCalc2": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Profit (loss), attributable to non-controlling interests", "terseLabel": "Non-controlling interests" } }, "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]" } } }, "auth_ref": [ "r97", "r317" ] }, "ifrs-full_ProfitLossAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncomeCalc2": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Profit/loss attributable to shareholders of Novartis AG", "label": "Profit (loss), attributable to owners of parent", "verboseLabel": "Shareholders of Novartis AG" } }, "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r318" ] }, "ifrs-full_ProfitLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossBeforeTax", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": "ifrs-full_ProfitLossFromContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Profit (loss) before tax", "totalLabel": "Income before taxes", "terseLabel": "Income before taxes" } } }, "auth_ref": [ "r156", "r361", "r362", "r371", "r372" ] }, "ifrs-full_ProfitLossFromContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossFromContinuingOperations", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Profit (loss) from continuing operations", "terseLabel": "Net income", "verboseLabel": "Net income from continuing operations" } }, "en": { "role": { "documentation": "The profit (loss) from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Profit (loss)]" } } }, "auth_ref": [ "r106", "r173", "r175", "r314" ] }, "ifrs-full_ProfitLossFromDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossFromDiscontinuedOperations", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ", "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Profit (loss) from discontinued operations", "terseLabel": "Net income from discontinued operations", "totalLabel": "Net income from discontinued operations" } } }, "auth_ref": [ "r107", "r155", "r323", "r327" ] }, "ifrs-full_ProfitLossFromOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProfitLossFromOperatingActivities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Profit (loss) from operating activities", "totalLabel": "Operating income", "terseLabel": "Operating income" } } }, "auth_ref": [ "r332", "r416" ] }, "nvs_ProfitSharingIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ProfitSharingIncome", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails4Q" ], "lang": { "en-us": { "role": { "label": "Profit sharing income" } } }, "auth_ref": [] }, "nvs_ProformaNetSales": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ProformaNetSales", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Proforma net sales" } } }, "auth_ref": [] }, "nvs_PromactaRevoladeMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "PromactaRevoladeMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Promacta/Revolade [member]" } } }, "auth_ref": [] }, "nvs_PromotedBrandsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "PromotedBrandsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Promoted Brands [member]" } } }, "auth_ref": [] }, "ifrs-full_PropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment", "periodStartLabel": "Property, plant and equipment at beginning of period", "periodEndLabel": "Property, plant and equipment at end of period" } }, "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]" } } }, "auth_ref": [ "r10", "r220", "r292" ] }, "ifrs-full_PropertyPlantAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PropertyPlantAndEquipmentMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment [member]", "terseLabel": "Property, plant and equipment" } }, "en": { "role": { "documentation": "This member stands for property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r11", "r221", "r333", "r349", "r365", "r366" ] }, "ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment recognised as of acquisition date", "terseLabel": "Property, plant and equipment" } }, "en": { "role": { "documentation": "The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Total for all business combinations [member]]" } } }, "auth_ref": [ "r353", "r355", "r367" ] }, "nvs_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDateMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDateMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment recognised as of acquisition date [member]", "terseLabel": "Property, plant and equipment recognised as of acquisition date" } } }, "auth_ref": [] }, "nvs_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment recognised as of acquisition date through acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "ifrs-full_ProportionOfOwnershipInterestInAssociate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProportionOfOwnershipInterestInAssociate", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Proportion of ownership interest in associate" } }, "en": { "role": { "documentation": "The proportion of ownership interest in an associate attributable to the entity. [Refer: Total for all associates [member]]" } } }, "auth_ref": [ "r28", "r30", "r100" ] }, "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProportionOfOwnershipInterestInSubsidiary", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Proportion of ownership interest in subsidiary" } }, "en": { "role": { "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]]" } } }, "auth_ref": [ "r28", "r30", "r99" ] }, "ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ProportionOfOwnershipInterestsHeldByNoncontrollingInterests", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Proportion of ownership interests held by non-controlling interests" } }, "en": { "role": { "documentation": "The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Total for all subsidiaries [member]; Non-controlling interests]" } } }, "auth_ref": [ "r96" ] }, "ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": -1.0, "order": 15.5 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Investments in time deposits and marketable securities", "label": "Purchase of financial instruments, classified as investing activities" } }, "en": { "role": { "documentation": "The cash outflow for the purchase of financial instruments. [Refer: Classes of financial instruments [domain]]" } } }, "auth_ref": [ "r397" ] }, "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Purchase of intangible assets, classified as investing activities", "negatedTerseLabel": "Purchases of intangible assets" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r340" ] }, "ifrs-full_PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PurchaseOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Purchase of investments other than investments accounted for using equity method", "negatedTerseLabel": "Purchases of financial assets" } }, "en": { "role": { "documentation": "The cash outflow for the purchase of investments other than investments accounted for using equity method. [Refer: Investments accounted for using equity method; Investments other than investments accounted for using equity method]" } } }, "auth_ref": [ "r397" ] }, "nvs_PurchaseOfNonControllingInterests": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "PurchaseOfNonControllingInterests", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Purchase of non-controlling interests" } } }, "auth_ref": [] }, "ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Purchase of other long-term assets, classified as investing activities", "negatedTerseLabel": "Purchases of other non-current assets" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of long-term assets that the entity does not separately disclose in the same statement or note, classified as investing activities. [Refer: Assets]" } } }, "auth_ref": [ "r340" ] }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Purchase of property, plant and equipment, classified as investing activities", "negatedTerseLabel": "Purchases of property, plant and equipment" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r340" ] }, "ifrs-full_PurchaseOfTreasuryShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "PurchaseOfTreasuryShares", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Purchase of treasury shares", "terseLabel": "Purchase of treasury shares, equity impact", "negatedTerseLabel": "Purchase of treasury shares", "negatedLabel": "Purchase of treasury shares, equity impact" } }, "en": { "role": { "documentation": "The decrease in equity resulting from the purchase of treasury shares. [Refer: Treasury shares]" } } }, "auth_ref": [ "r409" ] }, "ifrs-full_ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ReceiptsFromRoyaltiesFeesCommissionsAndOtherRevenue", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails4Q" ], "lang": { "en-us": { "role": { "label": "Receipts from royalties, fees, commissions and other revenue" } } }, "auth_ref": [ "r338" ] }, "nvs_ReceivablesAndPayablesContingentConsiderationNet": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ReceivablesAndPayablesContingentConsiderationNet", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Receivables and payables contingent consideration, net", "terseLabel": "Contingent consideration payables, net" } } }, "auth_ref": [] }, "nvs_ReceivablesAssociatedCompanies": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ReceivablesAssociatedCompanies", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureOtherCurrentAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentNonfinancialAssets", "weight": 1.0, "order": 5.0 } }, "lang": { "en-us": { "role": { "label": "Receivables associated companies" } } }, "auth_ref": [] }, "nvs_ReclastAclastaMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ReclastAclastaMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Reclast/Aclasta [member]" } } }, "auth_ref": [] }, "ifrs-full_RecurringFairValueMeasurementMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RecurringFairValueMeasurementMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q", "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Recurring fair value measurement [member]" } } }, "auth_ref": [ "r118", "r267" ] }, "ifrs-full_ReductionOfIssuedCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ReductionOfIssuedCapital", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetails1Q", "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Reduction of issued capital", "negatedTerseLabel": "Reduction of share capital" } }, "en": { "role": { "documentation": "The decrease in equity resulting from a reduction in issued capital. [Refer: Issued capital]" } } }, "auth_ref": [ "r409" ] }, "nvs_ReductionOfNonControllingInterests": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ReductionOfNonControllingInterests", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Reduction of non-controlling interests" } } }, "auth_ref": [] }, "nvs_ReductionParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://novartis.com/20260630", "localname": "ReductionParValuePerShare", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetails1Q" ], "lang": { "en-us": { "role": { "label": "Reduction par value per share" } } }, "auth_ref": [] }, "ifrs-full_RefundsProvision": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RefundsProvision", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails": { "parentTag": "ifrs-full_OtherCurrentNonfinancialLiabilities", "weight": 1.0, "order": 6.0 } }, "lang": { "en": { "role": { "documentation": "The amount of provision for refunds to be made by the entity to its customers. [Refer: Other provisions]" } } }, "auth_ref": [ "r335", "r337" ] }, "nvs_RegulusTherapeuticsInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "RegulusTherapeuticsInc.Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Regulus Therapeutics Inc. [member]", "terseLabel": "Regulus Therapeutics Inc." } } }, "auth_ref": [] }, "nvs_RepaymentOfIntercompanyBalances": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "RepaymentOfIntercompanyBalances", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Repayment of intercompany balances", "negatedTerseLabel": "Repayment of intercompany balances" } } }, "auth_ref": [] }, "ifrs-full_RepaymentsOfCurrentBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RepaymentsOfCurrentBorrowings", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": -1.0, "order": 6.5 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Repayments of current borrowings", "terseLabel": "Repayments of other current financial debts", "negatedTerseLabel": "Repayments of other current financial debts" } }, "en": { "role": { "documentation": "The cash outflow for repayments of current borrowings. [Refer: Current borrowings]" } } }, "auth_ref": [ "r398" ] }, "ifrs-full_RepaymentsOfNoncurrentBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RepaymentsOfNoncurrentBorrowings", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Repayments of non-current borrowings", "terseLabel": "Repayments of non-current financial debts", "negatedTerseLabel": "Repayments of the current portion of non-current financial debts" } }, "en": { "role": { "documentation": "The cash outflow for repayments of non-current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r398" ] }, "nvs_ReplacementOfCreditFacilityWithASyndicateOfBanksMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ReplacementOfCreditFacilityWithASyndicateOfBanksMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Replacement of credit facility with a syndicate of banks [member]" } } }, "auth_ref": [] }, "nvs_ReportedValueMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ReportedValueMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Reported value [member]" } } }, "auth_ref": [] }, "nvs_ReprixysPharmaceuticalsCorporationMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ReprixysPharmaceuticalsCorporationMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Reprixys Pharmaceuticals Corporation [member]", "terseLabel": "Reprixys Pharmaceuticals Corporation" } } }, "auth_ref": [] }, "nvs_RepurchaseOfOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "RepurchaseOfOptions", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Repurchase of options", "negatedTerseLabel": "Repurchase of options" } } }, "auth_ref": [] }, "nvs_ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureCommitmentsAndContingenciesDetails2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "lang": { "en-us": { "role": { "label": "Research and Development and other intangible asset purchase commitments", "totalLabel": "Total" } } }, "auth_ref": [] }, "nvs_ResearchAndDevelopmentCommitmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "ResearchAndDevelopmentCommitmentsAbstract", "lang": { "en-us": { "role": { "label": "Research and development and other intangible asset purchase commitments [abstract]" } } }, "auth_ref": [] }, "ifrs-full_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Research and development expense", "negatedTerseLabel": "Research and development" } } }, "auth_ref": [ "r56", "r243" ] }, "nvs_RestOfPortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "RestOfPortfolioMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Rest of portfolio [member]" } } }, "auth_ref": [] }, "nvs_RestOfTheWorldMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "RestOfTheWorldMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Rest of the world [member]" } } }, "auth_ref": [] }, "ifrs-full_RestatedMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RestatedMember", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Currently stated [member]" } }, "en": { "role": { "documentation": "This member stands for the information currently stated in the financial statements. It also represents the standard value for the 'Retrospective application and retrospective restatement' and 'Departure from requirement of IFRS' axes if no other member is used." } } }, "auth_ref": [ "r82", "r84", "r86", "r138", "r205", "r207", "r210", "r282", "r411" ] }, "nvs_RestatedValueAdjustmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "RestatedValueAdjustmentsMember", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Restated Value Adjustments [member]" } } }, "auth_ref": [] }, "ifrs-full_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RetainedEarningsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ", "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Retained earnings [member]", "terseLabel": "Retained earnings" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r287", "r373" ] }, "ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RetrospectiveApplicationAndRetrospectiveRestatementAxis", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Retrospective application and retrospective restatement [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r82", "r84", "r86", "r205", "r207", "r210", "r282" ] }, "ifrs-full_RevenueFromInterest": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RevenueFromInterest", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails2": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": 1.0, "order": 9.0 } }, "lang": { "en-us": { "role": { "label": "Interest income" } }, "en": { "role": { "documentation": "The amount of income arising from interest." } } }, "auth_ref": [ "r112", "r169", "r178", "r410" ] }, "ifrs-full_RevenueFromRoyalties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RevenueFromRoyalties", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails4Q" ], "lang": { "en-us": { "role": { "label": "Royalty income" } } }, "auth_ref": [ "r410" ] }, "ifrs-full_RevenueFromSaleOfGoods": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RevenueFromSaleOfGoods", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": "ifrs-full_GrossProfit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ", "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Revenue from sale of goods", "terseLabel": "Net sales", "verboseLabel": "Net sales to third parties" } } }, "auth_ref": [ "r410" ] }, "nvs_RevenueFromSaleOfGoodsAsPercentOfTotalNetSales": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "RevenueFromSaleOfGoodsAsPercentOfTotalNetSales", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Revenue from sale of goods, as percent of total net sales", "terseLabel": "Net sales (in % of total net sales)" } } }, "auth_ref": [] }, "nvs_RevenueFromSaleOfGoodsChangeInPercent": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "RevenueFromSaleOfGoodsChangeInPercent", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Revenue from sale of goods, change in percent", "terseLabel": "Net sales, change in %" } } }, "auth_ref": [] }, "nvs_RevenueFromSaleOfGoodsChangeInPercentCc": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "RevenueFromSaleOfGoodsChangeInPercentCc", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Revenue from sale of goods, change in percent, cc", "terseLabel": "Net sales, change in %, cc" } } }, "auth_ref": [] }, "nvs_RevenueFromSaleOfGoodsSalesToOtherSegments": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "RevenueFromSaleOfGoodsSalesToOtherSegments", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": "ifrs-full_RevenueFromSaleOfGoods", "weight": 1.0, "order": 3.0 } }, "lang": { "en-us": { "role": { "label": "Revenue from sale of goods, sales to other segments", "terseLabel": "Sales to discontinued operations", "verboseLabel": "Sales to other segments" } } }, "auth_ref": [] }, "nvs_RevenueFromSaleOfGoodsThirdParties": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "RevenueFromSaleOfGoodsThirdParties", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": "ifrs-full_RevenueFromSaleOfGoods", "weight": 1.0, "order": 2.0 } }, "lang": { "en-us": { "role": { "label": "Revenue from sale of goods third parties", "terseLabel": "Net sales to third parties", "verboseLabel": "Net sales to third parties from continuing operations" } } }, "auth_ref": [] }, "nvs_RevenueFromSaleOfGoodsToThirdParties": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "RevenueFromSaleOfGoodsToThirdParties", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Third party sales" } } }, "auth_ref": [] }, "ifrs-full_RevenueOfAcquiree": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RevenueOfAcquiree", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Revenue of acquiree since acquisition date" } } }, "auth_ref": [ "r150" ] }, "nvs_RevenueOfAcquireeFullYear": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "RevenueOfAcquireeFullYear", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Revenue of acquiree full year" } } }, "auth_ref": [] }, "ifrs-full_ReversalOfImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ReversalOfImpairmentLoss", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Reversal of impairment loss" } } }, "auth_ref": [ "r39", "r40" ] }, "ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Reversal of impairment loss recognised in profit or loss, intangible assets other than goodwill", "terseLabel": "Reversal of impairment charge" } } }, "auth_ref": [ "r52", "r239" ] }, "ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Reversal of impairment loss recognised in profit or loss, property, plant and equipment", "terseLabel": "Property, plant and equipment impairment reversal" } } }, "auth_ref": [ "r8", "r218", "r326" ] }, "ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ReversalOfImpairmentLossRecognisedInProfitOrLossRightofuseAssets", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Reversal of impairment loss recognised in profit or loss, right-of-use assets" } } }, "auth_ref": [ "r391" ] }, "nvs_RhapsidoMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "RhapsidoMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "Rhapsido [member]" } } }, "auth_ref": [] }, "nvs_RightOfUseAssetsAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "RightOfUseAssetsAsOfAcquisitionDate", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Right of use assets as of acquisition date", "terseLabel": "Right-of-use assets" } } }, "auth_ref": [] }, "nvs_RightOfUseAssetsAsOfAcquisitionDateMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "RightOfUseAssetsAsOfAcquisitionDateMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Right of use assets as of acquisition date [member]", "terseLabel": "Right of use assets as of acquisition date" } } }, "auth_ref": [] }, "nvs_RightOfUseAssetsAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "RightOfUseAssetsAsOfAcquisitionDateThroughAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Right of use assets as of acquisition date through acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "ifrs-full_RightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RightofuseAssets", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets", "periodStartLabel": "Right-of-use assets at beginning of period", "periodEndLabel": "Right-of-use assets at end of period" } }, "en": { "role": { "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee." } } }, "auth_ref": [ "r127", "r132", "r190" ] }, "ifrs-full_RightofuseAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "RightofuseAssetsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets [member]", "terseLabel": "Right-of-use assets" } }, "en": { "role": { "documentation": "This member stands for right-of-use assets. [Refer: Right-of-use assets]" } } }, "auth_ref": [ "r126" ] }, "nvs_RitalinFocalinMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "RitalinFocalinMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Ritalin/Focalin [member]" } } }, "auth_ref": [] }, "nvs_RocheHoldingAGMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "RocheHoldingAGMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Roche Holding AG [member]", "terseLabel": "Roche Holding AG, Switzerland" } } }, "auth_ref": [] }, "nvs_SOFR0.65USD500Million20262029NovartisCapitalCorporationNewYorkUnitedStatesIssuedAt100.000Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "SOFR0.65USD500Million20262029NovartisCapitalCorporationNewYorkUnitedStatesIssuedAt100.000Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "SOFR + 0.65% USD 500 million 2026/2029 Novartis Capital Corporation, New York, United States, issued at 100.000% [member]" } } }, "auth_ref": [] }, "nvs_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "SaleOfBusinessAssetsArisingFromContingenciesAmountRecognized", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Sale of business assets arising from contingencies amount recognized" } } }, "auth_ref": [] }, "nvs_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognizedOtherThanAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "SaleOfBusinessAssetsArisingFromContingenciesAmountRecognizedOtherThanAtFairValue", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Sale of business assets arising from contingencies amount recognized other than at fair value" } } }, "auth_ref": [] }, "nvs_SaleOfBusinessContingentConsiderationArrangementsRangeOfOutcomesValueHigh": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "SaleOfBusinessContingentConsiderationArrangementsRangeOfOutcomesValueHigh", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Sale of business, contingent consideration arrangements, range of outcomes, value, high" } } }, "auth_ref": [] }, "nvs_SaleOfBusinessContingentOptionArrangementsFeePaid": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "SaleOfBusinessContingentOptionArrangementsFeePaid", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Sale of business, contingent option arrangements, fee paid" } } }, "auth_ref": [] }, "nvs_SaleOfBusinessContingentOptionArrangementsRangeOfOutcomesValueHigh": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "SaleOfBusinessContingentOptionArrangementsRangeOfOutcomesValueHigh", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Sale of business, contingent option arrangements, range of outcomes, value, high" } } }, "auth_ref": [] }, "nvs_SandostatinMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "SandostatinMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Sandostatin Group [member]" } } }, "auth_ref": [] }, "nvs_SandozGroupAGMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "SandozGroupAGMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Sandoz Group AG [member]", "terseLabel": "Sandoz Group AG" } } }, "auth_ref": [] }, "nvs_SandozMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "SandozMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q", "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q", "http://novartis.com/20260630/role/DisclosureOperatingSegmentsQ", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails4Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ", "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetails1Q" ], "lang": { "en-us": { "role": { "label": "Sandoz [member]", "terseLabel": "Sandoz" } } }, "auth_ref": [] }, "nvs_ScemblixMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ScemblixMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Scemblix [member]" } } }, "auth_ref": [] }, "nvs_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails4Q" ], "lang": { "en-us": { "role": { "label": "Schedule for commitments under research and development and other intangible asset purchase [line items]" } } }, "auth_ref": [] }, "nvs_ScheduleForCommitmentsUnderResearchAndDevelopmentTable": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "ScheduleForCommitmentsUnderResearchAndDevelopmentTable", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails4Q" ], "lang": { "en-us": { "role": { "label": "Schedule for commitments under research and development and other intangible asset purchase [table]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12bTitle", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r380" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityExchangeName", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r382" ] }, "nvs_SeebriBreezhalerMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "SeebriBreezhalerMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "Seebri Breezhaler [member]" } } }, "auth_ref": [] }, "ifrs-full_SegmentConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SegmentConsolidationItemsAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails4Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Segment consolidation items [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r173" ] }, "ifrs-full_SegmentConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SegmentConsolidationItemsDomain", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails4Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "Segment consolidation items [domain]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Segment consolidation items' axis if no other member is used." } } }, "auth_ref": [ "r179" ] }, "ifrs-full_SegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SegmentsAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureOperatingSegmentsQ", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails4Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Segments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r40", "r124", "r173", "r185", "r330", "r352" ] }, "ifrs-full_SegmentsDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SegmentsDomain", "presentation": [ "http://novartis.com/20260630/role/DisclosureOperatingSegmentsQ", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails4Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Segments [domain]" } }, "en": { "role": { "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used." } } }, "auth_ref": [ "r40", "r124", "r179", "r185", "r330", "r352" ] }, "nvs_SelexysPharmaceuticalsCorporationMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "SelexysPharmaceuticalsCorporationMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Selexys Pharmaceuticals Corporation [member]", "terseLabel": "Selexys Pharmaceuticals Corporation" } } }, "auth_ref": [] }, "ifrs-full_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Selling, general and administrative expense", "negatedTerseLabel": "Selling, general and administration" } } }, "auth_ref": [ "r416" ] }, "nvs_ShareMovements": { "xbrltype": "sharesItemType", "nsuri": "http://novartis.com/20260630", "localname": "ShareMovements", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Share movements in period", "terseLabel": "Total movements" } } }, "auth_ref": [] }, "ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfComprehensiveIncome": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://novartis.com/20260630/role/StatementOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Share of other comprehensive income of associates and joint ventures accounted for using equity method that will be reclassified to profit or loss, net of tax", "verboseLabel": "Other comprehensive income effect", "terseLabel": "Associated companies' movements in comprehensive income" } }, "en": { "role": { "documentation": "Share of the other comprehensive income of associates and joint ventures accounted for using the equity method that will be reclassified to profit or loss, net of tax." } } }, "auth_ref": [ "r324" ] }, "ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/StatementOfIncome": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ", "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Share of profit (loss) of associates and joint ventures accounted for using equity method", "terseLabel": "Loss from associated companies", "negatedTerseLabel": "Loss from associated companies", "verboseLabel": "Net income statement effect" } } }, "auth_ref": [ "r171", "r178", "r321" ] }, "nvs_SharesCancelledForCapitalReduction": { "xbrltype": "sharesItemType", "nsuri": "http://novartis.com/20260630", "localname": "SharesCancelledForCapitalReduction", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Shares cancelled for capital reduction" } } }, "auth_ref": [] }, "nvs_SharesDeliveredToDivestedBusinessEmployees2": { "xbrltype": "sharesItemType", "nsuri": "http://novartis.com/20260630", "localname": "SharesDeliveredToDivestedBusinessEmployees2", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Shares delivered to divested business employees Sandoz" } } }, "auth_ref": [] }, "nvs_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ", "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Shares delivered to divested business employees, equity impact Alcon" } } }, "auth_ref": [] }, "nvs_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff2": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff2", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Shares delivered to divested business employees, equity impact Sandoz" } } }, "auth_ref": [] }, "ifrs-full_ShorttermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ShorttermBorrowings", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsDetails": { "parentTag": "ifrs-full_OtherCurrentFinancialLiabilities", "weight": 1.0, "order": 2.0 } }, "lang": { "en-us": { "role": { "label": "Current borrowings", "terseLabel": "Bank and other financial debt" } }, "en": { "role": { "documentation": "The amount of current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r412" ] }, "ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ShorttermDepositsNotClassifiedAsCashEquivalents", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureMarketableSecuritiesDetails": { "parentTag": "ifrs-full_OtherCurrentFinancialAssets", "weight": 1.0, "order": 6.0 } }, "lang": { "en-us": { "role": { "label": "Short-term deposits, not classified as cash equivalents", "terseLabel": "Time deposits and short-term investments with original maturity more than 90 days" } }, "en": { "role": { "documentation": "The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]" } } }, "auth_ref": [ "r412" ] }, "ifrs-full_ShorttermEmployeeBenefitsAccruals": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ShorttermEmployeeBenefitsAccruals", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails": { "parentTag": "ifrs-full_OtherCurrentNonfinancialLiabilities", "weight": 1.0, "order": 7.0 } }, "lang": { "en-us": { "role": { "label": "Short-term employee benefits accruals", "terseLabel": "Accruals for compensation and benefits including social security" } }, "en": { "role": { "documentation": "The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]" } } }, "auth_ref": [ "r414" ] }, "ifrs-full_ShorttermRestructuringProvision": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "ShorttermRestructuringProvision", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails": { "parentTag": "ifrs-full_OtherCurrentNonfinancialLiabilities", "weight": 1.0, "order": 2.0 } }, "lang": { "en-us": { "role": { "label": "Current restructuring provision", "terseLabel": "Restructuring provisions" } }, "en": { "role": { "documentation": "The amount of current provision for restructuring. [Refer: Restructuring provision]" } } }, "auth_ref": [ "r334" ] }, "nvs_SignificantAccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "SignificantAccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Significant Accounting Policies [abstract]" } } }, "auth_ref": [] }, "ifrs-full_SignificantInvestmentsInAssociatesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SignificantInvestmentsInAssociatesAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q", "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ", "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetails1Q" ], "lang": { "en-us": { "role": { "label": "Associates [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r29", "r31", "r117", "r265" ] }, "ifrs-full_SignificantInvestmentsInAssociatesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SignificantInvestmentsInAssociatesDomain", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q", "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ", "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetails1Q" ], "lang": { "en-us": { "role": { "label": "Associates [domain]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Associates' axis if no other member is used." } } }, "auth_ref": [ "r29", "r31", "r117", "r265" ] }, "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SignificantInvestmentsInSubsidiariesAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r29", "r31", "r116", "r264" ] }, "ifrs-full_SignificantInvestmentsInSubsidiariesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SignificantInvestmentsInSubsidiariesDomain", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [domain]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used." } } }, "auth_ref": [ "r29", "r31", "r116", "r264" ] }, "nvs_SolodynMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "SolodynMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Solodyn [member]" } } }, "auth_ref": [] }, "nvs_SpinifexMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "SpinifexMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Spinifex [member]", "terseLabel": "Spinifex" } } }, "auth_ref": [] }, "nvs_Statement1Table": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "Statement1Table", "presentation": [ "http://novartis.com/20260630/role/BalanceSheet", "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails1Q", "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q", "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails3Q", "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails1Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ", "http://novartis.com/20260630/role/StatementOfComprehensiveIncome", "http://novartis.com/20260630/role/StatementOfIncome", "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Statement [table]" } } }, "auth_ref": [] }, "nvs_StatementLine1Items": { "xbrltype": "stringItemType", "nsuri": "http://novartis.com/20260630", "localname": "StatementLine1Items", "presentation": [ "http://novartis.com/20260630/role/BalanceSheet", "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails1Q", "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q", "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails3Q", "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails1Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetailsQ", "http://novartis.com/20260630/role/StatementOfComprehensiveIncome", "http://novartis.com/20260630/role/StatementOfIncome", "http://novartis.com/20260630/role/StatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Statement [line items]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of cash flows [abstract]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfChangesInEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of changes in equity [abstract]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfChangesInEquityLineItems", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfChangesInEquityTable", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } } }, "auth_ref": [ "r287" ] }, "ifrs-full_StatementOfComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "Statement of comprehensive income [abstract]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of financial position [abstract]" } } }, "auth_ref": [] }, "nvs_StockRepurchaseProgramAuthorizedAmountShareBuyback": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "StockRepurchaseProgramAuthorizedAmountShareBuyback", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Stock repurchase program, authorized amount", "terseLabel": "Shares repurchased on the SIX Swiss Exchange second trading line under the share buyback authority approved", "negatedTerseLabel": "Increase of treasury share repurchase obligation under a share buyback trading plan" } } }, "auth_ref": [] }, "nvs_StraightBondsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "StraightBondsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Straight bonds [member]" } } }, "auth_ref": [] }, "ifrs-full_SubsidiariesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "SubsidiariesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [member]" } }, "en": { "role": { "documentation": "This member stands for entities that are controlled by another entity." } } }, "auth_ref": [ "r23", "r29", "r31", "r116", "r226", "r264" ] }, "nvs_SummaryOfTreasurySharesMovementsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://novartis.com/20260630", "localname": "SummaryOfTreasurySharesMovementsTableTextBlock", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersTablesQ" ], "lang": { "en-us": { "role": { "label": "Summary of treasury shares movements [table text block]", "terseLabel": "Schedule disclosing information related treasury shares movements" } } }, "auth_ref": [] }, "nvs_SystaneGroupMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "SystaneGroupMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "Systane Group [member]" } } }, "auth_ref": [] }, "nvs_TabrectaMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "TabrectaMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "Tabrecta [member]" } } }, "auth_ref": [] }, "nvs_TafinlarMekinistMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "TafinlarMekinistMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Tafinlar + Mekinist [member]" } } }, "auth_ref": [] }, "nvs_TakedaPharmaceuticalCompanyLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "TakedaPharmaceuticalCompanyLimitedMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Takeda Pharmaceutical Company Limited [member]", "terseLabel": "Takeda Pharmaceutical Company Limited" } } }, "auth_ref": [] }, "nvs_TasignaMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "TasignaMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Tasigna [member]" } } }, "auth_ref": [] }, "nvs_TaxOnTransactionCostsRecordedInEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "TaxOnTransactionCostsRecordedInEquity", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetails1Q" ], "lang": { "en-us": { "role": { "label": "Tax on transaction costs recorded in equity" } } }, "auth_ref": [] }, "ifrs-full_TaxRateEffectFromChangeInTaxRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TaxRateEffectFromChangeInTaxRate", "calculation": { "http://novartis.com/20260630/role/DisclosureTaxesDetails3": { "parentTag": "ifrs-full_AverageEffectiveTaxRate", "weight": 1.0, "order": 8.0 } }, "lang": { "en-us": { "role": { "label": "Tax rate, effect from change in tax rate", "terseLabel": "Effect of tax rate change on current and deferred tax assets and liabilities" } }, "en": { "role": { "documentation": "The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from a change in tax rate. [Refer: Average effective tax rate; Applicable tax rate]" } } }, "auth_ref": [ "r3", "r213" ] }, "nvs_TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries", "calculation": { "http://novartis.com/20260630/role/DisclosureTaxesDetails3": { "parentTag": "ifrs-full_AverageEffectiveTaxRate", "weight": 1.0, "order": 10.0 } }, "lang": { "en-us": { "role": { "label": "Tax rate, effect from write down and reversal of write down of invest subsidiaries", "terseLabel": "Effect of write down and reversal of write down of investments in subsidiaries" } } }, "auth_ref": [] }, "ifrs-full_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods", "calculation": { "http://novartis.com/20260630/role/DisclosureTaxesDetails3": { "parentTag": "ifrs-full_AverageEffectiveTaxRate", "weight": 1.0, "order": 11.0 } }, "lang": { "en-us": { "role": { "label": "Tax rate effect of adjustments for current tax of prior periods", "terseLabel": "Effect of prior year items" } } }, "auth_ref": [ "r390" ] }, "nvs_TaxRateEffectOfCreditsAndAllowances": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "TaxRateEffectOfCreditsAndAllowances", "calculation": { "http://novartis.com/20260630/role/DisclosureTaxesDetails3": { "parentTag": "ifrs-full_AverageEffectiveTaxRate", "weight": 1.0, "order": 6.0 } }, "lang": { "en-us": { "role": { "label": "Tax rate, effect of credits and allowances", "terseLabel": "Effect of tax credits and allowances" } } }, "auth_ref": [] }, "ifrs-full_TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss", "calculation": { "http://novartis.com/20260630/role/DisclosureTaxesDetails3": { "parentTag": "ifrs-full_AverageEffectiveTaxRate", "weight": 1.0, "order": 2.0 } }, "lang": { "en-us": { "role": { "label": "Tax rate, effect of expense not deductible in determining taxable profit tax loss", "terseLabel": "Effect of disallowed expenditures" } }, "en": { "role": { "documentation": "The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from the expenses not deductible in determining taxable profit. [Refer: Average effective tax rate; Applicable tax rate]" } } }, "auth_ref": [ "r3", "r213" ] }, "nvs_TaxRateEffectOfIncomeTaxedAtReducedRates": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "TaxRateEffectOfIncomeTaxedAtReducedRates", "calculation": { "http://novartis.com/20260630/role/DisclosureTaxesDetails3": { "parentTag": "ifrs-full_AverageEffectiveTaxRate", "weight": 1.0, "order": 4.0 } }, "lang": { "en-us": { "role": { "label": "Tax rate, effect of income taxed at reduced rates", "terseLabel": "Effect of income taxed at reduced rates" } } }, "auth_ref": [] }, "nvs_TaxRateEffectOfReleaseOfContingentConsiderationLiability": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "TaxRateEffectOfReleaseOfContingentConsiderationLiability", "calculation": { "http://novartis.com/20260630/role/DisclosureTaxesDetails3": { "parentTag": "ifrs-full_AverageEffectiveTaxRate", "weight": 1.0, "order": 7.0 } }, "lang": { "en-us": { "role": { "label": "Tax rate, effect of release of contingent consideration liability", "terseLabel": "Effect of release of contingent consideration liability" } } }, "auth_ref": [] }, "ifrs-full_TaxRateEffectOfRevenuesExemptFromTaxation": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TaxRateEffectOfRevenuesExemptFromTaxation", "calculation": { "http://novartis.com/20260630/role/DisclosureTaxesDetails3": { "parentTag": "ifrs-full_AverageEffectiveTaxRate", "weight": -1.0, "order": 5.0 } }, "lang": { "en-us": { "role": { "label": "Tax rate effect of revenues exempt from taxation", "terseLabel": "Effect of income not subject to tax", "negatedTerseLabel": "Effect of income not subject to tax" } }, "en": { "role": { "documentation": "The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from revenue that is exempt from taxation. [Refer: Average effective tax rate; Applicable tax rate]" } } }, "auth_ref": [ "r3", "r213" ] }, "nvs_TaxReformImpactOnDeferredTaxOnTreasuryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "TaxReformImpactOnDeferredTaxOnTreasuryShares", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Tax reform impact on deferred tax on treasury shares" } } }, "auth_ref": [] }, "nvs_TaxesOnTreasuryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "TaxesOnTreasuryShares", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ", "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Taxes on treasury shares", "negatedTerseLabel": "Taxes on treasury share transactions" } } }, "auth_ref": [] }, "nvs_TaxotereMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "TaxotereMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Taxotere [member]" } } }, "auth_ref": [] }, "ifrs-full_TechnologybasedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TechnologybasedIntangibleAssetsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Technology-based intangible assets [member]", "terseLabel": "Technologies" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing assets based on technology. Such assets may include patented and unpatented technology, databases as well as trade secrets. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r395" ] }, "nvs_TekturnaRasilezValturnaMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "TekturnaRasilezValturnaMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q" ], "lang": { "en-us": { "role": { "label": "Tekturna/Rasilez/Valturna [member]" } } }, "auth_ref": [] }, "nvs_TermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "TermLoanMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Term loan [member]" } } }, "auth_ref": [] }, "nvs_TheMedicinesCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "TheMedicinesCompanyMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "The Medicines Company, East Hanover, NJ [member]", "terseLabel": "The Medicines Company" } } }, "auth_ref": [] }, "nvs_TimeDepositsWithOriginalMaturityMoreThan90DaysMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "TimeDepositsWithOriginalMaturityMoreThan90DaysMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Time deposits with original maturity more than 90 days [member]" } } }, "auth_ref": [] }, "nvs_Top20ProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "Top20ProductsMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Top 20 products [member]" } } }, "auth_ref": [] }, "nvs_TopicalOlopatadineGroupMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "TopicalOlopatadineGroupMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "Topical Olopatadine Group [member]" } } }, "auth_ref": [] }, "nvs_TotalAvailableforsaleMarketableSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "TotalAvailableforsaleMarketableSecuritiesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Total available-for-sale marketable securities [member]" } } }, "auth_ref": [] }, "nvs_TotalConsiderationTransferredForBusinessCombinations": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "TotalConsiderationTransferredForBusinessCombinations", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Total consideration transferred for business combinations", "terseLabel": "Total purchase consideration for business combinations" } } }, "auth_ref": [] }, "nvs_TotalMarketableSecuritiesAndDerivativeFinancialInstrumentsGroupMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "TotalMarketableSecuritiesAndDerivativeFinancialInstrumentsGroupMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Marketable securities and derivative financial instruments [member]" } } }, "auth_ref": [] }, "nvs_TotalPercentageOfShareCapitalTenderedAfterTheSubsequentOfferingPeriodOfTheTenderOffer": { "xbrltype": "percentItemType", "nsuri": "http://novartis.com/20260630", "localname": "TotalPercentageOfShareCapitalTenderedAfterTheSubsequentOfferingPeriodOfTheTenderOffer", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Total percentage of share capital tendered after the subsequent offering period of the tender offer" } } }, "auth_ref": [] }, "nvs_TotalValueAdjustmentsAttributableToNovartisShareholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "TotalValueAdjustmentsAttributableToNovartisShareholdersMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ", "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Total value adjustments attributable to Novartis shareholders [Member]", "terseLabel": "Total value adjustments" } } }, "auth_ref": [] }, "nvs_TourmalineBioInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "TourmalineBioInc.Member", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Tourmaline Bio, Inc. [member]", "terseLabel": "Tourmaline Bio, Inc." } } }, "auth_ref": [] }, "ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TradeAndOtherPayablesRecognisedAsOfAcquisitionDate", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Trade and other payables recognised as of acquisition date", "negatedTerseLabel": "Trade payables and other liabilities" } }, "en": { "role": { "documentation": "The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Total for all business combinations [member]]" } } }, "auth_ref": [ "r404" ] }, "ifrs-full_TradeAndOtherPayablesToTradeSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TradeAndOtherPayablesToTradeSuppliers", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Trade payables", "negatedTerseLabel": "Trade payables" } }, "en": { "role": { "documentation": "The amount of payment due to suppliers for goods and services used in the entity's business." } } }, "auth_ref": [ "r414" ] }, "nvs_TradePayablesAndOtherLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "TradePayablesAndOtherLiabilitiesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Trade payables and other liabilities [member]", "terseLabel": "Trade payables and other liabilities" } } }, "auth_ref": [] }, "nvs_TradePayablesAndOtherLiabilitiesThroughAcquisitionsApplyingTheOptionalConcentrationTest": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "TradePayablesAndOtherLiabilitiesThroughAcquisitionsApplyingTheOptionalConcentrationTest", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q" ], "lang": { "en-us": { "role": { "label": "Trade payables and other liabilities through acquisitions applying the optional concentration test", "negatedTerseLabel": "Trade payables and other liabilities through acquisitions applying the optional concentration test" } } }, "auth_ref": [] }, "nvs_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails1Q" ], "lang": { "en-us": { "role": { "label": "Trade receivables and other current assets recognised as of acquisition date", "terseLabel": "Financial and other current assets recognised as of acquisition date" } } }, "auth_ref": [] }, "nvs_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDateMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDateMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Trade receivables and other current assets recognised as of acquisition date [member]", "terseLabel": "Trade receivables and other current assets recognised as of acquisition date" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "TradingSymbol", "presentation": [ "http://novartis.com/20260630/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "nvs_TransactionCostsRecordedInEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "TransactionCostsRecordedInEquity", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Transaction costs recorded in equity", "negatedTerseLabel": "Transaction costs, net of taxes" } } }, "auth_ref": [] }, "nvs_TransactionCostsRecordedInEquityPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "TransactionCostsRecordedInEquityPaid", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/StatementsOfCashFlow": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations", "weight": 1.0, "order": 8.0 } }, "lang": { "en-us": { "role": { "label": "Transaction costs recorded in equity paid", "terseLabel": "Transaction costs payments", "negatedTerseLabel": "Transaction costs payments" } } }, "auth_ref": [] }, "nvs_TransactionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "TransactionRelatedCosts", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Transaction related costs", "negatedTerseLabel": "Transaction related costs" } } }, "auth_ref": [] }, "nvs_TransactionRelatedCostsPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "TransactionRelatedCostsPaid", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Transaction related costs paid", "negatedTerseLabel": "Transaction related costs paid" } } }, "auth_ref": [] }, "nvs_TranscendMedicalIncMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "TranscendMedicalIncMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails2Q", "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Transcend Medical Inc [member]", "terseLabel": "Transcend Medical Inc." } } }, "auth_ref": [] }, "ifrs-full_TransfersIntoLevel3OfFairValueHierarchyAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TransfersIntoLevel3OfFairValueHierarchyAssets", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Transfers into Level 3 of fair value hierarchy, assets" } }, "en": { "role": { "documentation": "The amount of transfers of assets into Level 3 of the fair value hierarchy. [Refer: Level 3 of fair value hierarchy [member]]" } } }, "auth_ref": [ "r120" ] }, "ifrs-full_TransfersOutOfLevel3OfFairValueHierarchyAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TransfersOutOfLevel3OfFairValueHierarchyAssets", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails3Q" ], "lang": { "en-us": { "role": { "label": "Transfers out of Level 3 of fair value hierarchy, assets", "negatedTerseLabel": "Transfers out of Level 3 of fair value hierarchy, assets" } }, "en": { "role": { "documentation": "The amount of transfers of assets out of Level 3 of the fair value hierarchy. [Refer: Level 3 of fair value hierarchy [member]]" } } }, "auth_ref": [ "r120" ] }, "nvs_TravoprostGroupMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "TravoprostGroupMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Travoprost Group [member]" } } }, "auth_ref": [] }, "ifrs-full_TreasuryShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TreasuryShares", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureEquityDetails": { "parentTag": "nvs_OutstandingShareCapital", "weight": -1.0, "order": 2.0 }, "http://novartis.com/20260630/role/BalanceSheet": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://novartis.com/20260630/role/BalanceSheet" ], "lang": { "en-us": { "role": { "label": "Treasury shares", "negatedTerseLabel": "Treasury shares", "negatedPeriodEndLabel": "Treasury shares at end of period", "negatedPeriodStartLabel": "Treasury shares at beginning of period" } }, "en": { "role": { "documentation": "An entity\u2019s own equity instruments, held by the entity or other members of the consolidated group." } } }, "auth_ref": [ "r33", "r370", "r376" ] }, "nvs_TreasurySharesAcquiredForCancellationValue": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "TreasurySharesAcquiredForCancellationValue", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Treasury shares acquired for cancellation, equity impact", "terseLabel": "Shares acquired for cancellation, equity impact", "negatedTerseLabel": "Shares acquired for cancellation, equity impact" } } }, "auth_ref": [] }, "nvs_TreasurySharesAcquiredToBeCancelled": { "xbrltype": "sharesItemType", "nsuri": "http://novartis.com/20260630", "localname": "TreasurySharesAcquiredToBeCancelled", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Treasury shares acquired to be cancelled", "terseLabel": "Shares acquired to be cancelled" } } }, "auth_ref": [] }, "nvs_TreasurySharesAcquiredToBeHeld": { "xbrltype": "sharesItemType", "nsuri": "http://novartis.com/20260630", "localname": "TreasurySharesAcquiredToBeHeld", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Treasury shares acquired to be held" } } }, "auth_ref": [] }, "ifrs-full_TreasurySharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TreasurySharesMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ", "http://novartis.com/20260630/role/StatementOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Treasury shares [member]", "terseLabel": "Treasury shares", "verboseLabel": "Total treasury shares" } }, "en": { "role": { "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group." } } }, "auth_ref": [ "r287" ] }, "nvs_TreasurySharesMovementOfPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "TreasurySharesMovementOfPeriod", "crdr": "credit", "calculation": { "http://novartis.com/20260630/role/DisclosureEquityDetails": { "parentTag": "nvs_OutstandingShareCapitalMovement", "weight": 1.0, "order": 3.0 } }, "lang": { "en-us": { "role": { "label": "Treasury shares movement of period", "terseLabel": "Treasury shares movement of period" } } }, "auth_ref": [] }, "nvs_TreasurySharesWithRestrictedUse": { "xbrltype": "sharesItemType", "nsuri": "http://novartis.com/20260630", "localname": "TreasurySharesWithRestrictedUse", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Treasury shares with restricted use" } } }, "auth_ref": [] }, "ifrs-full_TypesOfInterestRatesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TypesOfInterestRatesAxis", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails2Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Types of interest rates [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r406" ] }, "ifrs-full_TypesOfInterestRatesDomain": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "TypesOfInterestRatesDomain", "presentation": [ "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails2Q", "http://novartis.com/20260630/role/DisclosureOtherInterimDisclosuresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Types of interest rates [domain]" } }, "en": { "role": { "documentation": "This member stands for all types of interest rates. It also represents the standard value for the 'Types of interest rates' axis if no other member is used. [Refer: Interest rate risk [member]]" } } }, "auth_ref": [ "r406" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2025", "localname": "US", "presentation": [ "http://novartis.com/20260630/role/DisclosureLegalProceedingsUpdateDetails1Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetailsQ" ], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "US" } } }, "auth_ref": [] }, "nvs_UltibroBreezhalerMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "UltibroBreezhalerMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "Ultibro Breezhaler [member]" } } }, "auth_ref": [] }, "nvs_UltibroGroupMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "UltibroGroupMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Ultibro Group [member]" } } }, "auth_ref": [] }, "nvs_ValueOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "ValueOfEquity", "crdr": "credit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Value of equity" } } }, "auth_ref": [] }, "nvs_ValuedAtAmortizedCostMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ValuedAtAmortizedCostMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetails2Q", "http://novartis.com/20260630/role/DisclosureFinancialInstrumentsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Valued at amortized cost [member]" } } }, "auth_ref": [] }, "nvs_VanrafiaMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "VanrafiaMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "Vanrafia [member]" } } }, "auth_ref": [] }, "nvs_VoltarenCataflamMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "VoltarenCataflamMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Voltaren/Cataflam [member]" } } }, "auth_ref": [] }, "nvs_VotrientMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "VotrientMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Votrient [member]" } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full", "localname": "WeightedAverageShares", "presentation": [ "http://novartis.com/20260630/role/StatementOfIncome" ], "lang": { "en-us": { "role": { "label": "Weighted average number of ordinary shares outstanding", "terseLabel": "Weighted average number of shares outstanding used in the basic earnings per share" } }, "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } } }, "auth_ref": [ "r37" ] }, "nvs_WithholdingTaxOnTheGrossDividend": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "WithholdingTaxOnTheGrossDividend", "crdr": "debit", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetailsQ" ], "lang": { "en-us": { "role": { "label": "Withholding tax on the gross dividend", "negatedTerseLabel": "Withholding tax on the gross dividend" } } }, "auth_ref": [] }, "nvs_WithholdingTaxRecoverable": { "xbrltype": "monetaryItemType", "nsuri": "http://novartis.com/20260630", "localname": "WithholdingTaxRecoverable", "crdr": "debit", "calculation": { "http://novartis.com/20260630/role/DisclosureOtherCurrentAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentNonfinancialAssets", "weight": 1.0, "order": 6.0 } }, "lang": { "en-us": { "role": { "label": "Withholding tax recoverable" } } }, "auth_ref": [] }, "nvs_WrittenCallOptionsContractualLive": { "xbrltype": "integerItemType", "nsuri": "http://novartis.com/20260630", "localname": "WrittenCallOptionsContractualLive", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetails1Q" ], "lang": { "en-us": { "role": { "label": "Written call options, contractual live" } } }, "auth_ref": [] }, "nvs_WrittenCallOptionsContractualLiveRemaining": { "xbrltype": "integerItemType", "nsuri": "http://novartis.com/20260630", "localname": "WrittenCallOptionsContractualLiveRemaining", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetails1Q" ], "lang": { "en-us": { "role": { "label": "Written call options, contractual live, remaining" } } }, "auth_ref": [] }, "nvs_WrittenCallOptionsHeldByMarketMaker": { "xbrltype": "integerItemType", "nsuri": "http://novartis.com/20260630", "localname": "WrittenCallOptionsHeldByMarketMaker", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetails1Q" ], "lang": { "en-us": { "role": { "label": "Written call options held by market maker" } } }, "auth_ref": [] }, "nvs_WrittenCallOptionsWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://novartis.com/20260630", "localname": "WrittenCallOptionsWeightedAverageExercisePrice", "presentation": [ "http://novartis.com/20260630/role/DisclosureSummaryOfEquityToShareholdersDetails1Q" ], "lang": { "en-us": { "role": { "label": "Written call options, weighted average exercise price" } } }, "auth_ref": [] }, "nvs_XiidraMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "XiidraMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q" ], "lang": { "en-us": { "role": { "label": "Xiidra [member]" } } }, "auth_ref": [] }, "nvs_XolairMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "XolairMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Xolair [member]" } } }, "auth_ref": [] }, "nvs_ZiarcoGroupLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ZiarcoGroupLimitedMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSignificantTransactionsDetailsQ" ], "lang": { "en-us": { "role": { "label": "Ziarco Group Limited [member]", "terseLabel": "Ziarco Group Limited" } } }, "auth_ref": [] }, "nvs_ZolgensmaGroupMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ZolgensmaGroupMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Zolgensma Group [member]" } } }, "auth_ref": [] }, "nvs_ZortressCerticanMember": { "xbrltype": "domainItemType", "nsuri": "http://novartis.com/20260630", "localname": "ZortressCerticanMember", "presentation": [ "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails2Q", "http://novartis.com/20260630/role/DisclosureSegmentationOfKeyFiguresDetails3Q" ], "lang": { "en-us": { "role": { "label": "Zortress/Certican [member]" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2025-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI", "URIDate": "2025-03-27" }, "r1": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_79&doctype=Standard", "URIDate": "2025-03-27" }, "r2": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2025-03-27" }, "r3": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r4": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2025-03-27" }, "r5": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2025-03-27" }, "r6": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_i&doctype=Standard", "URIDate": "2025-03-27" }, "r7": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_v&doctype=Standard", "URIDate": "2025-03-27" }, "r8": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_vi&doctype=Standard", "URIDate": "2025-03-27" }, "r9": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_vii&doctype=Standard", "URIDate": "2025-03-27" }, "r10": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2025-03-27" }, "r11": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73&doctype=Standard", "URIDate": "2025-03-27" }, "r12": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "75", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_75_a&doctype=Standard", "URIDate": "2025-03-27" }, "r13": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "75", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_75_b&doctype=Standard", "URIDate": "2025-03-27" }, "r14": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "142", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_142&doctype=Standard", "URIDate": "2025-03-27" }, "r15": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "2", "IssueDate": "2025-01-01", "Paragraph": "36", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&anchor=para_36_b&doctype=Standard", "URIDate": "2025-03-27" }, "r16": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2025-01-01", "Paragraph": "52", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_52_a&doctype=Standard", "URIDate": "2025-03-27" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2025-01-01", "Paragraph": "A19", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_A19_c&doctype=Standard", "URIDate": "2025-03-27" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "23", "IssueDate": "2025-01-01", "Paragraph": "26", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=23&code=ifrs-tx-2025-en-r&anchor=para_26_a&doctype=Standard", "URIDate": "2025-03-27" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2025-03-27" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2025-03-27" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2025-03-27" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17&doctype=Standard", "URIDate": "2025-03-27" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2025-01-01", "Paragraph": "19", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_19_c&doctype=Standard", "URIDate": "2025-03-27" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2025-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2025-en-r&anchor=para_35_b_iv&doctype=Standard", "URIDate": "2025-03-27" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2025-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2025-en-r&anchor=para_35_b_vii&doctype=Standard", "URIDate": "2025-03-27" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2025-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2025-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2025-03-27" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2025-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_10&doctype=Standard", "URIDate": "2025-03-27" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2025-01-01", "Paragraph": "16", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2025-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2025-03-27" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2025-03-27" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "29", "IssueDate": "2025-01-01", "Paragraph": "9", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=29&code=ifrs-tx-2025-en-r&anchor=para_9&doctype=Standard", "URIDate": "2025-03-27" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "32", "IssueDate": "2025-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard", "URIDate": "2025-03-27" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard", "URIDate": "2025-03-27" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_67&doctype=Standard", "URIDate": "2025-03-27" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "68", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_68&doctype=Standard", "URIDate": "2025-03-27" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2025-01-01", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2025-03-27" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2025-01-01", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_126&doctype=Standard", "URIDate": "2025-03-27" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2025-01-01", "Paragraph": "130", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_130_b&doctype=Standard", "URIDate": "2025-03-27" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2025-01-01", "Paragraph": "130", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_130_d_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2025-01-01", "Paragraph": "130", "Subparagraph": "f", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_130_f_i&doctype=Standard", "URIDate": "2025-03-27" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2025-01-01", "Paragraph": "130", "Subparagraph": "f", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_130_f_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2025-01-01", "Paragraph": "134", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_134_a&doctype=Standard", "URIDate": "2025-03-27" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2025-01-01", "Paragraph": "134", "Subparagraph": "d", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_134_d_iv&doctype=Standard", "URIDate": "2025-03-27" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2025-01-01", "Paragraph": "134", "Subparagraph": "e", "Clause": "iiA", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_134_e_iiA&doctype=Standard", "URIDate": "2025-03-27" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2025-01-01", "Paragraph": "134", "Subparagraph": "e", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_134_e_iv&doctype=Standard", "URIDate": "2025-03-27" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2025-01-01", "Paragraph": "135", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_135_a&doctype=Standard", "URIDate": "2025-03-27" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2025-01-01", "Paragraph": "84", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_84&doctype=Standard", "URIDate": "2025-03-27" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2025-01-01", "Paragraph": "86", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_86_a&doctype=Standard", "URIDate": "2025-03-27" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "118", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2025-03-27" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_i&doctype=Standard", "URIDate": "2025-03-27" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_v&doctype=Standard", "URIDate": "2025-03-27" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_vi&doctype=Standard", "URIDate": "2025-03-27" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2025-03-27" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "122", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_122_e&doctype=Standard", "URIDate": "2025-03-27" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_126&doctype=Standard", "URIDate": "2025-03-27" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "39", "IssueDate": "2025-01-01", "Paragraph": "102", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=39&code=ifrs-tx-2025-en-r&anchor=para_102_a&doctype=Standard", "URIDate": "2025-03-27" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2025-01-01", "Paragraph": "32A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_32A&doctype=Standard", "URIDate": "2025-03-27" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2025-01-01", "Paragraph": "76", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_76&doctype=Standard", "URIDate": "2025-03-27" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2025-03-27" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_d&doctype=Standard", "URIDate": "2025-03-27" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2025-01-01", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_50&doctype=Standard", "URIDate": "2025-03-27" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2025-03-27" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_10&doctype=Standard", "URIDate": "2025-03-27" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "14", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_14&doctype=Standard", "URIDate": "2025-03-27" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20&doctype=Standard", "URIDate": "2025-03-27" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_21&doctype=Standard", "URIDate": "2025-03-27" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_25&doctype=Standard", "URIDate": "2025-03-27" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard", "URIDate": "2025-03-27" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard", "URIDate": "2025-03-27" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35&doctype=Standard", "URIDate": "2025-03-27" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "39", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_39&doctype=Standard", "URIDate": "2025-03-27" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "40", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_40_a&doctype=Standard", "URIDate": "2025-03-27" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "40", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_40_b&doctype=Standard", "URIDate": "2025-03-27" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "40", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_40_c&doctype=Standard", "URIDate": "2025-03-27" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "40", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_40_d&doctype=Standard", "URIDate": "2025-03-27" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "42A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_42A&doctype=Standard", "URIDate": "2025-03-27" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "42B", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_42B&doctype=Standard", "URIDate": "2025-03-27" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard", "URIDate": "2025-03-27" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2025-03-27" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Section": "Presentation of a statement of cash flows", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS07_g10-17_TI", "URIDate": "2025-03-27" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "f", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_f_i&doctype=Standard", "URIDate": "2025-03-27" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_g&doctype=Standard", "URIDate": "2025-03-27" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "29", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_29_c_i&doctype=Standard", "URIDate": "2025-03-27" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "30", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_30_b&doctype=Standard", "URIDate": "2025-03-27" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "49", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_49_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2025-01-01", "Section": "Accounting policies", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS08_g7-31_TI", "URIDate": "2025-03-27" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRIC", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "15", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRIC&num=17&code=ifrs-tx-2025-en-r&anchor=para_15&doctype=Standard", "URIDate": "2025-03-27" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRIC", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRIC&num=17&code=ifrs-tx-2025-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2025-03-27" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRIC", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRIC&num=17&code=ifrs-tx-2025-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2025-03-27" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2025-03-27" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2025-03-27" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2025-03-27" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "10", "IssueDate": "2025-01-01", "Paragraph": "22", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2025-en-r&anchor=para_22&doctype=Standard", "URIDate": "2025-03-27" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "12", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_c&doctype=Standard", "URIDate": "2025-03-27" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "12", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_e&doctype=Standard", "URIDate": "2025-03-27" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "12", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_f&doctype=Standard", "URIDate": "2025-03-27" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "19B", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19B_c&doctype=Standard", "URIDate": "2025-03-27" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "21", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_21_a_iv&doctype=Standard", "URIDate": "2025-03-27" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ix", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_vi&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_vii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B13", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_b&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B13", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_c&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B13", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_e&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B13", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B13", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B16&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B4", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B4", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B4_d&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2025-03-27" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2025-03-27" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "93", "Subparagraph": "e", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_e_iv&doctype=Standard", "URIDate": "2025-03-27" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2025-03-27" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "93", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93&doctype=Standard", "URIDate": "2025-03-27" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS13_g91-99_TI", "URIDate": "2025-03-27" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Paragraph": "115", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_115&doctype=Standard", "URIDate": "2025-03-27" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Paragraph": "120", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_120_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_33&doctype=Standard", "URIDate": "2025-03-27" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2025-03-27" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2025-03-27" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "53", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_a&doctype=Standard", "URIDate": "2025-03-27" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "53", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_b&doctype=Standard", "URIDate": "2025-03-27" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "53", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_h&doctype=Standard", "URIDate": "2025-03-27" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "53", "Subparagraph": "j", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_j&doctype=Standard", "URIDate": "2025-03-27" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53&doctype=Standard", "URIDate": "2025-03-27" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_94&doctype=Standard", "URIDate": "2025-03-27" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "97", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_97&doctype=Standard", "URIDate": "2025-03-27" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "109", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_109&doctype=Standard", "URIDate": "2025-03-27" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "109A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_109A&doctype=Standard", "URIDate": "2025-03-27" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2025-03-27" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "120", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_120&doctype=Standard", "URIDate": "2025-03-27" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "132", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_132_b&doctype=Standard", "URIDate": "2025-03-27" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B64", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B64", "Subparagraph": "f", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_f_i&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B64", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B64", "Subparagraph": "g", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_g_i&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B64", "Subparagraph": "g", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_g_ii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B64", "Subparagraph": "k", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_k&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B64", "Subparagraph": "o", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_o_i&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B64", "Subparagraph": "p", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_p_i&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B64", "Subparagraph": "p", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_p_ii&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B64", "Subparagraph": "q", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_q_i&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B64", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B67", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B67&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Section": "Disclosures", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS03_g59-63_TI", "URIDate": "2025-03-27" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2025-03-27" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_c&doctype=Standard", "URIDate": "2025-03-27" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "38", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_38&doctype=Standard", "URIDate": "2025-03-27" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Section": "Presentation and disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS05_g30-42_TI", "URIDate": "2025-03-27" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "23B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_23B_a&doctype=Standard", "URIDate": "2025-03-27" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_25&doctype=Standard", "URIDate": "2025-03-27" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard", "URIDate": "2025-03-27" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35H", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2025-03-27" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35I&doctype=Standard", "URIDate": "2025-03-27" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35K", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35K&doctype=Standard", "URIDate": "2025-03-27" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2025-03-27" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "42E", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_42E_e&doctype=Standard", "URIDate": "2025-03-27" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard", "URIDate": "2025-03-27" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_c&doctype=Standard", "URIDate": "2025-03-27" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_d&doctype=Standard", "URIDate": "2025-03-27" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_g&doctype=Standard", "URIDate": "2025-03-27" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2025-03-27" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23&doctype=Standard", "URIDate": "2025-03-27" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2025-03-27" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2025-03-27" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2025-03-27" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2025-03-27" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2025-03-27" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard", "URIDate": "2025-03-27" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_32&doctype=Standard", "URIDate": "2025-03-27" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_33&doctype=Standard", "URIDate": "2025-03-27" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI", "URIDate": "2025-03-27" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2025-01-01", "Paragraph": "6.5.13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2025-en-r&anchor=para_6.5.13_a&doctype=Standard", "URIDate": "2025-03-27" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2026-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "30A", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_30A_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_104&doctype=Standard", "URIDate": "2025-03-27" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "108", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_108_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "115", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_a&doctype=Standard", "URIDate": "2025-03-27" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "115", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_b&doctype=Standard", "URIDate": "2025-03-27" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "115", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_g&doctype=Standard", "URIDate": "2025-03-27" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "115", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_i&doctype=Standard", "URIDate": "2025-03-27" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "115", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115&doctype=Standard", "URIDate": "2025-03-27" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "122", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_122_a_i&doctype=Standard", "URIDate": "2025-03-27" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "122", "Subparagraph": "a", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_122_a_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "122", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_122_a&doctype=Standard", "URIDate": "2025-03-27" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "124", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_124_a&doctype=Standard", "URIDate": "2025-03-27" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "124", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_124_c&doctype=Standard", "URIDate": "2025-03-27" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "124", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_124&doctype=Standard", "URIDate": "2025-03-27" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "133", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_133_a_iv&doctype=Standard", "URIDate": "2025-03-27" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "138", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138&doctype=Standard", "URIDate": "2025-03-27" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "160", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_iv&doctype=Standard", "URIDate": "2025-03-27" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "160", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a&doctype=Standard", "URIDate": "2025-03-27" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "164", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_164_b&doctype=Standard", "URIDate": "2025-03-27" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "169", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_169&doctype=Standard", "URIDate": "2025-03-27" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "176", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_176&doctype=Standard", "URIDate": "2025-03-27" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "178", "Subparagraph": "f", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_178_f_i&doctype=Standard", "URIDate": "2025-03-27" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "178", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_178_g&doctype=Standard", "URIDate": "2025-03-27" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "179", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_179_c_i&doctype=Standard", "URIDate": "2025-03-27" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "180", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_180_b&doctype=Standard", "URIDate": "2025-03-27" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "182", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_182&doctype=Standard", "URIDate": "2025-03-27" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "186", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_186_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "192", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_192&doctype=Standard", "URIDate": "2025-03-27" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "194", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_i&doctype=Standard", "URIDate": "2025-03-27" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "194", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "194", "Subparagraph": "f", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_f_i&doctype=Standard", "URIDate": "2025-03-27" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_d&doctype=Standard", "URIDate": "2025-03-27" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e_i&doctype=Standard", "URIDate": "2025-03-27" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "Subparagraph": "e", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e_v&doctype=Standard", "URIDate": "2025-03-27" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "Subparagraph": "e", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e_vi&doctype=Standard", "URIDate": "2025-03-27" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "Subparagraph": "e", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e_vii&doctype=Standard", "URIDate": "2025-03-27" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e&doctype=Standard", "URIDate": "2025-03-27" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "200", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200&doctype=Standard", "URIDate": "2025-03-27" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "218", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_218_a&doctype=Standard", "URIDate": "2025-03-27" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "223", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_223_c&doctype=Standard", "URIDate": "2025-03-27" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "225", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_225_a&doctype=Standard", "URIDate": "2025-03-27" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "227", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_227&doctype=Standard", "URIDate": "2025-03-27" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "231", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_231_c&doctype=Standard", "URIDate": "2025-03-27" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2025-03-27" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2025-03-27" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "250", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_250&doctype=Standard", "URIDate": "2025-03-27" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "254", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_254_a&doctype=Standard", "URIDate": "2025-03-27" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "254", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_254_d_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "254", "Subparagraph": "e", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_254_e_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "254", "Subparagraph": "f", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_254_f_i&doctype=Standard", "URIDate": "2025-03-27" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "255", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_255_a&doctype=Standard", "URIDate": "2025-03-27" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "257", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_257&doctype=Standard", "URIDate": "2025-03-27" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "259", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_259_a&doctype=Standard", "URIDate": "2025-03-27" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "263", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_c&doctype=Standard", "URIDate": "2025-03-27" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "263", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e_i&doctype=Standard", "URIDate": "2025-03-27" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "263", "Subparagraph": "e", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e_v&doctype=Standard", "URIDate": "2025-03-27" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "263", "Subparagraph": "e", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e_vi&doctype=Standard", "URIDate": "2025-03-27" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "263", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e&doctype=Standard", "URIDate": "2025-03-27" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "264", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_264_e&doctype=Standard", "URIDate": "2025-03-27" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "266", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_266&doctype=Standard", "URIDate": "2025-03-27" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "269", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_269&doctype=Standard", "URIDate": "2025-03-27" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "271", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_271_c&doctype=Standard", "URIDate": "2025-03-27" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "271", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_271_d&doctype=Standard", "URIDate": "2025-03-27" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "273", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_273&doctype=Standard", "URIDate": "2025-03-27" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "274", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_274_e&doctype=Standard", "URIDate": "2025-03-27" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_i&doctype=Standard", "URIDate": "2025-03-27" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "35", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_c&doctype=Standard", "URIDate": "2025-03-27" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "35", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_e_i&doctype=Standard", "URIDate": "2025-03-27" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "35", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_e&doctype=Standard", "URIDate": "2025-03-27" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "35", "Subparagraph": "f", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_f_i&doctype=Standard", "URIDate": "2025-03-27" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "35", "Subparagraph": "f", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_f_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "35", "Subparagraph": "j", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_j_i&doctype=Standard", "URIDate": "2025-03-27" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35&doctype=Standard", "URIDate": "2025-03-27" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_37&doctype=Standard", "URIDate": "2025-03-27" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "43", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_43&doctype=Standard", "URIDate": "2025-03-27" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "64A", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_64A_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard", "URIDate": "2025-03-27" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "70", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_70&doctype=Standard", "URIDate": "2025-03-27" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "71", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_71&doctype=Standard", "URIDate": "2025-03-27" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "75", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_a&doctype=Standard", "URIDate": "2025-03-27" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "75", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_c&doctype=Standard", "URIDate": "2025-03-27" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "89", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_89&doctype=Standard", "URIDate": "2025-03-27" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "95", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_a&doctype=Standard", "URIDate": "2025-03-27" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "95", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_b&doctype=Standard", "URIDate": "2025-03-27" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "95", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95&doctype=Standard", "URIDate": "2025-03-27" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B10", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_iv&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B10", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B12", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B12&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B13", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B13&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B15", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B15&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B9", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2017-en-b&anchor=para_7&doctype=Standard&forcepdf=true", "URIDate": "2025-03-27" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "91", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2017-en-b&anchor=para_91_a&doctype=Standard&forcepdf=true", "URIDate": "2025-03-27" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "20", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_20_a_ii&doctype=Standard&book=b", "URIDate": "2025-03-27" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37&doctype=Standard&book=b", "URIDate": "2025-03-27" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard", "URIDate": "2025-03-27" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_a&doctype=Standard", "URIDate": "2025-03-27" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_b&doctype=Standard", "URIDate": "2025-03-27" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_i&doctype=Standard", "URIDate": "2025-03-27" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2025-03-27" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d&doctype=Standard", "URIDate": "2025-03-27" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106&doctype=Standard", "URIDate": "2025-03-27" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "107", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_107&doctype=Standard", "URIDate": "2025-03-27" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_117&doctype=Standard", "URIDate": "2025-03-27" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "125", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_125&doctype=Standard", "URIDate": "2025-03-27" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_35&doctype=Standard", "URIDate": "2025-03-27" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_a&doctype=Standard", "URIDate": "2025-03-27" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_c&doctype=Standard", "URIDate": "2025-03-27" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_d&doctype=Standard", "URIDate": "2025-03-27" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_e&doctype=Standard", "URIDate": "2025-03-27" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_g&doctype=Standard", "URIDate": "2025-03-27" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_i&doctype=Standard", "URIDate": "2025-03-27" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "m", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_m&doctype=Standard", "URIDate": "2025-03-27" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "n", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_n&doctype=Standard", "URIDate": "2025-03-27" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "o", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_o&doctype=Standard", "URIDate": "2025-03-27" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "p", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_p&doctype=Standard", "URIDate": "2025-03-27" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "q", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_q&doctype=Standard", "URIDate": "2025-03-27" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "54", "Subparagraph": "r", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_r&doctype=Standard", "URIDate": "2025-03-27" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard", "URIDate": "2025-03-27" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "56", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_56&doctype=Standard", "URIDate": "2025-03-27" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "61", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_61_a&doctype=Standard", "URIDate": "2025-03-27" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "61", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_61&doctype=Standard", "URIDate": "2025-03-27" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_66&doctype=Standard", "URIDate": "2025-03-27" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_69&doctype=Standard", "URIDate": "2025-03-27" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_7&doctype=Standard", "URIDate": "2025-03-27" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard", "URIDate": "2025-03-27" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2025-03-27" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a&doctype=Standard", "URIDate": "2025-03-27" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_a&doctype=Standard", "URIDate": "2025-03-27" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81A", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_b&doctype=Standard", "URIDate": "2025-03-27" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81A", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_c&doctype=Standard", "URIDate": "2025-03-27" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81B", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_a_i&doctype=Standard", "URIDate": "2025-03-27" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81B", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_a_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81B", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_b_i&doctype=Standard", "URIDate": "2025-03-27" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "81B", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_b_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_c&doctype=Standard", "URIDate": "2025-03-27" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_d&doctype=Standard", "URIDate": "2025-03-27" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82", "Subparagraph": "ea", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_ea&doctype=Standard", "URIDate": "2025-03-27" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82A&doctype=Standard", "URIDate": "2025-03-27" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "91", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_91_a&doctype=Standard", "URIDate": "2025-03-27" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "98", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_98_a&doctype=Standard", "URIDate": "2025-03-27" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "98", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_98_e&doctype=Standard", "URIDate": "2025-03-27" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "99", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_99&doctype=Standard", "URIDate": "2025-03-27" }, "r329": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "138", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138_a&doctype=Standard", "URIDate": "2025-03-27" }, "r330": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "138", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138_d&doctype=Standard", "URIDate": "2025-03-27" }, "r331": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "147", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_147_c&doctype=Standard", "URIDate": "2025-03-27" }, "r332": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "32", "IssueDate": "2025-01-01", "Paragraph": "IE33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2025-en-r&anchor=para_IE33&doctype=Illustrative%20Examples", "URIDate": "2025-03-27" }, "r333": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "36", "IssueDate": "2025-01-01", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_127&doctype=Standard", "URIDate": "2025-03-27" }, "r334": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "37", "IssueDate": "2025-01-01", "Paragraph": "70", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_70&doctype=Standard", "URIDate": "2025-03-27" }, "r335": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "37", "IssueDate": "2025-01-01", "Paragraph": "87", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_87&doctype=Standard", "URIDate": "2025-03-27" }, "r336": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "37", "IssueDate": "2025-01-01", "Section": "Example 10 A court case", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&doctype=Illustrative%20Examples&dita_xref=IAS37_IE_C_ex10_TI", "URIDate": "2025-03-27" }, "r337": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "37", "IssueDate": "2025-01-01", "Section": "Example 4 Refunds policy", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&doctype=Illustrative%20Examples&dita_xref=IAS37_IE_C_ex4_TI", "URIDate": "2025-03-27" }, "r338": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "14", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_14_b&doctype=Standard", "URIDate": "2025-03-27" }, "r339": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "14", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_14_f&doctype=Standard", "URIDate": "2025-03-27" }, "r340": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2025-03-27" }, "r341": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2025-03-27" }, "r342": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2025-03-27" }, "r343": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2025-03-27" }, "r344": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r345": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_94&doctype=Standard", "URIDate": "2025-03-27" }, "r346": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2025-01-01", "Paragraph": "IE60", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_IE60&doctype=Illustrative%20Examples", "URIDate": "2025-03-27" }, "r347": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Paragraph": "B89", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r348": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2025-01-01", "Paragraph": "B89", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r349": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53&doctype=Standard", "URIDate": "2025-03-27" }, "r350": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2025-03-27" }, "r351": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "96", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_96_b&doctype=Standard", "URIDate": "2025-03-27" }, "r352": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2025-01-01", "Paragraph": "96", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_96_c&doctype=Standard", "URIDate": "2025-03-27" }, "r353": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B64", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r354": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B64", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r355": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "IE72", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_IE72&doctype=Illustrative%20Examples", "URIDate": "2025-03-27" }, "r356": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "35N", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35N&doctype=Standard", "URIDate": "2025-03-27" }, "r357": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "B11", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B11&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r358": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "B35", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r359": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "B35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B35&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r360": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "IG31A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance", "URIDate": "2025-03-27" }, "r361": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23&doctype=Standard", "URIDate": "2025-03-27" }, "r362": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2025-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2025-03-27" }, "r363": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "103", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_a&doctype=Standard", "URIDate": "2025-03-27" }, "r364": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "103", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_b&doctype=Standard", "URIDate": "2025-03-27" }, "r365": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "115", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115&doctype=Standard", "URIDate": "2025-03-27" }, "r366": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "251", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_251&doctype=Standard", "URIDate": "2025-03-27" }, "r367": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "35", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_g&doctype=Standard", "URIDate": "2025-03-27" }, "r368": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35&doctype=Standard", "URIDate": "2025-03-27" }, "r369": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B9", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_b&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r370": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Effective 2027-01-01", "Name": "IFRS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "B9", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r371": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_102&doctype=Standard", "URIDate": "2025-03-27" }, "r372": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard", "URIDate": "2025-03-27" }, "r373": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_108&doctype=Standard", "URIDate": "2025-03-27" }, "r374": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "68", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_68&doctype=Standard", "URIDate": "2025-03-27" }, "r375": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_b&doctype=Standard", "URIDate": "2025-03-27" }, "r376": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard", "URIDate": "2025-03-27" }, "r377": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "82A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82A&doctype=Standard", "URIDate": "2025-03-27" }, "r378": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2025-03-27" }, "r379": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r380": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r381": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r382": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r384": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r385": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r386": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r388": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r389": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r390": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "12", "IssueDate": "2025-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2025-03-27" }, "r391": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2025-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2025-03-27" }, "r392": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2025-01-01", "Paragraph": "135", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_135_b&doctype=Standard", "URIDate": "2025-03-27" }, "r393": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_iv&doctype=Standard", "URIDate": "2025-03-27" }, "r394": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "118", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118&doctype=Standard", "URIDate": "2025-03-27" }, "r395": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2025-01-01", "Paragraph": "119", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_119&doctype=Standard", "URIDate": "2025-03-27" }, "r396": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "14", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_14&doctype=Standard", "URIDate": "2025-03-27" }, "r397": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16&doctype=Standard", "URIDate": "2025-03-27" }, "r398": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17&doctype=Standard", "URIDate": "2025-03-27" }, "r399": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "20", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2025-03-27" }, "r400": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "20", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2025-03-27" }, "r401": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20&doctype=Standard", "URIDate": "2025-03-27" }, "r402": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard", "URIDate": "2025-03-27" }, "r403": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard", "URIDate": "2025-03-27" }, "r404": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "3", "IssueDate": "2025-01-01", "Paragraph": "B64", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B", "URIDate": "2025-03-27" }, "r405": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "5", "IssueDate": "2025-01-01", "Paragraph": "33", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_d&doctype=Standard", "URIDate": "2025-03-27" }, "r406": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "39", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_39&doctype=Standard", "URIDate": "2025-03-27" }, "r407": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "7", "IssueDate": "2025-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard", "URIDate": "2025-03-27" }, "r408": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_10_e&doctype=Standard", "URIDate": "2025-03-27" }, "r409": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d&doctype=Standard", "URIDate": "2025-03-27" }, "r410": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_112_c&doctype=Standard", "URIDate": "2025-03-27" }, "r411": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "20", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_20_d&doctype=Standard", "URIDate": "2025-03-27" }, "r412": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard", "URIDate": "2025-03-27" }, "r413": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_b&doctype=Standard", "URIDate": "2025-03-27" }, "r414": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "78", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78&doctype=Standard", "URIDate": "2025-03-27" }, "r415": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a&doctype=Standard", "URIDate": "2025-03-27" }, "r416": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expiry date 2027-01-01", "Name": "IAS", "Number": "1", "IssueDate": "2025-01-01", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_85&doctype=Standard", "URIDate": "2025-03-27" } } }